Days At A Glance Speakers Posters Session Type Search
Type

    07:30 - 20:00 
    REGISTRATION OPEN
    09:00 - 09:30 
    COFFEE
    09:30 - 12:00 
    Clinical Update 1
    Osteoporosis in premenopausal women and men
    Auditorium II
    Chairs: Serge Ferrari (Geneva, Switzerland) & Jaime da Cunha Branco (Lisbon, Portugal)
    CU1.1
    Clinical Update 1
    Osteoporosis in premenopausal women
    CU1.2
    Clinical Update 1
    Management of osteoporosis in premenopausal women
    Sheffield, UK
    CU1.3
    Clinical Update 1
    Male osteoporosis
    Gothenburg, Sweden
    CU1.4
    Clinical Update 1
    Medical management of Osteoporosis in men
    Leuven, Belgium
    CU1.5
    Clinical Update 1
    Glucocorticoid-induced osteoporosis
    Southampton, UK
    12:00 - 12:30 
    LUNCH
    12:30 - 15:05 
    Clinical Update 2
    Inflammatory disease and bone
    Auditorium II
    Chairs: Piet Geusens (Diepenbeek, Belgium) & Willem Lems (Amsterdam, The Netherlands)
    CU2.1
    Clinical Update 2
    Osteo-immunology, the basic concepts
    Erlangen, Germany
    CU2.2
    Clinical Update 2
    Osteoporosis and fragility fractures in rheumatoid arthritis
    Oslo, Norway
    CU2.3
    Clinical Update 2
    Osteoporosis in SLE
    Amsterdam, The Netherlands
    CU2.4
    Clinical Update 2
    Osteoporosis in ankylosing spondylitis
    Paris, France
    CU2.5
    Clinical Update 2
    The effect of anti-inflammatory treatments (except GC) on bone
    Amsterdam, The Netherlands
    12:30 - 13:40 
    Allied Health Professionals (AHP) Session
    Auditorium III
    Chairs: Margaret Paggiosi (Sheffield, UK) & Andrea Marques (Coimbra, Portugal)
    Allied Health Professionals (AHP) Session
    Introduction to the highlights of the meeting
    Coimbra, Portugal
    AHP1.2
    Allied Health Professionals (AHP) Session
    Compliance with Osteoporosis: Can we improve patient understanding through education?
    Barcelona, Spain
    13:30 - 13:45 
    Coffee Break
    13:45 - 15:00 
    Allied Health Professionals (AHP) Session continued
    AHP1.3
    Allied Health Professionals (AHP) Session continued
    Could compliance be improved through monitoring?
    Sheffield, UK
    PP439
    Allied Health Professionals (AHP) Session continued
    Abstract presentation - The Direct And Indirect Costs Of An Osteoporotic Fracture: A Prospective Evaluation Of Elderly Patients With A Clinical Fracture
    Amsterdam, The Netherlands
    PP450
    Allied Health Professionals (AHP) Session continued
    Abstract Presentation - Transdermal Delivery of BA058, A Novel Analog of hPTHrP (1-34), with a Short Wear Time Patch in Preclinical and Clinical Studies
    MA, USA
    PP286
    Allied Health Professionals (AHP) Session continued
    Abstract Presentation - Muscle function and quality of life in primary hyperparathyroidism
    PP111
    Allied Health Professionals (AHP) Session continued
    Abstract Presentation - The effect of gastric bypass treatment for obesity on hormones related to bone re-modeling and intestinal growth
    Copenhagen, Denmark
    15:00 - 15:30 
    BREAK
    15:30 - 17:00 
    Satellite Symposium - Treatment of Severe Osteoporosis: an update - supported by Lilly
    Supported by Lilly
    Auditorium I
    Satellite Symposium - Treatment of Severe Osteoporosis: an update - supported by Lilly
    Welcome & Introductions
    Satellite Symposium - Treatment of Severe Osteoporosis: an update - supported by Lilly
    Epidemiology of Fragility Fractures: an update
    Southampton, UK
    Satellite Symposium - Treatment of Severe Osteoporosis: an update - supported by Lilly
    Effects of Bone Active Agents on Cortical Bone
    Satellite Symposium - Treatment of Severe Osteoporosis: an update - supported by Lilly
    Role of Gender and Etiology in the Response to Bone Active Agents in Patients with Osteoporosis
    Hamilton, Canada
    Satellite Symposium - Treatment of Severe Osteoporosis: an update - supported by Lilly
    Q & A and Closing Remarks
    17:00 - 17:15 
    BREAK
    17:15 - 19:15 
    Opening Ceremony
    Auditorium I
    Opening Ceremony
    Welcome to the congress from the ECTS President
    Aarhus, Denmark
    Opening Ceremony
    Welcome to Lisbon from the Chair of the Local Organising Committee
    Lisbon, Portugal
    17:30 - 19:00 
    Opening Ceremony: ECTS 50th Anniversary Symposium: 50 years of research in bone and mineral metabolism
    Supported by Amgen in collaboration with GSK
    OPC1
    Opening Ceremony: ECTS 50th Anniversary Symposium: 50 years of research in bone and mineral metabolism
    50 years of progress in bone biology
    Boston, USA
    OPC2
    Opening Ceremony: ECTS 50th Anniversary Symposium: 50 years of research in bone and mineral metabolism
    50 years of progress in bone imaging
    San Francisco, USA
    OPC3
    Opening Ceremony: ECTS 50th Anniversary Symposium: 50 years of research in bone and mineral metabolism
    50 years of progress in treatment of bone diseases
    Oxford, UK
    19:00 - 19:15 
    Awards 1 - 2013 ECTS / AMGEN BONE BIOLOGY FELLOWSHIP, 2013 ECTS / THE ALLIANCE FOR BETTER BONE HEALTH (WARNER CHILCOTT AND SANOFI) IAIN T BOYLE AWARD, 2013 ECTS PHILIPPE BORDIER CLINICAL AWARD, 2013 ECTS MIKE HORTON BASIC/TRANSLATIONAL AWARD
    Auditorium I
    Awards 1 - 2013 ECTS / AMGEN BONE BIOLOGY FELLOWSHIP, 2013 ECTS / THE ALLIANCE FOR BETTER BONE HEALTH (WARNER CHILCOTT AND SANOFI) IAIN T BOYLE AWARD, 2013 ECTS PHILIPPE BORDIER CLINICAL AWARD, 2013 ECTS MIKE HORTON BASIC/TRANSLATIONAL AWARD
    2010 ECTS / SERVIER FELLOWSHIP,
    Lisbon, Portugal
    19:15 - 01:00 
    50th Anniversary Welcome Reception
    Following the Opening Ceremony, we are delighted to invite all delegates to attend the Anniversary Welcome Reception to help us celebrate our 50-year anniversary. Complimentary drinks and refreshments and entertainment will be available, continuing with a pay bar into the late evening.
    LISBON CONGRESS CENTRE

    07:30 - 19:30 
    REGISTRATION OPEN
    08:00 - 09:00 
    Symposium 1: Developmental origins of metabolic bone disease
    Auditorium I
    Chairs: Tim Spector (London, UK) & Jácome Bruges Armas (Porto, Portugal)
    S1.1
    Symposium 1: Developmental origins of metabolic bone disease
    Developmental epigenetics and the intrauterine origins of chronic disease
    Southampton, UK
    S1.2
    Symposium 1: Developmental origins of metabolic bone disease
    Maternal environment and intrauterine skeletal development
    Oxford, UK
    09:00 - 10:00 
    Plenary Orals 1
    Osteoporosis epidemiology and long term treatment complications
    Auditorium I
    Chairs: Bo Abrahamsen (Copenhagen, Denmark) & Katharina Jähn (Hamburg Germany)
    OC1.1
    Plenary Orals 1
    Disease-specific perception of fracture risk and incident fracture rates among postmenopausal women: findings from the Global Longitudinal Study of Osteoporosis in Women (GLOW)
    Bristol, UK
    OC1.2
    Plenary Orals 1
    Hip fractures and bone mineral density of the elderly - importance of serum 25-hydroxy vitamin D
    Reykjavik, Iceland
    OC1.3
    Plenary Orals 1
    Size at birth is not associated with risk of hip fracture. Results from two population-based cohorts
    Uppsala, Sweden
    OC1.4
    Plenary Orals 1
    Intake and serum levels of α-tocopherol in relation to fractures in elderly women and men
    OC1.5
    Plenary Orals 1
    Heart failure in patients treated with bisphosphonates
    Aalborg, Denmark
    OC1.6
    Plenary Orals 1
    Femur Geometrical Parameters in the Pathogenesis of Atypical Femur Fractures
    Montréal, Canada
    09:00 - 10:00 
    Plenary Orals 2
    Bone quality and fracture repair - animal models
    Auditorium II
    Chairs: Martine Cohen-Solal (Paris, France) & Joana Caetano-Lopes (Lisbon, Portugal)
    OC2.1
    Plenary Orals 2
    Treatment With Soluble Activin Type IIB-Receptor Improves Bone Mass And Strength In A Mouse Model Of Duchenne Muscular Dystrophy
    Turku, Finland
    OC2.2
    Plenary Orals 2
    Intermittent human parathyroid hormone (1-84) treatment improves bone mass and bone defect healing in rats with type 2 diabetes mellitus
    Dresden, Germany
    OC2.3
    Plenary Orals 2
    Low-magnitude high-frequency vibration (LMHFV) improves fracture healing in aged, ovariectomized mice
    Ulm, Germany
    OC2.4
    Plenary Orals 2
    PPAR beta deficiency induces muscle and bone loss with aging but does not impair the bone biomechanical response to loading: a sarco-osteopenic mouse model
    Geneva, Switzerland
    OC2.5
    Plenary Orals 2
    Glucagon-like peptide 1 receptor is required for optimal bone strength and quality
    Angers, France
    OC2.6
    Plenary Orals 2
    Growth hormone excess in bGH transgenic mice adversely affects bone density, architecture and quality
    London, UK
    10:00 - 11:00 
    COFFEE AND POSTERS
    11:00 - 12:30 
    Workshop 1: Fat and bone
    Auditorium I
    Chairs: João Eurico Fonseca (Lisbon, Portugal) & Barbara Obermayer-Pietsch (Graz, Austria)
    W1.1
    Workshop 1: Fat and bone
    Effects of fat on bone: location and age matter
    Sheffield, UK
    W1.2
    Workshop 1: Fat and bone
    Anorexia and bone
    Boston, USA
    W1.3
    Workshop 1: Fat and bone
    Obesity,bariatric surgery and bone
    11:00 - 12:30 
    Workshop 2: Developmental biology and bone
    Auditorium II
    Chairs: Tim Arnett (London, UK) & Andrea del Fattore
    W2.1
    Workshop 2: Developmental biology and bone
    Fish as a model organism for mineralization related pathologies
    Faro, Portugal
    W2.2
    Workshop 2: Developmental biology and bone
    Chondrocyte growth and differentiation during endochondral ossification
    Essen, Germany
    W2.3
    Workshop 2: Developmental biology and bone
    Bone shaping by muscle force during embryogenesis
    Rehovot, Israel
    12:30 - 13:45 
    LUNCH AND POSTERS
    12:45 - 13:45 
    Meet the Professor Parallel Sessions
    MTP1
    Meet the Professor Parallel Sessions
    ECTS Excellence in Research Lecture: Methods for assessing bone microstructure - AUDITORIUM III
    London, UK
    MTP2
    Meet the Professor Parallel Sessions
    The wnt signalling in and out of bone - AUDITORIUM IV
    Boston, USA
    MTP3
    Meet the Professor Parallel Sessions
    Epigenetic regulation: what and why? - Room 5A
    Southampton, UK
    MTP4
    Meet the Professor Parallel Sessions
    Fish as a model system for exploring skeletal development and regeneration - Room 5B
    Faro, Portugal
    MTP5
    Meet the Professor Parallel Sessions
    Mineralisation: the key role of extracellular ATP - Room 5C
    London, UK & Isabelle Orriss
    12:45 - 13:45 
    New Investigator Workshop 1
    Auditorium II
    Chair: Tim Spector (London, UK)
    NIW1
    New Investigator Workshop 1
    Genomics and proteomics as emerging technologies in bone research
    Rotterdam, The Netherlands
    13:45 - 14:45 
    Symposium 2: Sarcopenia – causes and consequences
    Joint Session with ASBMR
    Auditorium I
    Chairs: Steven Boonen (Leuven, Belgium) & José Melo-Gomes (Lisbon, Portugal)
    S2.1
    Symposium 2: Sarcopenia – causes and consequences
    Skeletal muscle loss: sarcopenia and inactivity
    Liverpool, UK
    S2.2
    Symposium 2: Sarcopenia – causes and consequences
    Sarcopenia: Prevalence and consequences
    Boston, USA
    14:45 - 15:00 
    Awards 2
    Previous Grant Winner Presentations
    Auditorium I
    Awards 2
    2010 ECTS POSTDOCTORAL FELLOWSHIP
    Zurich, Switzerland
    Awards 2
    2010 ECTS PHD STUDENTSHIP
    Aberdeen, UK
    Awards 2
    2010 ECTS CAREER ESTABLISHMENT AWARD
    15:00 - 16:00 
    Oral Posters 1: Pre-clinical
    Auditorium I
    Chairs: Miep Helfrich (Aberdeen, UK) & Sandra Casimiro (Lisbon, Portugal)
    OP21
    Oral Posters 1: Pre-clinical
    IGF-1 regulates MC-3T3 and human primary osteoblast to osteocyte differentiation in 3D culture
    Cardiff, UK
    OP22
    Oral Posters 1: Pre-clinical
    The Effect of mTORC1 on Postnatal Skeletal Development
    Adelaide, Australia
    OP23
    Oral Posters 1: Pre-clinical
    MEK inhibitors in fracture healing and NF1 pseudarthrosis
    OP24
    Oral Posters 1: Pre-clinical
    Identification and Characterization of a Mesenchymal Progenitor Cell Population Involved in Fracture Healing
    Farmington, USA
    OP25
    Oral Posters 1: Pre-clinical
    Oxygen tension-mediated regulation of chondrogenic differentiation: application to stem cells based osteochondral repair
    Nantes, France
    OP26
    Oral Posters 1: Pre-clinical
    Bone is the main target of activation of Canonical Wnt pathway in osteoarthritis
    Paris, France
    OP27
    Oral Posters 1: Pre-clinical
    Milk fat globule-epidermal growth factor 8 (MFG-E8) is a critical determinant of bone mass and alters the course of inflammation in arthritis
    Dresden, Germany
    OP28
    Oral Posters 1: Pre-clinical
    Functional assessment of Paget's disease-causing mutations in Sequestosome-1 (SQSTM1)
    Aberdeen, UK
    OP29
    Oral Posters 1: Pre-clinical
    miR-192 Impairs Invasion and Tumor-Induced Osteolysis by Repressing CCL2 in Bone Metastatic Colonization
    Pamplona, Spain
    OP30
    Oral Posters 1: Pre-clinical
    Clusterin Inhibition using OGX-011 Synergistically Enhances Zoledronic Acid Activity in Osteosarcoma.
    Nantes, France
    Oral Posters 1: Pre-clinical
    Q&A
    15:00 - 16:00 
    Oral Posters 1: Clinical
    Auditorium II
    Chairs: Robert Lindsay (West Haverstraw, USA) & Isabelle Orriss
    PP384
    Oral Posters 1: Clinical
    Does Vitamin D status impact on hip fracture incidence? - evidence of fracture variation with latitude and season in Sweden
    OP2
    Oral Posters 1: Clinical
    Meta-Analysis of the Effects of Vitamin D Supplements on Bone Mineral Density in Adults
    Auckland, New Zealand
    OP3
    Oral Posters 1: Clinical
    The risk of fractures in cirrhosis and chronic pancreatitis. A Danish nationwide retrospective matched cohort study
    Hvidovre, Denmark
    OP4
    Oral Posters 1: Clinical
    Relationship between bone mineral density, body composition, skin sclerosis and serum 25(OH) vitamin D levels in  systemic sclerosis
    Foggia, Italy
    PP22
    Oral Posters 1: Clinical
    Generalized Long Term Bone Loss in Early Rheumatoid Arthritis in the Biologic Treatment Era - A 10 Year prospective Observational Study
    Bærum, Norway
    OP6
    Oral Posters 1: Clinical
    Cortical and Trabecular Alterations in Patients with Bone Marrow Edema of the Lower Limb
    Vienna, Austria
    OP7
    Oral Posters 1: Clinical
    Bone Marrow Fat Is Metabolically Distinct Fat Depot
    OP8
    Oral Posters 1: Clinical
    Genome-Wide Association Study meta-analysis identifies the SOAT1/AXDND1 locus to be associated with hip and forearm fracture risk
    Umeå, Sweden
    OP9
    Oral Posters 1: Clinical
    Interaction between FGF23 R176W mutation and C716T nonsynonymous change (T239M, rs 7955866) in FGF23 on the clinical phenotype in a family with autosomal dominant hypophosphatemic rickets
    Siena, Italy
    OP10
    Oral Posters 1: Clinical
    Regional heterogeneity of trabecular bone microdamage density in association with trabecular microarchitecture and bone resorption in whole human lumbar vertebrae
    Paris, France
    Oral Posters 1: Clinical
    Q&A
    16:00 - 16:30 
    COFFEE
    16:30 - 18:00 
    Educational Symposium 1
    ECTS-OARSI joint educational symposium on Osteoarthritis.
    Supported by Biocientifica
    Auditorium II
    Chairs: Stuart Ralston & Virginia Kraus
    Educational Symposium 1
    Chair's Welcome
    ES1.1
    Educational Symposium 1
    Epidemiology
    Keele, UK
    ES1.2
    Educational Symposium 1
    Disease mechanisms
    Newcastle, UK
    ES1.3
    Educational Symposium 1
    Management of osteoarthritis
    Paris, France
    18:00 - 18:30 
    BREAK
    18:30 - 20:00 
    Satellite Symposium - Current and Future Strategies for the Management of Osteoporosis: Signaling a Change in the Conversation - Supported by MSD
    MSD
    Auditorium I
    Chair: Jose Antonio Melo-Gomes
    Satellite Symposium - Current and Future Strategies for the Management of Osteoporosis: Signaling a Change in the Conversation - Supported by MSD
    Welcome & Introductions
    Satellite Symposium - Current and Future Strategies for the Management of Osteoporosis: Signaling a Change in the Conversation - Supported by MSD
    Optimizing Therapy in Osteoporosis
    Paris, France
    Satellite Symposium - Current and Future Strategies for the Management of Osteoporosis: Signaling a Change in the Conversation - Supported by MSD
    The Impact of Selective Cathepsin K Inhibition on Bone Homeostatis
    Boston, USA
    Satellite Symposium - Current and Future Strategies for the Management of Osteoporosis: Signaling a Change in the Conversation - Supported by MSD
    Odanacatib: A Novel Approach to the Treatment of Osteoporosis
    Melbourne, Australia
    Satellite Symposium - Current and Future Strategies for the Management of Osteoporosis: Signaling a Change in the Conversation - Supported by MSD
    Q & A and Closing Remarks
    20:00 - 22:00 
    ECTS New Investigator Seminar and Social Gathering
    Auditorium II
    Chairs: Riku Kiviranta & Andrea del Fattore & Davide Ruffoni
    ECTS New Investigator Seminar and Social Gathering
    Plenary Session: Bone Research – The Next 50 Years
    Boston, USA
    ECTS New Investigator Seminar and Social Gathering
    Plenary Session: Bone Research – The Next 50 Years
    San Francisco, USA
    ECTS New Investigator Seminar and Social Gathering
    Plenary Session: Bone Research – The Next 50 Years
    Oxford, UK
    PP27
    ECTS New Investigator Seminar and Social Gathering
    Sclerostin/MEPE axis in OA: lessons from long bone development
    Edinburgh, Scotland
    PP31
    ECTS New Investigator Seminar and Social Gathering
    A GWAS in an extreme high bone mass population shows exess signal from genes associated with BMD in normal population
    Bristol, UK
    PP38
    ECTS New Investigator Seminar and Social Gathering
    Bisphosphonate influence on bone quality at molecular level: study of human jaw bone sequesters by Raman microspectroscopy
    Lille, France
    PP139
    ECTS New Investigator Seminar and Social Gathering
    New PI3Kalpha-specific inhibitor, BYL719: therapeutic interest in osteosarcoma
    NANTES cedex, France
    PP175
    ECTS New Investigator Seminar and Social Gathering
    Identification of a small molecule kinase inhibitor that enhances osteoblast differentiation of human skeletal (mesenchymal) stem cells through regulation of TGFβ signaling
    Odense C, Denmark
    PP230
    ECTS New Investigator Seminar and Social Gathering
    Depletion of the autophagy adaptor OPTN leads to increased osteoclast formation, fusion and survival as well as increase NF-κB activation in vitro
    Edinburgh, UK
    PP282
    ECTS New Investigator Seminar and Social Gathering
    Phenotypic dissection of bone mineral density facilitates the identification of skeletal site specificity on the genetic regulation of bone
    (Bristol, UK)
    PP383
    ECTS New Investigator Seminar and Social Gathering
    Detection of autoantibodies to osteoprotegerin in patients with rheumatoid arthritis and their association with disease activity
    Edinburgh, UK

    07:30 - 19:30 
    REGISTRATION OPEN
    08:00 - 09:00 
    Symposium 3: Extreme bone phenotypes
    Auditorium I
    Chairs: Anna Teti (L’Aquila, Italy) & Jirko Kuehnisch
    S3.1
    Symposium 3: Extreme bone phenotypes
    Diagnosis and clinical management of of genetic skeletal disorders
    Istanbul, Turkey
    S3.2
    Symposium 3: Extreme bone phenotypes
    Insights from research in bone genetics: what do genetic skeletal disorders tell us on bone physiology?
    Lausanne, Switzerland
    09:00 - 10:00 
    Plenary Orals 3
    Osteoporosis pathophysiology and genetics
    Auditorium I
    Chairs: Andre Uitterlinden (Rotterdam, The Netherlands) & Ana Maria Rodrigues (Lisbon, Portugal)
    OC3.1
    Plenary Orals 3
    Heavy cannabis use negatively impacts on bone density - a population based prospective study
    Edinburgh, UK
    PP277
    Plenary Orals 3
    A genomic and transcriptomic approach to the high bone mass phenotype: evidence of heterogeneity and of additive effects of TWIST1, IL6R, DLX3 and PPARG
    Barcelona, Spain
    OC3.3
    Plenary Orals 3
    Distinct relationships of intramuscular and subcutaneous fat with cortical bone: findings from a cross-sectional study of young adult males and females
    Bristol, UK
    OC3.4
    Plenary Orals 3
    Cortical exceeds trabecular bone loss before menopause but net bone loss is modest because periosteal apposition occurs
    Tromsø, Norway
    OC3.5
    Plenary Orals 3
    Genome-wide association identifies a new susceptibility locus at 4q35 associated with clinical vertebral fractures in post-menopausal women: The GEFOS-GENOMOS consortium.
    Edinburgh, UK
    OC3.6
    Plenary Orals 3
    Causal metabolomic pathways to osteoporosis in elderly women
    London, UK
    09:01 - 10:00 
    Plenary Orals 4
    Osteoblasts and osteocytes
    Auditorium II
    OC4.1
    Plenary Orals 4
    High-Throughput DEXA and MicroCT Screening in Gene Knockout Mice Identifies Bone Mass Phenotypes
    Texas, USA
    OC4.2
    Plenary Orals 4
    The p38alpha MAPK pathway in osteoblasts contributes to ovariectomy-induced bone loss by upregulating interleukin-6 expression
    Geneva, Switzerland
    OC4.3
    Plenary Orals 4
    Severe osteopenia, increased bone marrow adipogenesis and fibronectin matrix changes in mice lacking both TG2 and FXIIIA transglutaminases
    Montreal, Canada
    OC4.4
    Plenary Orals 4
    Glucocorticoid exposure reduces expression of sclerostin in bone marrow stromal cells
    Dresden, Germany
    OC4.5
    Plenary Orals 4
    Mechanical loading increases the effect of sclerostin antibody treatment in a mouse model of high turnover osteoporosis
    Zurich, Switzerland
    OC4.6
    Plenary Orals 4
    Periostin (Postn) synergizes with osteocytes beta-catenin to mediate the adaptive skeletal response to loading
    Geneva, Switzerland
    10:00 - 11:00 
    COFFEE AND POSTERS
    10:00 - 11:00 
    AGM
    Auditorium I
    11:00 - 12:30 
    Workshop 3: Vertebral fractures
    Auditorium I
    Chairs: Richard Eastell (Sheffield, UK) & José António Pereira Silva (Coimbra, Portugal)
    W3.1
    Workshop 3: Vertebral fractures
    The impact of vertebral fractures on morbidity and mortality
    Barcelona, Spain
    W3.2
    Workshop 3: Vertebral fractures
    How are vertebral fractures best detected and diagnosed?
    (Bristol, UK)
    W3.3
    Workshop 3: Vertebral fractures
    Treatment of vertebral fractures
    Lisbon, Portugal
    11:00 - 12:30 
    Workshop 4: Osteoclast activity and haematopoiesis
    Auditorium II
    Chairs: Hans van Leeuwen (Rotterdam, The Netherlands) & Ines Perpetuo (Lisbon, Portugal)
    W4.1
    Workshop 4: Osteoclast activity and haematopoiesis
    The relationship between osteoclasts and haematopoiesis
    London, UK
    W4.2
    Workshop 4: Osteoclast activity and haematopoiesis
    Are osteoclasts dispensable for haematopoietic stem cell maintenance and mobilization?
    Nice, France
    W4.3
    Workshop 4: Osteoclast activity and haematopoiesis
    Osteoclasts and haematopoietic stem cell transplantation in clinical practice
    Ulm, Germany
    12:30 - 13:45 
    LUNCH AND POSTERS
    12:45 - 13:45 
    Meet the Professor Sessions
    MTP6
    Meet the Professor Sessions
    Bone Pain - Auditorium III
    Copenhagen, Denmark
    MTP7
    Meet the Professor Sessions
    Clinical utility of bone turnover markers - Auditorium IV
    MTP8
    Meet the Professor Sessions
    What does bone genetics tell us on bone physiology - Room 5A
    Edinburgh, UK
    MTP9
    Meet the Professor Sessions
    Failure of osteoporosis treatment - Room 5B
    Barcelona, Spain
    MTP10
    Meet the Professor Sessions
    New osteoporosis treatment modalities - Room 5C
    Lisbon, Portugal
    12:45 - 13:45 
    New Investigator Workshop 2
    Auditorium II
    NIW2
    New Investigator Workshop 2
    How to manage your research time and team
    Huddinge, Sweden
    13:45 - 15:00 
    ECTS / ASBMR Clinical Debate: This house believes that muscle, not bone, is the preferred target to reduce non-vertebral fractures
    Auditorium I
    Chairs: Bente Langdahl (Aarhus, Denmark) & Jane Lian (Burlington, USA)
    ECTS / ASBMR Clinical Debate: This house believes that muscle, not bone, is the preferred target to reduce non-vertebral fractures
    Against the Motion
    ECTS / ASBMR Clinical Debate: This house believes that muscle, not bone, is the preferred target to reduce non-vertebral fractures
    In Support of the Motion
    15:00 - 16:00 
    Oral Posters 2: Pre-clinical
    Auditorium II
    Chairs: Peter Croucher (Sydney, Australia) & Inês Perpétuo (Lisbon, Portugal)
    OP31
    Oral Posters 2: Pre-clinical
    ADIPOGENESIS OCCURS AT THE EXPENSE OF OSTEOBLAST DIFFERENTIATION IN PRIMARY OSTEOBLASTS DEFICIENT IN PROTEASE-ACTIVATED RECEPTOR-2
    Parkville, Australia
    OP32
    Oral Posters 2: Pre-clinical
    Hepatic lipase is expressed by osteoblasts and modulates bone remodeling in obesity
    OP33
    Oral Posters 2: Pre-clinical
    Regulation and function of immunosuppressive molecule human leukocyte antigen G5 in human bone tissue
    Toulouse, France
    OP34
    Oral Posters 2: Pre-clinical
    Activation of the Parathyroid Hormone-Receptor is Involved in the Pro-survival Effect of Hypotonic Shock in Osteocyte-like MLO-Y4 Cells
    Madrid, Spain
    OP35
    Oral Posters 2: Pre-clinical
    Effects of a mutated sclerostin peptide on bone and lean mass in mice.
    Geneva, Switzerland
    OP36
    Oral Posters 2: Pre-clinical
    N-Cadherin Governs Age-Related Determination in Mice Through Modulation of Wnt5a and Wnt10b.
    Paris, France
    OP37
    Oral Posters 2: Pre-clinical
    The D477N mutation in OPTN leads to increased bone turnover and enhanced osteoclast formation in OptnD477N/D477N mice
    Edinburgh, UK
    OP38
    Oral Posters 2: Pre-clinical
    BMP-9 induces the calcification of vascular smooth muscle cells.
    Edinburgh, UK
    OP39
    Oral Posters 2: Pre-clinical
    Thrombin receptor deficiency leads to osteopetrosis by decreasing the RANKL/OPG ratio
    OP40
    Oral Posters 2: Pre-clinical
    Insertion of the clcn7 gene mutation pG213R in mouse induces Autosomal Dominant Osteopetrosis Type II (ADO2).
    Rome, Italy
    15:00 - 16:00 
    Oral Posters 2: Clinical
    Auditorium I
    Chairs: Jon Tobias (Bristol, UK) & Nerea Alonso Lopez
    OP11
    Oral Posters 2: Clinical
    Health economic consequences of fractures in patients with osteoporosis: A national register based study of total and incremental health costs following fracture.

    Unknown speaker

    Holbæk, Denmark
    OP12
    Oral Posters 2: Clinical
    Fracture Risk Assessment In A Primary Care Population: Case Finding Using Routine GP Data and a health reporting, analysis & intelligence delivery tool, In The United Kingdom
    Newcastle upon Tyne, UK
    OP13
    Oral Posters 2: Clinical
    Hip Fracture Trends in Denmark 1980-2010 with Age-Period-Cohort-effects
    Malmo, Sweden
    OP14
    Oral Posters 2: Clinical
    Impact of hip fracture on mortality and life expectancy
    OP15
    Oral Posters 2: Clinical
    Fracture risk among men, in relation to osteopenia and osteoporosis defined by areal bone mineral density.
    Geelong, Australia
    OP16
    Oral Posters 2: Clinical
    Long-term effects of symptomatic versus intensive bisphosphonate therapy for Paget's disease of bone: The PRISM-EZ study.
    Edinburgh, UK
    OP17
    Oral Posters 2: Clinical
    Denosumab is associated with progressive improvements in hip cortical mass and thickness
    Zug, Switzerland
    OP18
    Oral Posters 2: Clinical
    Effects of Odanacatib on BMD and Safety in the Treatment of Osteoporosis in Postmenopausal Women Previously Treated with Alendronate- A Randomized Placebo-Controlled trial
    OP19
    Oral Posters 2: Clinical
    Effects of Sclerostin Antibody and Maintenance of New Bone Induced by Sclerostin Antibody in Animal Models
    Thousand Oaks, USA
    OP20
    Oral Posters 2: Clinical
    Resolution of Effects on Bone Turnover Markers and Bone Mineral Density after Discontinuation of Long-term Bisphosphonate Use 
    North Wales, USA
    16:00 - 16:30 
    COFFEE
    16:30 - 18:00 
    Educational Symposium 2
    Approach to the finding of abnormal laboratory results
    Supported by Alexion & IDS
    Auditorium II
    Chairs: Núria Guañabens (Barcelona, Spain) & Martina Rauner
    ES2.1
    Educational Symposium 2
    Low alkaline phosphatase
    St Louis, USA
    ES2.2
    Educational Symposium 2
    Low phosphate
    Tokushima, Japan
    ES2.3
    Educational Symposium 2
    Low vitamin D
    18:00 - 18:30 
    BREAK
    18:30 - 20:00 
    Satellite Symposium - New evidence for osteoporosis therapy - Supported by Amgen in collaboration with GSK
    Including panel discussion
    Supported by Amgen in collaboration with GSK
    Auditorium I
    Chairs: Bente Langdahl (Aarhus, Denmark) & Jose Pereira Da Silva (Coimbra, Portugal)
    Satellite Symposium - New evidence for osteoporosis therapy - Supported by Amgen in collaboration with GSK
    Denosumab : valuable for my patients at increased risk for hip fracture?
    Leuven, Belgium
    Satellite Symposium - New evidence for osteoporosis therapy - Supported by Amgen in collaboration with GSK
    What is the relevance for BMD increase in fracture risk reduction?
    Satellite Symposium - New evidence for osteoporosis therapy - Supported by Amgen in collaboration with GSK
    Transitioning osteoporosis therapies: what is the evidence?
    Vienna, Austria

    07:30 - 17:00 
    REGISTRATION OPEN
    08:00 - 09:00 
    Symposium 4: Energy metabolism and bone
    Auditorium I
    Chairs: Lorenz Hofbauer (Dresden, Germany) & Astrid Bakker
    S4.1
    Symposium 4: Energy metabolism and bone
    Energy metabolism, bone and reproduction
    S4.2
    Symposium 4: Energy metabolism and bone
    Sweet bones - the effect of diabetes on bone
    09:00 - 10:00 
    Orals 5 - Treatment of osteoporosis
    Auditorium I
    Chairs: John Eisman (Sydney, Australia) & Ana Maria Rodrigues
    OC5.1
    Orals 5 - Treatment of osteoporosis
    A Three Year Randomized Sham-Controlled Trial of Low Magnitude Mechanical Stimulation in an Elderly Sample:  The "VIBES" Trial
    Boston, USA
    OC5.2
    Orals 5 - Treatment of osteoporosis
    Fracture Risk Factors During Treatment With Denosumab
    OC5.3
    Orals 5 - Treatment of osteoporosis
    Effect of blosozumab on bone mineral density: Results of a Phase 2 study of postmenopausal women with low bone mineraly density
    indianapolis, USA
    OC5.4
    Orals 5 - Treatment of osteoporosis
    Effects of Romosozumab Administration on Trabecular and Cortical Bone Assessed With Quantitative Computed Tomography and Finite Element Analysis
    Thousand Oaks, USA
    OC5.5
    Orals 5 - Treatment of osteoporosis
    Bone Anabolic Efficacy and Safety of BA058, A Novel Analog of hPTHrP: 12 Month Extension Data from a Phase 2 Clinical Trial in Postmenopausal Women with Osteoporosis
    MA, USA
    OC5.6
    Orals 5 - Treatment of osteoporosis
    Testosterone Replacement has a Substantial Benefit on Bone Mass, Fracture Incidence, Libido and Sexual Activities in Male Cardiac Transplant Patients: A 5 Year Randomized Prospective Controlled Trial
    Graz, Austria
    09:00 - 10:00 
    Orals 6 - Mineralisation and energy metabolism
    Auditorium II
    Chairs: Graham Russell (Oxford, UK) & Eugénia Simões (Lisbon, Portugal)
    OC6.1
    Orals 6 - Mineralisation and energy metabolism
    NPP1 (ecto-nucleotide pyrophosphatase/phosphodiesterase 1) is a key regulator of skeletal and soft tissue mineralisation
    London, UK
    OC6.2
    Orals 6 - Mineralisation and energy metabolism
    Deficiency of the bone mineralisation inhibitor NPP1 protects against obesity and diabetes
    Paisley, UK
    OC6.3
    Orals 6 - Mineralisation and energy metabolism
    Collagen XV as a bone matrix organizer
    Oulu, Finland
    OC6.4
    Orals 6 - Mineralisation and energy metabolism
    Inhibition of PTH-induced vasorelaxation modulates its anabolic action
    London, UK
    OC6.5
    Orals 6 - Mineralisation and energy metabolism
    A protective role for FGF23 in local defence against disrupted arterial wall integrity?
    Edinburgh, UK
    OC6.6
    Orals 6 - Mineralisation and energy metabolism
    An Emerging Role of PHOSPHO1 in the Regulation of Energy Metabolism 
    Midlothian, UK
    10:00 - 11:15 
    COFFEE AND POSTERS
    11:15 - 12:45 
    Workshop 5: Anabolic bone therapies
    Auditorium I
    Chairs: Roland Baron (Boston, USA) & Eric Hesse
    W5.1
    Workshop 5: Anabolic bone therapies
    The effect of PTH on fracture healing
    Graz, Austria
    W5.2
    Workshop 5: Anabolic bone therapies
    Wnt signaling - a clinical drug target
    Boston, USA
    W5.3
    Workshop 5: Anabolic bone therapies
    Therapeutic targeting of activin signaling
    Rotterdam, Netherlands
    11:15 - 12:45 
    Workshop 6: Cancer cells and Bone
    Auditorium II
    Chairs: Aymen Idris (Edinburgh, UK) & Hanna Taipaleenmaeki
    W6.1
    Workshop 6: Cancer cells and Bone
    How do cancer cells home to bone?
    Sydney, Australia
    W6.2
    Workshop 6: Cancer cells and Bone
    Biology and clinical relevance of circulating tumour cells
    Hamburg, Germany
    W6.3
    Workshop 6: Cancer cells and Bone
    Clinical decision making in metastatic bone disease
    Marburg, Germany
    12:45 - 14:00 
    LUNCH AND POSTERS
    13:00 - 14:00 
    Meet the Professor Sessions
    MTP11
    Meet the Professor Sessions
    Long-term treatment of osteoporosis - Auditorium III
    MTP12
    Meet the Professor Sessions
    Breast cancer treatment induced osteoporosis - pathophysiology, prevention and treatment - Auditorium IV
    Marburg, Germany
    MTP13
    Meet the Professor Sessions
    Arthritis, inflammation and bone: from bench to bedside - Room 5A
    Lisboa, Portugal
    MTP14.1
    Meet the Professor Sessions
    ERC Grants - Room 5B
    Edinburgh, UK
    MTP14.2
    Meet the Professor Sessions
    EU-Funding - Room 5B
    Lisbon, Portugal
    MTP15
    Meet the Professor Sessions
    State-of the-Art techniques in Bone research - Room 5C
    Lisbon, Portugal
    13:00 - 14:00 
    New Investigator Workshop 3
    Auditorium II
    NIW3
    New Investigator Workshop 3
    How to get started as a posdoc
    Dresden, Germany
    14:00 - 15:00 
    Symposium 5: Uncoupling of resorption and formation
    Auditorium I
    Chairs: Viviana Tavares (Lisbon, Portugal) & Erik Fink Eriksen (Oslo, Norway)
    S5.1
    Symposium 5: Uncoupling of resorption and formation
    Novel antiresorptives - uncoupling or not?
    Toyko, Japan
    S5.2
    Symposium 5: Uncoupling of resorption and formation
    Effects of cathepsin K inhibition
    Sydney, Australia
    15:00 - 15:30 
    Closing Ceremony & Awards 3 - including 2013 ECTS NEW INVESTIGATOR AWARDS, 2013 ECTS ANNIVERSARY TRAVEL GRANTS, 2013 ECTS TRAVEL AWARDS, 2013 ECTS ALLIED HEALTH AWARD
    Auditorium I
Saba Abdulghani
Lisbon, Portugal
Sat 18
Awards 1 - 2013 ECTS / AMGEN BONE BIOLOGY FELLOWSHIP, 2013 ECTS / THE ALLIANCE FOR BETTER BONE HEALTH (WARNER CHILCOTT AND SANOFI) IAIN T BOYLE AWARD, 2013 ECTS PHILIPPE BORDIER CLINICAL AWARD, 2013 ECTS MIKE HORTON BASIC/TRANSLATIONAL AWARD
2010 ECTS / SERVIER FELLOWSHIP,
Lisbon, Portugal
Bo Abrahamsen
Holbæk, Denmark
Mon 20 15:00
OP11
Oral Posters 2: Clinical
Health economic consequences of fractures in patients with osteoporosis: A national register based study of total and incremental health costs following fracture.

Unknown speaker

Holbæk, Denmark
Yasmine Alanay
Istanbul, Turkey
Mon 20 08:00
S3.1
Symposium 3: Extreme bone phenotypes
Diagnosis and clinical management of of genetic skeletal disorders
Istanbul, Turkey
Omar Albagha
Edinburgh, UK
Tue 21 13:00
MTP14.1
Meet the Professor Sessions
ERC Grants - Room 5B
Edinburgh, UK
Tim Arnett
London, UK & Isabelle Orriss
Sun 19 12:45
MTP5
Meet the Professor Parallel Sessions
Mineralisation: the key role of extracellular ATP - Room 5C
London, UK & Isabelle Orriss
Terry Aspray
Newcastle upon Tyne, UK
Mon 20 15:05
OP12
Oral Posters 2: Clinical
Fracture Risk Assessment In A Primary Care Population: Case Finding Using Routine GP Data and a health reporting, analysis & intelligence delivery tool, In The United Kingdom
Newcastle upon Tyne, UK
Eman Azzam
Aberdeen, UK
Sun 19
Awards 2
2010 ECTS PHD STUDENTSHIP
Aberdeen, UK
Sun 19 15:35
OP28
Oral Posters 1: Pre-clinical
Functional assessment of Paget's disease-causing mutations in Sequestosome-1 (SQSTM1)
Aberdeen, UK
Susana Balcells
Barcelona, Spain
Mon 20 09:10
PP277
Plenary Orals 3
A genomic and transcriptomic approach to the high bone mass phenotype: evidence of heterogeneity and of additive effects of TWIST1, IL6R, DLX3 and PPARG
Barcelona, Spain
Ulrich Bang
Hvidovre, Denmark
Sun 19 15:10
OP3
Oral Posters 1: Clinical
The risk of fractures in cirrhosis and chronic pancreatitis. A Danish nationwide retrospective matched cohort study
Hvidovre, Denmark
Roland Baron
Boston, USA
Sat 18 17:30
OPC1
Opening Ceremony: ECTS 50th Anniversary Symposium: 50 years of research in bone and mineral metabolism
50 years of progress in bone biology
Boston, USA
Sun 19 18:55
Satellite Symposium - Current and Future Strategies for the Management of Osteoporosis: Signaling a Change in the Conversation - Supported by MSD
The Impact of Selective Cathepsin K Inhibition on Bone Homeostatis
Boston, USA
Sun 19 20:00
ECTS New Investigator Seminar and Social Gathering
Plenary Session: Bone Research – The Next 50 Years
Boston, USA
Claude Benhamou
North Wales, USA
Mon 20 15:45
OP20
Oral Posters 2: Clinical
Resolution of Effects on Bone Turnover Markers and Bone Mineral Density after Discontinuation of Long-term Bisphosphonate Use 
North Wales, USA
Charles Benson
indianapolis, USA
Tue 21 09:20
OC5.3
Orals 5 - Treatment of osteoporosis
Effect of blosozumab on bone mineral density: Results of a Phase 2 study of postmenopausal women with low bone mineraly density
indianapolis, USA
Åshild Bjørnerem
Tromsø, Norway
Mon 20 09:30
OC3.4
Plenary Orals 3
Cortical exceeds trabecular bone loss before menopause but net bone loss is modest because periosteal apposition occurs
Tromsø, Norway
Claudine Blin-Wakkach
Nice, France
Mon 20 11:30
W4.2
Workshop 4: Osteoclast activity and haematopoiesis
Are osteoclasts dispensable for haematopoietic stem cell maintenance and mobilization?
Nice, France
Nicolas Bonnet
Geneva, Switzerland
Sun 19 09:30
OC2.4
Plenary Orals 2
PPAR beta deficiency induces muscle and bone loss with aging but does not impair the bone biomechanical response to loading: a sarco-osteopenic mouse model
Geneva, Switzerland
Mon 20 09:50
OC4.6
Plenary Orals 4
Periostin (Postn) synergizes with osteocytes beta-catenin to mediate the adaptive skeletal response to loading
Geneva, Switzerland
Steve Boonen
Leuven, Belgium
Sat 18 11:00
CU1.4
Clinical Update 1
Medical management of Osteoporosis in men
Leuven, Belgium
Steven Boonen
Leuven, Belgium
Mon 20 18:35
Satellite Symposium - New evidence for osteoporosis therapy - Supported by Amgen in collaboration with GSK
Denosumab : valuable for my patients at increased risk for hip fracture?
Leuven, Belgium
Alan Boyde
London, UK
Sun 19 12:45
MTP1
Meet the Professor Parallel Sessions
ECTS Excellence in Research Lecture: Methods for assessing bone microstructure - AUDITORIUM III
London, UK
Robert Brommage
Texas, USA
Mon 20 09:00
OC4.1
Plenary Orals 4
High-Throughput DEXA and MicroCT Screening in Gene Knockout Mice Identifies Bone Mass Phenotypes
Texas, USA
Irene Bultink
Amsterdam, The Netherlands
Sat 18 13:30
CU2.3
Clinical Update 2
Osteoporosis in SLE
Amsterdam, The Netherlands
Liisa Byberg
Uppsala, Sweden
Sun 19 09:20
OC1.3
Plenary Orals 1
Size at birth is not associated with risk of hip fracture. Results from two population-based cohorts
Uppsala, Sweden
Joana Camilo
Lisbon, Portugal
Tue 21 13:00
MTP14.2
Meet the Professor Sessions
EU-Funding - Room 5B
Lisbon, Portugal
John Campbell
Mon 20
ECTS / ASBMR Clinical Debate: This house believes that muscle, not bone, is the preferred target to reduce non-vertebral fractures
In Support of the Motion
Leonar Cancela
Faro, Portugal
Sun 19 11:00
W2.1
Workshop 2: Developmental biology and bone
Fish as a model organism for mineralization related pathologies
Faro, Portugal
Leonor Cancela
Faro, Portugal
Sun 19 12:45
MTP4
Meet the Professor Parallel Sessions
Fish as a model system for exploring skeletal development and regeneration - Room 5B
Faro, Portugal
Helena Canhão
Lisbon, Portugal
Sat 18 17:20
Opening Ceremony
Welcome to Lisbon from the Chair of the Local Organising Committee
Lisbon, Portugal
Vincent Carpentier
Paris, France
Sun 19 15:45
OP10
Oral Posters 1: Clinical
Regional heterogeneity of trabecular bone microdamage density in association with trabecular microarchitecture and bone resorption in whole human lumbar vertebrae
Paris, France
Roland Chapurlat
Mon 20 15:35
OP18
Oral Posters 2: Clinical
Effects of Odanacatib on BMD and Safety in the Treatment of Osteoporosis in Postmenopausal Women Previously Treated with Alendronate- A Randomized Placebo-Controlled trial
Emma Clark
(Bristol, UK)
Mon 20 11:30
W3.2
Workshop 3: Vertebral fractures
How are vertebral fractures best detected and diagnosed?
(Bristol, UK)
Cyrus Cooper
Southampton, UK
Sat 18 11:30
CU1.5
Clinical Update 1
Glucocorticoid-induced osteoporosis
Southampton, UK
Sat 18 15:35
Satellite Symposium - Treatment of Severe Osteoporosis: an update - supported by Lilly
Epidemiology of Fragility Fractures: an update
Southampton, UK
Addolorata Corrado
Foggia, Italy
Sun 19 15:15
OP4
Oral Posters 1: Clinical
Relationship between bone mineral density, body composition, skin sclerosis and serum 25(OH) vitamin D levels in  systemic sclerosis
Foggia, Italy
Peter Croucher
Sydney, Australia
Tue 21 11:15
W6.1
Workshop 6: Cancer cells and Bone
How do cancer cells home to bone?
Sydney, Australia
Steven Cummings
Mon 20
ECTS / ASBMR Clinical Debate: This house believes that muscle, not bone, is the preferred target to reduce non-vertebral fractures
Against the Motion
Tue 21 09:10
OC5.2
Orals 5 - Treatment of osteoporosis
Fracture Risk Factors During Treatment With Denosumab
Kevin Deere
Bristol, UK
Mon 20 09:20
OC3.3
Plenary Orals 3
Distinct relationships of intramuscular and subcutaneous fat with cortical bone: findings from a cross-sectional study of young adult males and females
Bristol, UK
Frederic Deschaseaux
Toulouse, France
Mon 20 15:10
OP33
Oral Posters 2: Pre-clinical
Regulation and function of immunosuppressive molecule human leukocyte antigen G5 in human bone tissue
Toulouse, France
Adolfo Díez-Pérez
Barcelona, Spain
Sat 18 12:55
AHP1.2
Allied Health Professionals (AHP) Session
Compliance with Osteoporosis: Can we improve patient understanding through education?
Barcelona, Spain
Richard Eastell
Sheffield, UK
Sat 18 13:45
AHP1.3
Allied Health Professionals (AHP) Session continued
Could compliance be improved through monitoring?
Sheffield, UK
Marco Eijken
Rotterdam, Netherlands
Tue 21 12:15
W5.3
Workshop 5: Anabolic bone therapies
Therapeutic targeting of activin signaling
Rotterdam, Netherlands
John Eisman
Sydney, Australia
Tue 21 14:30
S5.2
Symposium 5: Uncoupling of resorption and formation
Effects of cathepsin K inhibition
Sydney, Australia
Erik Eriksen
Sat 18 09:30
CU1.1
Clinical Update 1
Osteoporosis in premenopausal women
Tue 21 13:00
MTP11
Meet the Professor Sessions
Long-term treatment of osteoporosis - Auditorium III
Astrid Fahrleitner-Pammer
Graz, Austria
Tue 21 09:50
OC5.6
Orals 5 - Treatment of osteoporosis
Testosterone Replacement has a Substantial Benefit on Bone Mass, Fracture Incidence, Libido and Sexual Activities in Male Cardiac Transplant Patients: A 5 Year Randomized Prospective Controlled Trial
Graz, Austria
Tue 21 11:15
W5.1
Workshop 5: Anabolic bone therapies
The effect of PTH on fracture healing
Graz, Austria
Andrea Fattore
Rome, Italy
Mon 20 15:45
OP40
Oral Posters 2: Pre-clinical
Insertion of the clcn7 gene mutation pG213R in mouse induces Autosomal Dominant Osteopetrosis Type II (ADO2).
Rome, Italy
Serge Ferrari
Mon 20 19:00
Satellite Symposium - New evidence for osteoporosis therapy - Supported by Amgen in collaboration with GSK
What is the relevance for BMD increase in fracture risk reduction?
Joao Fonseca
Lisboa, Portugal
Tue 21 13:00
MTP13
Meet the Professor Sessions
Arthritis, inflammation and bone: from bench to bedside - Room 5A
Lisboa, Portugal
Seiji Fukumoto
Tokushima, Japan
Mon 20 17:05
ES2.2
Educational Symposium 2
Low phosphate
Tokushima, Japan
Thomas Funck-Brentano
Paris, France
Sun 19 15:25
OP26
Oral Posters 1: Pre-clinical
Bone is the main target of activation of Canonical Wnt pathway in osteoarthritis
Paris, France
Harry Genant
San Francisco, USA
Sat 18 18:00
OPC2
Opening Ceremony: ECTS 50th Anniversary Symposium: 50 years of research in bone and mineral metabolism
50 years of progress in bone imaging
San Francisco, USA
Sun 19 20:00
ECTS New Investigator Seminar and Social Gathering
Plenary Session: Bone Research – The Next 50 Years
San Francisco, USA
Maude Gerbaix
Geneva, Switzerland
Mon 20 15:20
OP35
Oral Posters 2: Pre-clinical
Effects of a mutated sclerostin peptide on bone and lean mass in mice.
Geneva, Switzerland
C-C Glüer
Thousand Oaks, USA
Tue 21 09:30
OC5.4
Orals 5 - Treatment of osteoporosis
Effects of Romosozumab Administration on Trabecular and Cortical Bone Assessed With Quantitative Computed Tomography and Finite Element Analysis
Thousand Oaks, USA
Bérengère Gobin
NANTES cedex, France
Sun 19 21:15
PP139
ECTS New Investigator Seminar and Social Gathering
New PI3Kalpha-specific inhibitor, BYL719: therapeutic interest in osteosarcoma
NANTES cedex, France
Keith Godfrey
Southampton, UK
Sun 19 08:00
S1.1
Symposium 1: Developmental origins of metabolic bone disease
Developmental epigenetics and the intrauterine origins of chronic disease
Southampton, UK
Sun 19 12:45
MTP3
Meet the Professor Parallel Sessions
Epigenetic regulation: what and why? - Room 5A
Southampton, UK
Stephanie Gohin
London, UK
Tue 21 09:30
OC6.4
Orals 6 - Mineralisation and energy metabolism
Inhibition of PTH-induced vasorelaxation modulates its anabolic action
London, UK
Celia Gregson
Bristol, UK
Sun 19 09:00
OC1.1
Plenary Orals 1
Disease-specific perception of fracture risk and incident fracture rates among postmenopausal women: findings from the Global Longitudinal Study of Osteoporosis in Women (GLOW)
Bristol, UK
Sun 19 21:05
PP31
ECTS New Investigator Seminar and Social Gathering
A GWAS in an extreme high bone mass population shows exess signal from genes associated with BMD in normal population
Bristol, UK
Nuria Guanabens
Sun 19 12:00
W1.3
Workshop 1: Fat and bone
Obesity,bariatric surgery and bone
Mon 20 12:45
MTP7
Meet the Professor Sessions
Clinical utility of bone turnover markers - Auditorium IV
Peyman Hadju
Marburg, Germany
Tue 21 12:15
W6.3
Workshop 6: Cancer cells and Bone
Clinical decision making in metastatic bone disease
Marburg, Germany
Tue 21 13:00
MTP12
Meet the Professor Sessions
Breast cancer treatment induced osteoporosis - pathophysiology, prevention and treatment - Auditorium IV
Marburg, Germany
Christine Hamann
Dresden, Germany
Sun 19 09:10
OC2.2
Plenary Orals 2
Intermittent human parathyroid hormone (1-84) treatment improves bone mass and bone defect healing in rats with type 2 diabetes mellitus
Dresden, Germany
Bolette Hartmann
Copenhagen, Denmark
Sat 18 14:50
PP111
Allied Health Professionals (AHP) Session continued
Abstract Presentation - The effect of gastric bypass treatment for obesity on hormones related to bone re-modeling and intestinal growth
Copenhagen, Denmark
Gary Hattersley
MA, USA
Sat 18 14:30
PP450
Allied Health Professionals (AHP) Session continued
Abstract Presentation - Transdermal Delivery of BA058, A Novel Analog of hPTHrP (1-34), with a Short Wear Time Patch in Preclinical and Clinical Studies
MA, USA
Tue 21 09:40
OC5.5
Orals 5 - Treatment of osteoporosis
Bone Anabolic Efficacy and Safety of BA058, A Novel Analog of hPTHrP: 12 Month Extension Data from a Phase 2 Clinical Trial in Postmenopausal Women with Osteoporosis
MA, USA
Glen Haugeberg
Oslo, Norway
Sat 18 13:00
CU2.2
Clinical Update 2
Osteoporosis and fragility fractures in rheumatoid arthritis
Oslo, Norway
Glenn Haugeberg
Bærum, Norway
Sun 19 15:20
PP22
Oral Posters 1: Clinical
Generalized Long Term Bone Loss in Early Rheumatoid Arthritis in the Biologic Treatment Era - A 10 Year prospective Observational Study
Bærum, Norway
Barbara Hauser
Edinburgh, UK
Sun 19 21:35
PP383
ECTS New Investigator Seminar and Social Gathering
Detection of autoantibodies to osteoprotegerin in patients with rheumatoid arthritis and their association with disease activity
Edinburgh, UK
Eric Haÿ
Paris, France
Mon 20 15:25
OP36
Oral Posters 2: Pre-clinical
N-Cadherin Governs Age-Related Determination in Mice Through Modulation of Wnt5a and Wnt10b.
Paris, France
Anne Heegard
Copenhagen, Denmark
Mon 20 12:45
MTP6
Meet the Professor Sessions
Bone Pain - Auditorium III
Copenhagen, Denmark
Eric Hesse
Huddinge, Sweden
Mon 20
NIW2
New Investigator Workshop 2
How to manage your research time and team
Huddinge, Sweden
Nicole Horwood
London, UK
Mon 20 11:00
W4.1
Workshop 4: Osteoclast activity and haematopoiesis
The relationship between osteoclasts and haematopoiesis
London, UK
Carmen Huesa
Paisley, UK
Tue 21 09:10
OC6.2
Orals 6 - Mineralisation and energy metabolism
Deficiency of the bone mineralisation inhibitor NPP1 protects against obesity and diabetes
Paisley, UK
Franz Jakob
Sat 18 15:30
Satellite Symposium - Treatment of Severe Osteoporosis: an update - supported by Lilly
Welcome & Introductions
Sat 18 16:50
Satellite Symposium - Treatment of Severe Osteoporosis: an update - supported by Lilly
Q & A and Closing Remarks
Professsor  Kassim	 Javaid
Oxford, UK
Sun 19 08:30
S1.2
Symposium 1: Developmental origins of metabolic bone disease
Maternal environment and intrauterine skeletal development
Oxford, UK
Mari Kaartinen
Montreal, Canada
Mon 20 09:20
OC4.3
Plenary Orals 4
Severe osteopenia, increased bone marrow adipogenesis and fibronectin matrix changes in mice lacking both TG2 and FXIIIA transglutaminases
Montreal, Canada
Ivo Kalajzic
Farmington, USA
Sun 19 15:15
OP24
Oral Posters 1: Pre-clinical
Identification and Characterization of a Mesenchymal Progenitor Cell Population Involved in Fracture Healing
Farmington, USA
Gerard Karsenty
Tue 21 08:00
S4.1
Symposium 4: Energy metabolism and bone
Energy metabolism, bone and reproduction
Hua Ke
Thousand Oaks, USA
Mon 20 15:40
OP19
Oral Posters 2: Clinical
Effects of Sclerostin Antibody and Maintenance of New Bone Induced by Sclerostin Antibody in Animal Models
Thousand Oaks, USA
John Kemp
(Bristol, UK)
Sun 19 21:30
PP282
ECTS New Investigator Seminar and Social Gathering
Phenotypic dissection of bone mineral density facilitates the identification of skeletal site specificity on the genetic regulation of bone
(Bristol, UK)
Douglas Kiel
Boston, USA
Sun 19 14:15
S2.2
Symposium 2: Sarcopenia – causes and consequences
Sarcopenia: Prevalence and consequences
Boston, USA
Tue 21 09:00
OC5.1
Orals 5 - Treatment of osteoporosis
A Three Year Randomized Sham-Controlled Trial of Low Magnitude Mechanical Stimulation in an Elderly Sample:  The "VIBES" Trial
Boston, USA
Riku Kiviranta
Sun 19
Awards 2
2010 ECTS CAREER ESTABLISHMENT AWARD
Sun 19 15:30
OP7
Oral Posters 1: Clinical
Bone Marrow Fat Is Metabolically Distinct Fat Depot
Venkatesh Krishnan
Boston, USA
Sun 19 12:45
MTP2
Meet the Professor Parallel Sessions
The wnt signalling in and out of bone - AUDITORIUM IV
Boston, USA
Tue 21 11:45
W5.2
Workshop 5: Anabolic bone therapies
Wnt signaling - a clinical drug target
Boston, USA
Gisela Kuhn
Zurich, Switzerland
Mon 20 09:40
OC4.5
Plenary Orals 4
Mechanical loading increases the effect of sclerostin antibody treatment in a mouse model of high turnover osteoporosis
Zurich, Switzerland
Francois Lamoureux
Nantes, France
Sun 19 15:45
OP30
Oral Posters 1: Pre-clinical
Clusterin Inhibition using OGX-011 Synergistically Enhances Zoledronic Acid Activity in Osteosarcoma.
Nantes, France
Professor Bente Langdahl
Aarhus, Denmark
Sat 18 17:15
Opening Ceremony
Welcome to the congress from the ECTS President
Aarhus, Denmark
Willem Lems
Amsterdam, The Netherlands
Sat 18 14:30
CU2.5
Clinical Update 2
The effect of anti-inflammatory treatments (except GC) on bone
Amsterdam, The Netherlands
Sat 18 14:20
PP439
Allied Health Professionals (AHP) Session continued
Abstract presentation - The Direct And Indirect Costs Of An Osteoporotic Fracture: A Prospective Evaluation Of Elderly Patients With A Clinical Fracture
Amsterdam, The Netherlands
Su-Vern Lim
London, UK
Sun 19 09:50
OC2.6
Plenary Orals 2
Growth hormone excess in bGH transgenic mice adversely affects bone density, architecture and quality
London, UK
David Little
Sun 19 15:10
OP23
Oral Posters 1: Pre-clinical
MEK inhibitors in fracture healing and NF1 pseudarthrosis
Nerea Lopez
Edinburgh, UK
Mon 20 09:40
OC3.5
Plenary Orals 3
Genome-wide association identifies a new susceptibility locus at 4q35 associated with clinical vertebral fractures in post-menopausal women: The GEFOS-GENOMOS consortium.
Edinburgh, UK
John Loughlin
Newcastle, UK
Sun 19 17:05
ES1.2
Educational Symposium 1
Disease mechanisms
Newcastle, UK
Guillaume Mabilleau
Angers, France
Sun 19 09:40
OC2.5
Plenary Orals 2
Glucagon-like peptide 1 receptor is required for optimal bone strength and quality
Angers, France
Eleanor Mackie
Parkville, Australia
Mon 20 15:00
OP31
Oral Posters 2: Pre-clinical
ADIPOGENESIS OCCURS AT THE EXPENSE OF OSTEOBLAST DIFFERENTIATION IN PRIMARY OSTEOBLASTS DEFICIENT IN PROTEASE-ACTIVATED RECEPTOR-2
Parkville, Australia
Andrea Marques
Coimbra, Portugal
Sat 18 12:30
Allied Health Professionals (AHP) Session
Introduction to the highlights of the meeting
Coimbra, Portugal
Mary Matthews
Adelaide, Australia
Sun 19 15:05
OP22
Oral Posters 1: Pre-clinical
The Effect of mTORC1 on Postnatal Skeletal Development
Adelaide, Australia
Marta Maycas
Madrid, Spain
Mon 20 15:15
OP34
Oral Posters 2: Pre-clinical
Activation of the Parathyroid Hormone-Receptor is Involved in the Pro-survival Effect of Hypotonic Shock in Osteocyte-like MLO-Y4 Cells
Madrid, Spain
Ann McArdle
Liverpool, UK
Sun 19 13:45
S2.1
Symposium 2: Sarcopenia – causes and consequences
Skeletal muscle loss: sarcopenia and inactivity
Liverpool, UK
Eugene McCloskey
Sun 19 15:00
PP384
Oral Posters 1: Clinical
Does Vitamin D status impact on hip fracture incidence? - evidence of fracture variation with latitude and season in Sweden
Jose Melo-Gomes
Sun 19
Satellite Symposium - Current and Future Strategies for the Management of Osteoporosis: Signaling a Change in the Conversation - Supported by MSD
Welcome & Introductions
Sun 19 19:35
Satellite Symposium - Current and Future Strategies for the Management of Osteoporosis: Signaling a Change in the Conversation - Supported by MSD
Q & A and Closing Remarks
Daniela Merlotti
Siena, Italy
Sun 19 15:40
OP9
Oral Posters 1: Clinical
Interaction between FGF23 R176W mutation and C716T nonsynonymous change (T239M, rs 7955866) in FGF23 on the clinical phenotype in a family with autosomal dominant hypophosphatemic rickets
Siena, Italy
Karl Michaëlsson
Sun 19 09:30
OC1.4
Plenary Orals 1
Intake and serum levels of α-tocopherol in relation to fractures in elderly women and men
Mon 20 15:15
OP14
Oral Posters 2: Clinical
Impact of hip fracture on mortality and life expectancy
Madhusmita Misra
Boston, USA
Sun 19 11:30
W1.2
Workshop 1: Fat and bone
Anorexia and bone
Boston, USA
Alireza Moayyeri
London, UK
Mon 20 09:50
OC3.6
Plenary Orals 3
Causal metabolomic pathways to osteoporosis in elderly women
London, UK
Suzanne Morin
Montréal, Canada
Sun 19 09:50
OC1.6
Plenary Orals 1
Femur Geometrical Parameters in the Pathogenesis of Atypical Femur Fractures
Montréal, Canada
Christian Muschitz
Vienna, Austria
Mon 20 19:25
Satellite Symposium - New evidence for osteoporosis therapy - Supported by Amgen in collaboration with GSK
Transitioning osteoporosis therapies: what is the evidence?
Vienna, Austria
Andreas Niemeier
Mon 20 15:05
OP32
Oral Posters 2: Pre-clinical
Hepatic lipase is expressed by osteoblasts and modulates bone remodeling in obesity
Rami Obaid
Edinburgh, UK
Sun 19 21:25
PP230
ECTS New Investigator Seminar and Social Gathering
Depletion of the autophagy adaptor OPTN leads to increased osteoclast formation, fusion and survival as well as increase NF-κB activation in vitro
Edinburgh, UK
Barbara Obermayer-Pietsch
Mon 20 17:30
ES2.3
Educational Symposium 2
Low vitamin D
Claes Ohlson
Gothenburg, Sweden
Sat 18 10:30
CU1.3
Clinical Update 1
Male osteoporosis
Gothenburg, Sweden
Karla Oldknow
Midlothian, UK
Tue 21 09:50
OC6.6
Orals 6 - Mineralisation and energy metabolism
An Emerging Role of PHOSPHO1 in the Regulation of Energy Metabolism 
Midlothian, UK
Cécile Olejnik
Lille, France
Sun 19 21:10
PP38
ECTS New Investigator Seminar and Social Gathering
Bisphosphonate influence on bone quality at molecular level: study of human jaw bone sequesters by Raman microspectroscopy
Lille, France
Isabel Orriss
London, UK
Tue 21 09:00
OC6.1
Orals 6 - Mineralisation and energy metabolism
NPP1 (ecto-nucleotide pyrophosphatase/phosphodiesterase 1) is a key regulator of skeletal and soft tissue mineralisation
London, UK
Klaus Pantel
Hamburg, Germany
Tue 21 11:45
W6.2
Workshop 6: Cancer cells and Bone
Biology and clinical relevance of circulating tumour cells
Hamburg, Germany
Alexandra Papaiouannou
Hamilton, Canada
Sat 18 16:15
Satellite Symposium - Treatment of Severe Osteoporosis: an update - supported by Lilly
Role of Gender and Etiology in the Response to Bone Active Agents in Patients with Osteoporosis
Hamilton, Canada
Julie Pasco
Geelong, Australia
Mon 20 15:20
OP15
Oral Posters 2: Clinical
Fracture risk among men, in relation to osteopenia and osteoporosis defined by areal bone mineral density.
Geelong, Australia
George Peat
Keele, UK
Sun 19 16:40
ES1.1
Educational Symposium 1
Epidemiology
Keele, UK
Adolfo Perez
Barcelona, Spain
Mon 20 11:00
W3.1
Workshop 3: Vertebral fractures
The impact of vertebral fractures on morbidity and mortality
Barcelona, Spain
Mon 20 12:45
MTP9
Meet the Professor Sessions
Failure of osteoporosis treatment - Room 5B
Barcelona, Spain
Ulrika Pettersson-Kymmer
Umeå, Sweden
Sun 19 15:35
OP8
Oral Posters 1: Clinical
Genome-Wide Association Study meta-analysis identifies the SOAT1/AXDND1 locus to be associated with hip and forearm fracture risk
Umeå, Sweden
K Poole
Zug, Switzerland
Mon 20 15:30
OP17
Oral Posters 2: Clinical
Denosumab is associated with progressive improvements in hip cortical mass and thickness
Zug, Switzerland
Sophie Portron
Nantes, France
Sun 19 15:20
OP25
Oral Posters 1: Pre-clinical
Oxygen tension-mediated regulation of chondrogenic differentiation: application to stem cells based osteochondral repair
Nantes, France
Tero Puolakkainen
Turku, Finland
Sun 19 09:00
OC2.1
Plenary Orals 2
Treatment With Soluble Activin Type IIB-Receptor Improves Bone Mass And Strength In A Mouse Model Of Duchenne Muscular Dystrophy
Turku, Finland
Stuart Ralston
Edinburgh, UK
Mon 20 12:45
MTP8
Meet the Professor Sessions
What does bone genetics tell us on bone physiology - Room 5A
Edinburgh, UK
Mon 20 15:25
OP16
Oral Posters 2: Clinical
Long-term effects of symptomatic versus intensive bisphosphonate therapy for Paget's disease of bone: The PRISM-EZ study.
Edinburgh, UK
Francois Rannou
Paris, France
Sun 19 17:30
ES1.3
Educational Symposium 1
Management of osteoarthritis
Paris, France
Professor Martina Rauner
Dresden, Germany
Tue 21 13:00
NIW3
New Investigator Workshop 3
How to get started as a posdoc
Dresden, Germany
Ian Reid
Auckland, New Zealand
Sun 19 15:05
OP2
Oral Posters 1: Clinical
Meta-Analysis of the Effects of Vitamin D Supplements on Bone Mineral Density in Adults
Auckland, New Zealand
Lars Rolighed
Sat 18 14:40
PP286
Allied Health Professionals (AHP) Session continued
Abstract Presentation - Muscle function and quality of life in primary hyperparathyroidism
Bjorn Rosengren
Malmo, Sweden
Mon 20 15:10
OP13
Oral Posters 2: Clinical
Hip Fracture Trends in Denmark 1980-2010 with Age-Period-Cohort-effects
Malmo, Sweden
Christian Roux
Paris, France
Sat 18 14:00
CU2.4
Clinical Update 2
Osteoporosis in ankylosing spondylitis
Paris, France
Sun 19 18:35
Satellite Symposium - Current and Future Strategies for the Management of Osteoporosis: Signaling a Change in the Conversation - Supported by MSD
Optimizing Therapy in Osteoporosis
Paris, France
Davide Ruffoni
Zurich, Switzerland
Sun 19
Awards 2
2010 ECTS POSTDOCTORAL FELLOWSHIP
Zurich, Switzerland
Graham Russell
Oxford, UK
Sat 18 18:30
OPC3
Opening Ceremony: ECTS 50th Anniversary Symposium: 50 years of research in bone and mineral metabolism
50 years of progress in treatment of bone diseases
Oxford, UK
Sun 19 20:00
ECTS New Investigator Seminar and Social Gathering
Plenary Session: Bone Research – The Next 50 Years
Oxford, UK
Georg Schett
Erlangen, Germany
Sat 18 12:30
CU2.1
Clinical Update 2
Osteo-immunology, the basic concepts
Erlangen, Germany
Ansgar Schulz
Ulm, Germany
Mon 20 12:00
W4.3
Workshop 4: Osteoclast activity and haematopoiesis
Osteoclasts and haematopoietic stem cell transplantation in clinical practice
Ulm, Germany
Nicole Scully
Cardiff, UK
Sun 19 15:00
OP21
Oral Posters 1: Pre-clinical
IGF-1 regulates MC-3T3 and human primary osteoblast to osteocyte differentiation in 3D culture
Cardiff, UK
Ego Seeman
Melbourne, Australia
Sun 19 19:15
Satellite Symposium - Current and Future Strategies for the Management of Osteoporosis: Signaling a Change in the Conversation - Supported by MSD
Odanacatib: A Novel Approach to the Treatment of Osteoporosis
Melbourne, Australia
Jochen Seufert
Tue 21 08:30
S4.2
Symposium 4: Energy metabolism and bone
Sweet bones - the effect of diabetes on bone
Majken Siersbaek
Odense C, Denmark
Sun 19 21:20
PP175
ECTS New Investigator Seminar and Social Gathering
Identification of a small molecule kinase inhibitor that enhances osteoblast differentiation of human skeletal (mesenchymal) stem cells through regulation of TGFβ signaling
Odense C, Denmark
Saba Silva
Lisbon, Portugal
Tue 21 13:00
MTP15
Meet the Professor Sessions
State-of the-Art techniques in Bone research - Room 5C
Lisbon, Portugal
Kathrin Sinningen
Dresden, Germany
Sun 19 15:30
OP27
Oral Posters 1: Pre-clinical
Milk fat globule-epidermal growth factor 8 (MFG-E8) is a critical determinant of bone mass and alters the course of inflammation in arthritis
Dresden, Germany
Antonia Sophocleous
Edinburgh, UK
Mon 20 09:00
OC3.1
Plenary Orals 3
Heavy cannabis use negatively impacts on bone density - a population based prospective study
Edinburgh, UK
Katherine Staines
Edinburgh, Scotland
Sun 19 21:00
PP27
ECTS New Investigator Seminar and Social Gathering
Sclerostin/MEPE axis in OA: lessons from long bone development
Edinburgh, Scotland
Laufey Steingrimsdottir
Reykjavik, Iceland
Sun 19 09:10
OC1.2
Plenary Orals 1
Hip fractures and bone mineral density of the elderly - importance of serum 25-hydroxy vitamin D
Reykjavik, Iceland
Jan Stepán
Sat 18 15:50
Satellite Symposium - Treatment of Severe Osteoporosis: an update - supported by Lilly
Effects of Bone Active Agents on Cortical Bone
Andrea Superti-Furga
Lausanne, Switzerland
Mon 20 08:30
S3.2
Symposium 3: Extreme bone phenotypes
Insights from research in bone genetics: what do genetic skeletal disorders tell us on bone physiology?
Lausanne, Switzerland
Hiroshi Takayanagi
Toyko, Japan
Tue 21 14:00
S5.1
Symposium 5: Uncoupling of resorption and formation
Novel antiresorptives - uncoupling or not?
Toyko, Japan
Viviana Tavares
Lisbon, Portugal
Mon 20 12:00
W3.3
Workshop 3: Vertebral fractures
Treatment of vertebral fractures
Lisbon, Portugal
Mon 20 12:45
MTP10
Meet the Professor Sessions
New osteoporosis treatment modalities - Room 5C
Lisbon, Portugal
Sylvia Thiele
Dresden, Germany
Mon 20 09:30
OC4.4
Plenary Orals 4
Glucocorticoid exposure reduces expression of sclerostin in bone marrow stromal cells
Dresden, Germany
Cyril Thouverey
Geneva, Switzerland
Mon 20 09:10
OC4.2
Plenary Orals 4
The p38alpha MAPK pathway in osteoblasts contributes to ovariectomy-induced bone loss by upregulating interleukin-6 expression
Geneva, Switzerland
André Uitterlinden
Rotterdam, The Netherlands
Sun 19
NIW1
New Investigator Workshop 1
Genomics and proteomics as emerging technologies in bone research
Rotterdam, The Netherlands
Karmele Valencia
Pamplona, Spain
Sun 19 15:40
OP29
Oral Posters 1: Pre-clinical
miR-192 Impairs Invasion and Tumor-Induced Osteolysis by Repressing CCL2 in Bone Metastatic Colonization
Pamplona, Spain
Peter Vestergaard
Aalborg, Denmark
Sun 19 09:40
OC1.5
Plenary Orals 1
Heart failure in patients treated with bisphosphonates
Aalborg, Denmark
David Vicente
Oulu, Finland
Tue 21 09:20
OC6.3
Orals 6 - Mineralisation and energy metabolism
Collagen XV as a bone matrix organizer
Oulu, Finland
Andrea Vortkamp
Essen, Germany
Sun 19 11:30
W2.2
Workshop 2: Developmental biology and bone
Chondrocyte growth and differentiation during endochondral ossification
Essen, Germany
Jennifer Walsh
Sheffield, UK
Sat 18 10:00
CU1.2
Clinical Update 1
Management of osteoporosis in premenopausal women
Sheffield, UK
Sun 19 11:00
W1.1
Workshop 1: Fat and bone
Effects of fat on bone: location and age matter
Sheffield, UK
Sachin Wani
Edinburgh, UK
Mon 20 15:30
OP37
Oral Posters 2: Pre-clinical
The D477N mutation in OPTN leads to increased bone turnover and enhanced osteoclast formation in OptnD477N/D477N mice
Edinburgh, UK
Esther Wehrle
Ulm, Germany
Sun 19 09:20
OC2.3
Plenary Orals 2
Low-magnitude high-frequency vibration (LMHFV) improves fracture healing in aged, ovariectomized mice
Ulm, Germany
Michael Whyte
St Louis, USA
Mon 20 16:40
ES2.1
Educational Symposium 2
Low alkaline phosphatase
St Louis, USA
Elazar Zelzer
Rehovot, Israel
Sun 19 12:00
W2.3
Workshop 2: Developmental biology and bone
Bone shaping by muscle force during embryogenesis
Rehovot, Israel
Afrodite Zendeli
Vienna, Austria
Sun 19 15:25
OP6
Oral Posters 1: Clinical
Cortical and Trabecular Alterations in Patients with Bone Marrow Edema of the Lower Limb
Vienna, Austria
Dongxing Zhu
Edinburgh, UK
Mon 20 15:35
OP38
Oral Posters 2: Pre-clinical
BMP-9 induces the calcification of vascular smooth muscle cells.
Edinburgh, UK
Tue 21 09:40
OC6.5
Orals 6 - Mineralisation and energy metabolism
A protective role for FGF23 in local defence against disrupted arterial wall integrity?
Edinburgh, UK
Paediatric bone disease
PP1
10 years follow up after prenatal transplantation of fetal mesenchymal stem cell in a patient with severe osteogenesis imperfecta.
Cecilia Götherström, Katarina Le Blanc, Eva Åström, Jahan Taslimi, Gail E Graham, Uwe Ewald, Magnus Westgren
PP502
Craniofacial consequences of high dose zoledronic acid injections in onco-pediatric patients
Frédéric LEZOT, Julie CHESNEAU, Séverine BATTAGLIA, Régis BRION, Jean-Christophe FARGES, Géraldine LESCAILLE, Beatriz CASTANEDA, Perrine MAREC-BERARD, Laurence BRUGIERES, Nadège CORRADINI, Dominique HEYMANN, Françoise REDINI
PP503
High dickkopf-1 levels in sera and leukocytes from children with 21-hydroxylase deficiency on chronic glucocorticoid treatment.
Giacomina Brunetti, Maria Felicia Faienza, Laura Piacente, Annamaria Ventura, Angela Oranger, Claudia Carbone, Adriana Di Benedetto, Graziana Colaianni, Giorgio Mori, Silvia Colucci, Luciano Cavallo, Maria Grano
PP504
The serum levels of carboxylated and undercarboxylated osteocalcin in children with cystic fibrosis
Jadwiga Ambroszkiewicz, Dorota Sands, Joanna Gajewska, Magdalena Chelchowska, Teresa Laskowska-Klita
PP505
Associations between leptin, growth factors and bone turnover markers in prepubertal obese children
Joanna Gajewska, Jadwiga Ambroszkiewicz, Magdalena Chelchowska, Witold Klemarczyk, Patrycja Kurpinska, Halina Weker, Teresa Laskowska-Klita
PP506
Body composition in 3- and 4-years-old preterm and full-term infants - preliminary data
Elzbieta Karczmarewicz, Edyta Czekuc-Kryskiewicz, Justyna Czech-Kowalska, Maciej Jaworski, Pawel Pludowski, Dorota Bulsiewicz, Maria Kornacka, Anna Niezgoda, Agata Pleskaczynska, Monika Nowakowska-Rysz, Anna Dobrzanska, Roman Lorenc
PP507
Percieved activity capability in children and adolescents with Osteogenesis Imperfecta
Maud Hagberg, Kristina Löwing, Eva Åström
PP508
Comparison the bone densitometry and anthropometric parameters between the Ukraininan, Indian and Nigerian young male students, graduated in Lugansk State Medical University
Luzin V, Stklyanina L, Ushko Y, Ignatyev A
Osteoporosis: pathophysiology and epidemiology
PP2
Osteonecrosis of the Jaw in a Patient with Rheumatoid Artritis treated with an oral aminobisphosphonate: a clinical case report
Lorena Longato, Loredana Cavalli, Gemma Marcucci, Alessia Metozzi, Francesca Giusti, Maria Luisa Brandi, Prisco Piscitelli
PP341
VITAMIN D LEVELS IN IMMOBILIZED SPANISH ADULTS. THE CAMARGO COHORT STUDY. 
José M. Olmos, Pilar García Velasco, José L. Hernández, Josefina Martínez, Verónica Cabrero, Carmen Valero, Jesús González-Macías
PP342
BONE MINERAL DENSITY IN STATIN USERS: ANALYSIS OF A POPULATION-BASED COHORT FROM SPAIN
José L. Hernández, José M. Olmos, Galo Romaña, Josefina Martínez, Irina Yezerska, Julia de Juan, Jesús González-Macías
PP343
Fracture risk among men, in relation to osteopenia and osteoporosis defined by areal bone mineral density.
Julie Pasco, Stephen Lane, Sharon Brennan, Elizabeth Timney, Gosia Bucki-Smith, Amelia Dobbins, Mark Kotowicz
PP344
BONE TURNOVER MARKERS IN OLD OLD VS POSTMENOPAUSAL WOMEN
Charles Inderjeeth, Kien Chan, Preeti Nair, Pang Wee Yang, Anupham Chauhan, EEmun Lim
PP345
Mortality after osteoporosis-related hip fractures in Austria 2008-2010
Wolfgang Brozek, Berthold Reichardt, Oliver Kimberger, Daniela Kritsch, Klaus Klaushofer, Elisabeth Zwettler
PP346
Association of osteoprotegerin gene polymorphisms with bone mineral density and bone turnover markers in postmenopausal women and elderly men.
Martina Smolic, Selma Cvijetic, Tomislav Kizivat, Robert Smolic, Ivana Maric, Teuta Opacak-Bernardi, Hrvoje Roguljic, Antun Tucak
PP347
Acute effects of glucocorticoids on CRP and bone markers
Jan Stepan, Kristyna Brabnikova Maresova, Karel Pavelka
PP348
Variation in osteoporosis patients' service utilization in general practice clinics
Troels Kristensen, Kim Rose Olsen, Charlotte Ejersted, Anders Halling
PP349
Women with hormone sensitive breast cancer who have received chemotherapy including prednisolone have reduced bone mass
Sofie Rønn, Jannie D Hald, Marianne Thisted, Louise Andersen, Louise Grønhøj, Anders Bonde Jensen, Bente L Langdahl
PP350
The risk of fractures in cirrhosis and chronic pancreatitis. A Danish nationwide retrospective matched cohort study
Ulrich Christian Bang, Thomas Benfield, Flemming Bendtsen, Lars Hyldstrup, Jens-Erik Beck Jensen
PP351
Cytokine levels in the bone marrow are not just a reflection of the levels in serum - suggesting that bone marrow constitutes an independent compartment
Torben Harsløf, Lotte Sørensen, Steen Pedersen, Bente Langdahl
PP352
The relationship between urban-rural migration and bone mineral density in an urban-rural adult population: cross sectional findings from the Hyderabad Indian Migration study
Heli Viljakainen, Yoav Ben-Shlomo, Sanjay Kinra, Shah Ebrahim, Hannah Kuper, KV Radhakrishna, Bharathi Kulkarni, Jon Tobias
PP353
Apolipoprotein-E (ApoE) deficiency prevents obesity but predisposes to the development of osteoporosis following long-term exposure to Western-type diet, in mice
Nicholaos Papachristou, Elena Kalyvioti, Irene-Eva Triantaphyllidou, Eleni Karavia, Eva Plakoula, Harry Blair, Kyriakos Kypreos, Dionysios Papachristou
PP354
Apolipoprotein A-I deficiency is associated with decreased expression of osteoblast-specific regulators in mice 
Elena Kalyvioti, Nicholaos Papachristou, Irene-Eva Triantaphyllidou, Eleni Karavia, Eva Plakoula, Harry Blair, Kyriakos Kypreos, Dionysios Papachristou
PP355
Diabetes and obesity as independent risk factors for osteoporosis in postmenopausal women: a population study of 3.354 people. First results of the PROF Project (Prevention of Osteoporosis and Fractures).
Cosimo Neglia, Alberto Argentiero, Giovanna Chitano, Nadia Agnello, Giuseppe Quarta, Vincenzo Caiaffa, Alessandro Distante, Prisco Piscitelli
PP356
MICROGRAVITY-INDUCED OSTEOPOROSIS: A CHALLENGE FOR THE FUTURE OF SPACE PROGRAMS
Prisco Piscitelli, Alberto Argentiero, Giovanna Chitano, Cosimo Neglia, Emiliano Sordi, Giovanni Iolascon, Alessandro Distante, Maria Luisa Brandi
PP357
THE PREVALENCE OF OSTEOPOROSIS AND RISK FACTORS FOR BONE DEMINERALIZATION IN ITALY: FIRST RESULTS FROM THE FIRMO STUDY
Caterina Fossi, Loredana Cavalli, Francesca Giusti, Alessia Metozzi, Simone Parri, Andrea Guazzini, Maria Luisa Brandi
PP358
OSTEOPOROSIS AND "FRAGILITY FRACTURES" IN 110 CENTENARIANS LIVING AT THE NURSING HOME OF MILAN
Ivana Santi, Monica Gianotto, Valentina Guercio, Francesco Cetta, Massimo Monti
PP359
Ten Years of Increasing Hip Fractures Incidence in Italy but First Good News from the Analysis of National Hospitalizations Records 2000-2009
Prisco Piscitelli, Maurizio Feola, Cecilia Rao, Monica Celi, Eleonora Piccirilli, Elena Gasbarra, Simone Parri, Giovanni Iolascon, Maria Luisa Brandi, Umberto Tarantino
PP360
Osteoporosis risk factor correlation with BMD in Latvia
Inese Pavlina, Ingvars Rasa, Inara Adamsone, Ilze Daukste, Sandra Jaundzeikare, Dainis Kaneps, Ingrida Kaze, Agita Medne, Signe Zelca
PP361
Referral Rate of Lebanese Males for Osteodensitimetry
Yasser Yaghi, Ghassan Maalouf, Ahmad Ghazzawi, Kinda Yaghi
PP362
Asssesment of Osteoporosis Knowledge among Lebanese Physicians
Yasser Yaghi, Fatiha El Horr, Yousef Mousa, Kinda Yaghi, Nancy Maan
PP363
Adolescents´lifestyle and bone health - what about the young bones in Norway?
Anne Winther, Elaine Dennison, Luai Awad Ahmed, Anne-Sofie Furberg, Guri Grimnes, Rolf Jorde, Clara Gram Gjesdal, Nina Emaus
PP364
Osteoporosis an Independent Predictor of Mortality in Hip Fracture Patients
Andreas P. Diamantopoulos, Mari Hoff, Marc Hochberg, Glenn Haugeberg
PP365
Effect of sitagliptin on bone growth and remodeling in non-ovariectomized and ovariectomized rats
Maria Pytlik, Joanna Folwarczna, Justyna Fronczek-Sokół, Adam Smyła, Patrycja Więcek, Maria Zych
PP366
Caffeine at a moderate dose favorably affected bone mechanical properties in ovariectomized rats
Joanna Folwarczna, Maria Pytlik, Maria Zych, Urszula Cegieła, Ilona Kaczmarczyk-Sedlak, Barbara Nowińska, Leszek Śliwiński
PP367
Estimated glomerular filtration rate is associated with bone fragility in the elderly
Maria João Gonçalves, Ana Rodrigues, Joana Caetano-Lopes, Emilia Raquel, Ana Lopes, Bruno Vidal, Ana Catarina Vale, Marco Sarmento, Maria Fátima Vaz, Jacinto Monteiro, João Eurico Fonseca, Helena Canhão
PP368
Portuguese and Spanish FRAX® tool versions: a comparative analysis from EpiReumaPt
Nelia Gouveia, Helena Canhao, Tania Rego, Susana Sousa, Jaime Branco
PP369
Change in Bone Mineral Density of the proximal femur after Total Knee Replacement
KwnagKyoun Kim
PP370
Up-regulation of inhibitors of DNA binding/differentiation gene during alendronate-induced osteoblast differentiation
Heung Yeol Kim, Hoon Choi
PP371
Comparative Analysis of Vitamin D level with or without Osteoporotic Spinal Compression Fracture in Korean Elderly Patients
Ye-Soo Park, Hong-Sik Kim, Dong-Yi Kong, Ye-Yeon Won, Byung-Moon Kang
PP372
Decreased bone mineral density is associated with coronoary atherosclerosis in healthy postmenopausal women
Mihyun Jo, SiHyun Cho, Young Sik Choi, Byung Seok Lee, Seok Kyo Seo
PP373
Prevalence of vitamin D deficiency and low bone mineral density in healthy Saudi Women
Khulood Hussein, Hanan Alkadi, Susan Lanham-New, Mohamad Ardawi
PP374
Effect of two types of bariatric surgery (gastrojejunal bypass and sleeve gastroplasty) on gene expression of bone remodeling markers in Goto-Kakizaki rats
José-Luis Pérez-Castrillon, José-Antonio Riancho, Daniel DeLuis, Manuel Gonzalez-Sagrado, Marta Ruiz-Mambrilla, María Domingo-Anfres, Rosa Conde, David Primo, Antonio Dueñas-Laita
PP375
25-hydroxyvitamin D values in liver transplant candidates.
Ana Monegal, Pilar Peris, Andrea Cuervo, Africa Muxi, Laia Gifre, Nuria Guañabens
PP376
URSODEOXYCHOLIC ACID PROTECTS OSTEOBLASTIC CELLS FROM BILIRUBIN AND LITHOCHOLIC ACID INDUCED APOPTOSIS.
Silvia Ruiz-Gaspà, Marta Dubreuil, Andrés Combalia, Pilar Peris, Ana Monegal, Albert Parés, Nuria Guañabens
PP377
Effect of glucocorticoid treatment on Wnt signalling antagonists (sclerostin and Dkk-1) and their relationship to bone turnover and bone mass.
Laia Gifre, Pilar Peris, Silvia Ruiz-Gaspà, Ana Monegal, Benet Nomdedeu, Núria Guañabens
PP378
Role of Wnt antagonists (sclerostin and Dkk-1) on bone turnover markers and bone mass, in patients with complete spinal cord injury. Preliminary results.
Laia Gifre, Joan Vidal, Silvia Ruiz-Gaspà, Enric Portell, Ana Monegal, Africa Muxi, Núria Guañabens, Pilar Peris
PP379
Where and when do hip fractures occur? A population-based study
Breiffni Leavy, Anna Cristina Åberg, Håkan Melhus, Hans Mallmin, Karl Michaëlsson, Liisa Byberg
PP380
Hip Fracture Trends in Denmark 1980-2010 with Age-Period-Cohort-effects
Bjorn Rosengren, Jonas Björk, Cyrus Cooper, Bo Abrahamsen
PP381
Impact of hip fracture on mortality and life expectancy
Karl Michaëlsson, Peter Nordström, Anna Nordström, Hans Garmo, Liisa Byberg, Nancy Pedersen, Håkan Melhus
PP382
The relationship between cardiovascular risk and bone mineral density: an important role for anthropometry.
Renate de Jongh, Karen Jameson, Holly Syddall, Avan Sayer, Martin den Heijer, Cyrus Cooper, Elaine Dennison
PP383
Detection of autoantibodies to osteoprotegerin in patients with rheumatoid arthritis and their association with disease activity
Barbara Hauser, Philip Riches, Tamara Gilchrist, Jim F Wilson, William D Fraser, Stuart H Ralston
PP384
Does Vitamin D status impact on hip fracture incidence? - evidence of fracture variation with latitude and season in Sweden
Eugene McCloskey, Helena Johansson, Anders Oden, John Kanis
PP385
Fracture Risk Assessment in a Primary Care Population: Case Finding Using Routine GP Data, FRAX® and RAIDR® in the United Kingdom
Terry Aspray, Erica Whalley, Mike Scott, Steve Summers, Steve Turley, Rachel Wright, Valerie Maddison, Sharon Abdy, Lesley Kay
PP386
Effect of thymogen injections on dentinogenesis in mandibular incisors after thymectomy
A.A. Kochubey, V.I. Luzin, A.V. Yeryomin
PP387
Sclerostin associated with vertebral bone marrow fat in older men but not women
Vivian Ma, Xiaojuan Li, Sigurdur Sigurdsson, Gudny Eriksdottir, Alda Hauksdottir, Lisa Palermo, Trisha Hue, Thomas Lang, Tamara Harris, Clifford Rosen, Eric Vittinghoff, Kristin Siggeirsdottir, Gunnar Sigurdsson, Diana Oskarsdottir, Vilmundur Gudnason, Ann Schwartz
PP388
The association of leptin-adiponectin ratio with bone in overweight and obese postmenopausal women
Yi-Chih Chi, Pei-Yang Liu, Maria Spicer, Jasminka Ilich
PP389
Serum leptin and adiponectin in overweight and obese postmenopausal women after the 6-month weight loss program and their relationship with BMD
Yi-Chih Chi, Pei-Yang Liu, Maria Spicer, Jasminka Ilich
Other diseases of bone and mineral metabolism
PP3
The possibility rule of new mutations in juvenile Paget's disease (A rare case of mild JPD)
Judit Donath, Gabor Speer, Janos Kosa, Peter Lakatos, Gyula Poor
PP4
The impact of calcimimetic treatment on bone turnover in a renal patient with high turnover hyperparathyroid bone disease
Barbara Murray, Sinead Kinsella, Rory McQuillan, Alan Watson
PP5
Late onset autosomal dominant hypophosphatemic rickets; confirmation of the diagnosis with genomic analysis.
Symeon Tournis, Ioannis Stathopoulos, Kalliopi Lampropoulou-Adamidou, Theodora Koromila, Nikolaos Chatzistamatas, Michail Droggaris, Christos Zafeiris, Konstantinos Makris, Helen Marketou, Nikolaos Papaioannou, Panagoula Kollia, Gazi Gazi
PP6
Diagnosis of Fibrous Dysplasia with DNA tests.
Ioannis Stathopoulos, Alexia Balanika, Christos Baltas, Kalliopi Lampropoulou-Adamidou, Theodora Koromila, Panagoula Kollia, Symeon Tournis, Nikolaos Papaioannou, Aikaterini Katsalira
PP8
Phenotypic change in a patient with hypophosphatasia with the onset of renal failure
Tim Cundy, Toshimi Michigami, Kanako Tachikawa, Michael Dray, John Collins
PP9
FİBRODYSPLASIA OSSIFICANS PROGRESSIVA: CASE REPORT
Firuzan Altın, Özer Burnaz, Levent Özgönenel, Nil Çağlar
PP10
Hajdu-Cheney syndrome: report of two cases in a family
Georgina Terroso, Miguel Bernardes, Abelha Aleixo, Pedro Madureira, Romana Vieira, Rita Fonseca, Diana Goncalves, Lucia Costa
PP11
Gorham disease: description of a case with severe cervical spine involvement
Georgina Terroso, André Rodrigues Pinho, Manuel Santos Carvalho, Joana Freitas, Francisco Serdoura, Vitorino Veludo
PP454
Long bone fragility in NF1 is due to deficiency of architecture, micro-structure and matrix mineralization.
Jirko Kühnisch, Jong Seto, Claudia Lange, Susanne Schrof, Sabine Stumpp, Karolina Kobus, Julia Grohmann, Nadine Kossler, Peter Varga, Monika Osswald, Sigrid Tinschert, Wenke Seifert, Thaqif el Khassawna, David Stevenson, Florent Elefteriou, Uwe Kornak, Kay Raum, Peter Fratzl, Mateusz Kolanczyk, Stefan Mundlos
PP455
Cortical and Trabecular Alterations in Patients with Bone Marrow Edema of the Lower Limb
Afrodite Zendeli, Christian Muschitz, Roland Kocijan, Lukas Fischer, Daniela Suess, Heinrich Resch
PP456
Altered bone material properties in HLA-B27 rats, an animal model for arthritis, ankylosing spondylitis, and gastrointestinal inflammation
Sonja Gamsjaeger, Eleftherios P. Paschalis, Ruth Zoehrer, Klaus Klaushofer, Dimitris N. Tatakis
PP457
DPP4 inhibition attenuates bone loss in diabetic rats
Lorenzo Glorie, Geert Behets, Lesley Baerts, Ingrid De Meester, Patrick D'Haese, Anja Verhulst
PP458
EVALUATION OF BONE AND MINERAL METABOLISM IN PATIENTS WITH THE SYNDROME OF RESISTANCE TO THYROID HORMONE
Ludmilla Cardoso, Francisco de Paula, Lea Maciel
PP459
Correlates of tissue mineral density (TMD) of bone samples from total hip arthroplasty patients with type 2 diabetes: an ex vivo study
Janet Pritchard, Alexandra Papaioannou, Mark Hurtig, Lora Giangregorio, Stephanie Atkinson, Karen Beattie, J.D. Adachi, Justin DeBeer, Mitchell Winemaker, Victoria Avram, Henry Schwarcz
PP460
Osteopontin ASARM Peptide Binding to Crystal Faces of Hydroxyapatite - Computational Simulations
Ahmad Mansouri, David Masica, Jeffrey Gray, Marc McKee
PP461
QTc INTERVAL IN HYPERCALCEMIC KIDNEY TRANSPLANT RECIPIENTS
Ruzica Smalcelj, Anton Smalcelj
PP462
EXPRESSION OF RANKL/RANK/OPG IN COLON DURING EXPERIMENTAL INFLAMMATORY BOWEL DISEASE
Ivana Maric, Ivana Smoljan, Tamara Turk Wensveen, Andrica Lekic, Sanja Zoricic Cvek, Tanja Celic, Zeljka Crncevic Orlic, Dragica Bobinac
PP463
Bone morphogenetic protein-7 reduces kidney cold ischemic injury by maintaining epithelial phenotype of tubular cells
Tanja Celic, Josip Spanjol, Ivana Maric, Olga Cvijanovic, Dragica Bobinac
PP464
Effects of add on PTH(1-84) substitution therapy in hypoparathyroidism: results from 2.5 years of PTH treatment
Tanja Sikjaer, Emil Moser, Lars Rolighed, Leif Mosekilde, Lars Rejnmark
PP465
Post-surgical hypoparathyroidism and the risk of fractures
Line Underbjerg, Tanja Sikjaer, Leif Mosekilde, Lars Rejnmark
PP466
Bone cross-sectional geometry in adult patients with hypophosphatemic rickets: a hip structural analysis study
Charlotte Ejersted, Signe Beck-Nielsen, Jeppe Gram, Kim Brixen
PP467
Bone Marrow Fat Is Metabolically Distinct Fat Depot
Riku Kiviranta, Tam Pham, Jarna Hannukainen, Juho Järvelin, Anna Karmi, Minna Soinio, Pauliina Salminen, Pirjo Nuutila
PP468
Miglustat therapy normalizes bone mass in a mouse model of cystic fibrosis
Carole Le Henaff, Eric Haÿ, Frédéric Velard, Caroline Marty, Pierre J. Marie, Jacky P. Jacquot
PP469
MEPE-derived ASARM peptide impairs mineralization in tooth models of X-linked hypophosphatemia
Benjamin Salmon, Claire Bardet, Mayssam Khaddam, Brigitte Baroukh, Julie Lesieur, Dominique Le Denmat, Antonino Nicoletti, Anne Poliard, Peter S Rowe, Agnes Linglart, Marc D McKee, Catherine Chaussain
PP470
DETERMINANTS OF BONE LOSS IN CYSTIC FIBROSIS
Déborah GENSBURGER, Roland CHAPURLAT, Raphaele NOVE-JOSSERAND, Muriel RABILLOUD, Isabelle DURIEU
PP471
Long term energy deficiency in mice induces bone alterations reversed by long term recovery
Sara ZGHEIB, Stéphanie LUCAS, Mathieu MEQUINION, Odile BROUX, Damien LETERME, Pierre HARDOUIN, Odile VILTART, Christophe CHAUVEAU
PP472
Monocytic expression of osteoclast-associated receptor (OSCAR) is induced in atherosclerotic mice and regulated by oxidized low-density lipoprotein in vitro
Kathrin Sinningen, Martina Rauner, Nadia Al-Fakhri, Michael Schoppet, Lorenz Hofbauer
PP473
Evidence of increased bone resorption in early post menopausal women with Idiopathic Hypercalciuria. Study with biochemical markers and pQCT of the tibia.
Konstantinos Stathopoulos, Ilias Bournazos, Pelagia Katsimbri, Andonios Partsinevelos, Aristeides B. Zoubos, Panagiotis Papaggelopoulos, Erato Atsali, Grigoris Skarandavos
PP474
Insertion of the clcn7 gene mutation pG213R in mouse induces Autosomal Dominant Osteopetrosis Type II (ADO2).
Andrea Del Fattore, Amie K. Gray, Shoji Ichikawa, Kang Chu, Khalid S. Mohammad, Marta Capannolo, Maurizio Muraca, Anna Teti, Michael J. Econs, Imranul Alam
PP475
MULTIDISCIPLINARY STUDIES OF ANCIENT CALCIFIED TISSUES: I-RENAL STONES FROM MUMMIES
Mattia Capulli, Lorenzo Arrizza, Nadia Rucci, Sara Gemini Piperni, Raimondo Quaresima, Valentina Giuffra, Gino Fornaciari, Anna Teti, Luca Ventura
PP476
MULTIDISCIPLINARY STUDIES OF ANCIENT CALCIFIED TISSUES: II - CONTENTS FROM EGYPTIAN CANOPIC JARS
Nadia Rucci, Lorenzo Arrizza, Mattia Capulli, Antonio Maurizi, Cinzia Mercurio, Maria Cristina Guidotti, Gino Fornaciari, Anna Teti, Luca Ventura
PP477
A OPTN variant (rs1561570) interacts with TNFRSF11A polymorphism (rs1805034) on the clinical phenotype of sporadic Paget’s disease of bone.
Daniela Merlotti, Luigi Gennari, Fernando Gianfrancesco, Domenico Rendina, Marco Di Stefano, Teresa Esposito, Giuseppina Divisato, Giovanna Morello, Riccardo Muscariello, Giancarlo Isaia, Pasquale Strazzullo, Ranuccio Nuti
PP478
Circulating Sclerostin level in Patients with Ossification of the Posterior Longitudinal Ligament of the Spine
Masafumi Kashii, Yohei Matsuo, Tsuyoshi Sugiura, Takahito Fujimori, Yukitaka Nagamoto, Hirotsugu Honda, Takashi Kaito, Motoki Iwasaki, Hideki Yoshikawa
PP479
The activation of RANK/RANKL/OPG system in normal pregnancy and pre-eclampsia.Dorota
Dorota Darmochwal-Kolarz
PP480
Effect of polyphenolic compounds from Aronia melanocarpa berries on cadmium accumulation in the bone tissue
Malgorzata M. Brzóska, Malgorzata Galazyn-Sidorczuk, Maria Jurczuk
PP481
Single nucleotide polymorphisms identification and functional analysis in PDB6 locus – A target locus for Paget’s Disease of Bone
Iris Silva, Natércia Conceição, Laetitia Michou, M. Leonor Cancela
PP482
ZOLEDRONATE EFFICACY AND SAFETY IN ACTIVE PAGET'S DISEASE Long-term follow-up and retreatment in clinical practice
Elsa Vieira-Sousa, Ana Rodrigues, Joana Caetano-Lopes, Susana Capela, Filipa Ramos, Ricardo Figueira, Joaquim Polido-Pereira1, Cristina Ponte, Raquel Campanilho-Marques1, Rita Barros, José Carlos Romeu, José Alberto Pereira da Silva
PP483
Did Paget's Bone Disease Changed Over the Last Decade?
Susana Fernandes, Joana Borges, Inês Gonçalves, Luís Cunha Miranda, Rui Leitão, Alexandra Cardoso, Manuela Micaelo, Eugénia Simões, Augusto Faustino, Filipe Barcelos, Candida Silva, Miguel Sousa, Manuela Parente, Margarida Silva, Helena Madeira, Vera Las, Sara Cortes, José Melo Gomes, José Vaz Patto
PP484
Osteocyte metabolism on post-menopausal bone loss and role of hormone replacement therapy
Ana Maria Silva, Ana Carolina Moreira, Maria Sancha Santos, Anabela Albuquerque, Izilda Ferreira, Paulo Gil, Jorge Isidoro, Romeu Videira, Rui Carvalho, Vilma Sardão
PP485
The effect of hormone therapy on the change of bone mineral density in women with early menopause from pelvic radiation therapy for uterine cervical cancer
Dong Ock Lee, Hoon Choi, Jung Gu Kim
PP486
The relationship between renal function, bone mineral density and arterial stiffness in healthy postmenopausal women.
Yeon Soo Jung, Heejin Hwang, Young Sik Choi, Byung Seok Lee, Seok Kyo Seo
PP487
Preliminary study for the effect of PDGF or mesenchymal stem cells on tissue repair of cutaneous radiation injury
Soon Jung Hwang, Tae Hyung Cho, Beomseok Lee, Ji Hye Oh, In Sook Kim
PP488
Circulating RANKL is not a reliable biomarker for bone loss in primary hyperparathyroidism
Daniel Grigorie, Alina Sucaliuc, Elena Neacsu, Roxana Militaru, Alina Diaconescu, Mirela Ivan
PP489
Homeostasis of Calcium and Vitamin D in Patients with Aggressive Periodontitis.
Maria Zyablitskaya, Victoria Atrushkevich, Ashot Mkrtumian
PP490
Fracture predictors in patients with endogenous cortisol excess
Zhanna Belaya, Natalia Dragunova, Liudmila Rozhinskaya, Larisa Dzeranova, Galina Melnichenko
PP491
Cross sectional study of bone mass and 25OH vitamin D levels in Erythropoietic Protoporphyria
Gonzalo Allo, Guillermo Martínez-Diaz-Guerra, Maria del Carmen Garrido-Astray, Rafael Enríquez de Salamanca, Federico Hawkins
PP492
Allele Dependent Silencing of Collagen Type I Using Small Interfering RNAs Targeting 3’UTR Indels – a Novel Therapeutic Approach in Osteogenesis Imperfecta
Katarina Lindahl, Andreas Kindmark, Navya Laxman, Eva Åström, Carl-Johan Rubin, Östen Ljunggren
PP493
Functional assessment of Paget's disease-causing mutations in Sequestosome-1 (SQSTM1)
Eman Azzam, Miep Helfrich, Lynne Hocking
PP494
BMP-9 induces the calcification of vascular smooth muscle cells.
Dongxing Zhu, Neil Mackenzie, Colin Farquharson, Vicky MacRae
PP495
Long-term effects of symptomatic versus intensive bisphosphonate therapy for Paget's disease of bone: The PRISM-EZ study.
Kirsteen Goodman, Graeme MacLennan, William Fraser, Peter Selby, Stuart Ralston
PP496
The miR-221/222 family regulates vascular smooth muscle cell calcification.
Neil Mackenzie, Dongxing Zhu, Paul Genever, Vicky MacRae
PP497
A frameshift mutation in receptor activator of NFkB reveals a potential ligand-independent mechanism for NFκΒ activation.
Cahal Dignan, David Mellis, Angela Duthie, Alessandra Pangrazio, Cristina Sobacchi, Ansgar Schulz, Miep Helfrich, Julie Crockett
PP498
TOXIC OSTEOMYELITIS OF THE JAW ONES AGAINST THE BACKGROUNDS OF CHRONIC INTOXICATION
Margarita Skikevich, Liudmyla Voloshyna
PP499
Histological structure of the albino rats lower incisors of different ages after thymectomy
A.A. Kochubey, V.I. Luzin, A.V. Yeryomin
PP500
IFITM5 c.-14C>T mutation causes variable type V osteogenesis imperfecta phenotype and decreased COL1A1 expression but increased mineralization by cultured proband osteoblasts
Adi Reich, Alison S. Bae, Aileen M. Barnes, Wayne A. Cabral, David Chitayat, Joan C. Marini
PP501
Abnormal Type I Collagen Glycosylation Pattern and Cross-linking in a Cyclophilin B KO Mouse Model of Recessive Osteogenesis Imperfecta
Wayne Cabral, Irina Perdivara, MaryAnn Weis, Masahiko Terajima, Angela Blissett, Weizhong Chang, Elena Makareeva, Sergey Leikin, David Eyre, Mitsuo Yamauchi
Osteoporosis: treatment
PP7
SEVERE PREGNANCY- AND LACTATION- ASSOCIATED OSTEOPOROSIS. Teriparatide treatment
Kalliopi Lampropoulou-Adamidou, Christos Kosmidis, Ioannis P. Stathopoulos, Nikolaos A. Papaioannou, George Trovas
PP12
Severe osteoporosis associated with Hajdu-Cheney syndrome : follow-up after 2 years of teriparatide therapy
Georgina Terroso, Miguel Bernardes, Abelha Aleixo, Romana Vieira, Pedro Madureira, Rita Fonseca, Diana Goncalves, Lucia Costa
PP390
Cathepsin K Inhibition as a Therapeutic Target in Osteoporosis
John Eisman
PP391
Electronic clinical decision support for the management of osteoporosis in primary care.
Yvonne Selecki, Jaqui Center, Tuan Nguyen, John Eisman
PP392
Anti-osteoporosis treatment amongst Austrian hip fracture patients: Status quo, and effects on mortality and subsequent fracture risk
Wolfgang Brozek, Berthold Reichardt, Oliver Kimberger, Daniela Kritsch, Klaus Klaushofer, Elisabeth Zwettler
PP393
Remarkable bone mineral density increases on teriparatide in patients with glucocorticoid-induced osteoporosis and Crohn's disease
Danny Ko-Wu Kuo, Kenny To, David Kendler
PP394
Effects of a new conjugate drug in a rat model of postmenopausal osteoporosis
Careesa Liu, Robert Young, Marc Grynpas
PP395
Renal function and safety result after one year treatment of Zoledronic Acid in Chinese women with postmenopausal osteoporosis
Huiyong Shen, Yue Sun, Xun Liu
PP396
Characterization and Risk Factors of Acute-Phase Response Following a First-dose Administration of Zoledronic Acid for Treatment of Osteoporosis
DECAI CHEN
PP397
Intact heparin inhibits BMP6 osteogenic activity
Jelena Brkljacic, Martina Pauk, Igor Erjavec, Slobodan Vukicevic
PP398
Health economic consequences of fractures in patients with osteoporosis: A national register based study of total and incremental health costs following fracture.
Kim Rose Olsen, Carrinna Hansen, Bo Abrahamsen
PP399
Assessment of serum 25-Hydroxyvitamin D concentrations in postmenopausal osteoporotic women: a retrospective study to evaluate long-term treatment with vitamin D3
Camilla Sand Andersen, Peter Vestergaard, Parisa Gazerani, Hans Christian Hoeck
PP400
Osteonecrosis of the jaw and non-malignant disease
Amélie COUDERT, Géraldine LESCAILLE, Vanessa BAAROUN, Jean AZERAD, Martine COHEN-SOLAL, Ariane BERDAL, Vianney DESCROIX
PP401
Effectiveness of Strontium Renalate therapy for osteoporosis in men.  National Association of Osteoporosis in Georgia
Lali Kilasonia, Medea Kopaliani, Nana Kirvalidze, Luba Lagvilava, Neriman Tsintsadze
PP402
Do Bisphosphonates remain basic drugs for the treatment of osteoporosis?
Lali Kilasonia, Luba Lagvilava, Nana Kirvalidze, Medea Kopaliani, Neriman Tsartsidze
PP403
Parathyroid hormone changes following denosumab treatment in postmenopausal osteoporosis
Polyzois Makras, Stergios Polyzos, Athanasios Papatheodorou, Panagiotis Kokkoris, Daniel Chatzifotiadis, Athanasios Anastasilakis
PP404
Sequential therapy after PTH 1-84 treatment: comparison among bisphosphonates and strontium ranelate
Renato Pastore, Daniela Mentuccia, Patrizio Pasqualetti, Gaetano Frajese
PP405
Adherence to therapy: outcomes after seven years of treatment with Bisphosphonates
Renato Pastore, Daniela Mentuccia
PP406
IN REAL CLINICAL PRACTICE OSTEOPOROSIS DRUGS ARE TAKEN  FOR A VERY SHORT PERIOD: ANALYSIS OF PERSISTENCE IN THE CAMPANIA REGION
Giovanni Iolascon, Annarita Capaldo, Valentina Orlando, Enrica Menditto, Francesca Gimigliano
PP407
EFFECT OF A MIXTURE OF CALCIUM, VITAMIN D, INULIN AND SOY ISOFLAVONES ON BONE METABOLISM IN POST-MENOPAUSAL WOMEN: A RETROSPECTIVE ANALYSIS
Maurizio Bevilacqua, Vellela Righini, Diana Certan, Matteo Alemanni, Giorgio Gandolini
PP408
Vertebroplasty versus Kyphoplasty in Osteoporotic Vertebral Fractures: a Finite Element Comparative Analysis.
Luca Pietrogrande, Claudia Ottardi, Luigi La Barbera, Emanuela Raimondo, Tomaso Villa
PP409
25-OH vitamin D and γ-δ TCR lymphocyte interplay in the pathogenesis of acute phase reaction after zoledronic acid infusion for osteoporosis treatment
Chiara Crotti, Francesca Cavaciocchi, Maria De Santis, Angela Ceribelli, Gianluigi Fabbriciani, Carlo Selmi
PP410
BONE TURNOVER MARKERS AND RADIOGRAPHIC PROGRESSION OF VERTEBRAL COMPRESSION FRACTURES DURING ANTI-OSTEOPOROTIC THERAPY
Costantino Corradini, Vittorio Macchi, Stefano Pasqualotto, Francesca Boisio, Daniele Tradati, Calogero Crapanzano, Cesare Verdoia
PP411
Changes in low back pain and upper gastrointestinal symptoms in Japanese osteoporotic patients after switching to once-monthly oral minodronate from daily or weekly bisphosphonates  
Nobukazu Okimoto, Akinori Sakai, Satoshi Ikeda, Toru Yoshioka, Kitau Teshima, Hidehiro Matsumoto, Hiroshi Tsurukami, Yuichi Okazaki, Masato Nagashima, Fumio Fukuda, Shinobu Arita
PP412
Preoperative bisphosphonate treatment in patients with neuromuscular scoliosis improves bone strength of vertebral body
Masafumi Kashii, Yukitaka Nagamoto, Takahito Fujimori, Hirotsugu Honda, Takashi Kaito, Hideki Yoshikawa, Motoki Iwasaki
PP413
Early response to once-monthly oral minodronate after switching from daily or weekly bisphosphonates in Japanese osteoporotic patients
Akinori Sakai, Satoshi Ikeda, Nobukazu Okimoto, Kitau Teshima, Shinobu Arita, Hidehiro Matsumoto, Hiroshi Tsurukami, Yuichi Okazaki, Masato Nagashima, Fumio Fukuda, Toru Yoshioka
PP414
Treatment with eldecalcitol (ED-71) and raloxifene combined increases cancellous and cortical bone strength in ovariectomized rats.
Sadaoki Sakai, Satoshi Takeda, Ayako Shiraishi, Nobuo Koike, Masahiko Mihara, Koichi Endo
PP415
Patient preference and adherence to once-monthly oral minodronate in Japanese osteoporotic patients previously using daily or weekly bisphosphonates
Satoshi Ikeda, Akinori Sakai, Nobukazu Okimoto, Kitau Teshima, Shinobu Arita, Hidehiro Matsumoto, Hiroshi Tsurukami, Yuichi Okazaki, Masato Nagashima, Fumio Fukuda, Toru Yoshioka
PP416
Meta-Analysis of the Effects of Vitamin D Supplements on Bone Mineral Density in Adults
Ian R Reid, Mark Bolland, Andrew Grey
PP417
A case of Atypical Femoral Fracture with Abnormal Cortical Bone characterized by Impaired Mineralization and Pyrophosphate Accumulation
Maziar Shabestari, Erik Fink Eriksen, Paul Roschger, Eleftherios Paschalis, Adolfo Diez-Perez
PP418
Myricetin suppress LPS-induced MMP expression in human periodontal ligament fibroblasts and inhibit osteoclastogenesis by downregulating NFATc1 in LPS-induced RAW 264.7 cells
Seon-Yle Ko, Young-Joo Jang
PP419
Analysis of clinical assessment and efficacy of once-yearly intravenous zoledronic acid for osteoporosis
Ye-Soo Park, Hong-Sik Kim, Jung-Hwan Lee, Ye-Yeon Won, Byung-Moon Kang
PP420
Subsequent Hip Fracture in Inchon and Bucheon area of Korea (Cohort study)
Kyoung Ho Moon, Ju Young Kim, Kee haeng Lee
PP421
The efficiency of  bisphosphonates (alendronate, risedronate, ibandronate) for postmenopausal osteoporosis after 1 year of therapy
Diana Paun, Nicoleta Totolici, Monica Chirita, Rodica Petris, Constantin Dumitrache
PP422
Bisphosphonates poisonous action
Buyko Maria, Atrushkevich Victoria
PP423
Three years' experience of zoledronic acid use in the treatment of postmenopausal osteoporosis
Svetlana Yureneva, Oksana Yakushevskaya, Sergey Kuznetsov, Tatyana Ivanets, Vera Smetnik, Gennady Sukchich
PP424
Acute phase response and zoledronic acid therapy
Svetlana Yureneva, Oksana Yakushevskaya, Vera Smetnik, Gennady Sukchich
PP425
EVALUATION WITH DENSITOMETRY OF PATIENTS WITH BREAST CANCER AND LOW BONE MINERAL DENSITY (LBMD) AFTER 2 YEARS OF TREATMENT.
Sonia Muñoz Gil, Tomás Mut Dólera, Belén C Garrido López, MD Torregrosa Maicas, R Gironés Sarrió, P López Tendero, MD García Armario, Pascual Muñoz Mira
PP426
CHARACTERIZATION AND INCIDENCE ON ACUTE PHASE REACTION IN PAGET'S DISEASE AFTER ZOLEDRONIC ACID INFUSION
A. Conesa Mateos, D. Rotés Sala, J. Carbonell Abelló
PP427
Risk factors for the development of  vertebral fractures after percutaneous vertebroplasty.  
Àngels Martinez-Ferrer, Jordi Blasco, Laia Gifre, Ana Monegal, Nuria Guañabens, Pilar Peris
PP428
Persistence with different anti-osteoporosis medications: a population-based cohort study.
Aina Pagès-Castellà, Cristina Carbonell-Abella, Xavier Nogués, M Kassim Javaid, Nigel K Arden, Cirus Cooper, Adolfo Díez-Pérez, Daniel Prieto-Alhambra
PP429
STUDY DESCRIPTION AND BASELINE CHARACTERISTICS OF THE POPULATION ENROLLED IN THE EXTENDED FORSTEO® OBSERVATIONAL STUDY (ExFOS)
Bente Langdahl, Claude Benhamou, Erik Lindh, Joannes Dekker, Giorgios Kapetanos, Tomaz Kocjan, Östen Ljunggren, Nicola Napoli, Helmut Petto, Tatjana Nicolic
PP430
First in Man Study of a Novel and Highly Selective Cathepsin K Inhibitor MIV-711 - Safety, Pharmacokinetics and Pharmacodynamics of Single Ascending Oral Doses in Healthy Subjects
Urszula Grabowska, Erik Lindström, Markus Jerling, Torbjörn Larsson, Disa Böttiger, Kerstin Danielson, Jens D Kristensen, Charlotte Edenius
PP431
Bisphosphonate treatment of painful vertebral fractures due to osteoporosis in five boys with Duchenne muscular dystrophy
Eva Åström
PP432
Effects of a mutated sclerostin peptide on bone and lean mass in mice.
Maude Gerbaix, Dominique Pierroz, Nicolas Bonnet, Verena Boschert, Thomas Mueller, Serge Ferrari
PP433
Denosumab is associated with progressive improvements in hip cortical mass and thickness
K Poole, G Treece, A Gee, JP Brown, MR McClung, A Wang, C Libanati
PP434
Bone histology and histomorphometry: effects of 5 years of denosumab (DMAb) in the FREEDOM extension
Jacques P Brown, Rachel Wagman, David W Dempster, David Kendler, Paul Miller, Michael Bolognese, Ivo Valter, Jens-Erik Beck Jensen, Cristiano Zerbini, Jose R Zanchetta, Nadia Daizadeh, Ian Reid
PP435
Denosumab's dynamic CTX profile is maintained over 6 years of treatment: first 3 years of the FREEDOM extension study
C Roux, MR McClung, N Franchimont, S Adami, PR Ebeling, IR Reid, H Resch, G Weryha, N Daizadeh, A Wang, RB Wagman, R Eastell
PP436
Bone mineral density (BMD) changes in patients with prior fracture suboptimally treated with a bisphosphonate (BP): results from denosumab (DMAb)/ibandronate (IBN) and DMAb/risedronate (RIS) trials
Christopher Recknor, Christian Roux, Pei-Ran Ho, Jesse Hall, Henry Bone, Sydney Bonnick, Joop van den Bergh, Irene Ferreira, Rachel Wagman, Jacques P Brown
PP437
The spatial relationship between bone formation and bone resorption in healthy and ovariectomized mice treated with PTH, bisphosphonate or mechanical loading
Davide Ruffoni, Claudia Weigt, Elisa Fattorini, Alina Levchuk, Friederike Schulte, Gisela Kuhn, Ralph Müller
PP438
OPTIMIZING FRACTURE PREVENTION: THE FRACTURE LIAISON SERVICE, AN OBSERVATIONAL STUDY
Danielle Eekman, Sven van Helden, Margriet Huisman, Harald Verhaar, Irene Bultink, Piet Geusens, Paul Lips, Willem Lems
PP439
THE DIRECT AND INDIRECT COSTS OF AN OSTEOPOROTIC FRACTURE: A PROSPECTIVE EVALUATION OF ELDERLY PATIENTS WITH A CLINICAL FRACTURE
Danielle Eekman, Marieke ter Wee, Veerle Coupé, Seher Erisek-Demirtas, Mark Kramer, Willem Lems
PP440
Strontium potently inhibits mineralisation in bone-forming osteoblast cultures while osteoclast formation from marrow mononuclear cells is moderately reduced.   
Daniel Wornham, Mark Hajjawi, Isabel Orriss, Timothy Arnett
PP441
Reducing the risk of hypocalcaemia with parenteral antiresorptive therapies: an audit.
Wei Xu, Kenneth Baker, Rachel Reavley, Emily Oates, Terry Aspray
PP442
Design of a prospective observational study to evaluate persistence and adherence during denosumab treatment, and patient characteristics in postmenopausal women with osteoporosis in routine clinical practice
Maurille Feudjo Tepie,, Gerd Möller, Peyman Hadji, Irene Ferreira, Suresh Siddhanti, Stephen Boonen, Astrid Fahrleitner-Pammer, Nikos Papaioannou
PP443
Zoledronic acid versus Alendronate in the Management of Osteoporosis
Lyn Ferguson, Maurizio Panarelli, Rosemary Dargie
PP444
CORRECTION OF VITAMIN D DEFICIENCY IN WOMEN WITH POSTMENOPAUSAL OSTEOPOROSIS
Vladyslav Povoroznyuk, Nataliya Balatska
PP445
EFFECTIVENESS OF THE ACTIVE METABOLITE OF VITAMIN D IN THE TREATMENT OF POSTMENOPAUSAL OSTEOPOROSIS
Fedir Klimovitskiy, Vladyslav Povoroznyuk, Nataliya Balatska
PP446
Effects of Odanacatib on BMD and Safety in the Treatment of Osteoporosis in Postmenopausal Women Previously Treated with Alendronate- A Randomized Placebo-Controlled trial
Roland Chapurlat, Tobias De Villiers, Sydney Bonnick, Alberto Odio, Santiago Palacios, Boyd Scott, Celine Le Bailly De Tilleghem, Carolyn DaSilva, Albert Leung, Deborah Gurner
PP447
Effects of Sclerostin Antibody and Maintenance of New Bone Induced by Sclerostin Antibody in Animal Models
Xiaodong Li, Michael S Ominsky, Min Liu, Rogely W Boyce, Hua Zhu Ke
PP448
Resolution of Effects on Bone Turnover Markers and Bone Mineral Density after Discontinuation of Long-term Bisphosphonate Use 
Claude Benhamou, Tobias De Villiers, C Conrad Johnston, Bente Langdahl, Kenneth Saag, Andrew Denker, Annpey Pong, John P McGinnis II, Elizabeth Rosenberg, Arthur Santora
PP449
Odanacatib Treatment Reduces Remodeling- and Stimulates Modeling-based Bone Formation in Adult OVX Monkeys
C Chen, M Shih, H Zheng, L Duong
PP450
Transdermal Delivery of BA058, A Novel Analog of hPTHrP (1-34), with a Short Wear Time Patch in Preclinical and Clinical Studies
Gary Hattersley, Kris Hansen, Amy Determan, Ken Brown, Kate Mckay, Jonathan Guerriero, Dan McCarthy, C Richard Lyttle, Louis St L O'Dea
PP451
Estimation of Vertebral and Femoral Strength During the First Three Years of Denosumab Therapy Using an Alternative Smooth Non-linear Finite Element Methodology
Philippe Zysset, Dieter Pahr, Klaus Engelke, Harry Genant, Michael McClung, David Kendler, Christopher Recknor, Michael Kinzl, Jakob Schwiedrzik, Oleg Museyko, Andrea Wang, Cesar Libanati
PP452
Curbing Our Enthusiasm When Prescribing Strenuous Exercises in Osteopenia/Osteoporosis, When Fracture May Occur Under Good Intensions
Mehrsheed Sinaki
PP453
Factors Influencing Levels of Bone Resorption During Denosumab Dosing
Richard Eastell, Ethel Siris, Christian Roux, Dennis M. Black, Nathalie Franchimont, Graham Jang, Nadia Daizadeh, Rachel B. Wagman, Matt Austin
Arthritis and other joint diseases: translational and clinical
PP13
CLINICAL AND HISTOMORPHOMETRICAL ASSESSMENT OF BONE QUALITY IN HIP OSTEOARTHRITIS AND OSTEOPOROSIS
Maurizio Feola, Cecilia Rao, Monica Celi, Elena Gasbarra, Umberto Tarantino
PP14
PROPHYLAXIS OF GOUT FLARE WITH COLCHICINE AND VITAMIN C
Simeon Monov, Daniela Monova, Rasho Rashkov
PP15
Cartilage intermediate layer protein (CILP) is produced in synovial membrane of osteoarthritic joint and upregulated in osteoarthritis associated fibrosis
Irina Kerna, Kalle Kisand, Ann Tamm, Agu Tamm
PP16
Biomarker u-C2C in Estonian early knee OA cohort: progressive and non-progressive cases
Agu Tamm, Ann Tamm, Jaanika Kumm, Maret Vija, Mare Lintrop
PP17
Bone is the main target of activation of Canonical Wnt pathway in osteoarthritis
Thomas Funck-Brentano, Wafa Bouaziz, Valerie Geoffroy, Didier Hannouche, Caroline Marty, Eric Hay, Martine Cohen-Solal
PP18
Milk fat globule-epidermal growth factor 8 (MFG-E8) is a critical determinant of bone mass and alters the course of inflammation in arthritis
Kathrin Sinningen, Sylvia Thiele, Sylvia Grossklaus, Mark Udey, Lorenz C Hofbauer, Triantafyllos Chavakis, Martina Rauner
PP19
Vitamin K2 administration is associated with decreased disease activity in patients with rheumatoid arthritis
Kosuke Ebina, Tokimitsu Morimoto, Kenrin Shi, Shoichi Kaneshiro, Kota Koizumi, Makoto Hirao, Jun Hashimoto, Hideki Yoshikawa
PP20
Immunological profile of 110 rheumatoid arthritis
kawtar nassar, saadia janani, wafaa rachidi, ouafaa mkinsi
PP21
Monosodium urate crystals inhibit tenocyte viability and function: implications for periarticular involvement in chronic gout
Ashika Chhana, Karen Callon, Michael Dray, Bregina Pool, Dorit Naot, Greg Gamble, Brendan Coleman, Fiona McQueen, Jillian Cornish, Nicola Dalbeth
PP22
Generalized Long Term Bone Loss in Early Rheumatoid Arthritis in the Biologic Treatment Era - A 10 Year prospective Observational Study
Anne Prøven, Knut Helgetveit, Glenn Haugeberg
PP23
Ultrasound carotid plaque morphology in Rheumatoid Arthritis women without previous cardiovascular events
Alice Castro, Diana Carmona-Fernandes, Maria José Santos, Luís Mendes-Pedro, Helena Canhão, João Eurico Fonseca
PP24
bone mineral density changes after total knee replacement in women over the age of 65
Deog Yoon Kim
PP25
Rehabilitation of patients with early rheumatoid arthritis, including cryotherapy, physical exercises, occupational therapy, orthoses and therapeutic education
Evgeniya Orlova, Dmitry Karateev, Andrey Kochetkov, Lev Denisov
PP26
THE FEMORAL NECK FRACTURES IN PATIENTS WITH RHEUMATOID ARTHRITIS
Marina Podvorotova, Irina Dydykina
PP27
Sclerostin/MEPE axis in OA: lessons from long bone development
Katherine Staines, Blandine Poulet, Colin Farquharson, Andrew Pitsillides
PP28
The glutamate receptor antagonist NBQX alleviates inflammation, pathology and gait abnormalities in rat antigen induced arthritis.
Cleo Bonnet, Anwen Williams, Sophie Gilbert, Ann Harvey, Bronwen Evans, Deborah Mason
PP29
A deletion mutation of the gene P58IPK, the cellular inhibitor of PKR and PERK, results in a degenerative joint phenotype in mice.
Sophie Gilbert, Mari Nowell, Cleo Bonnet, Warren Ladiges, John Morton, Vic Duance, Debbie Mason
PP30
CHANGES AND COMPARISON OF BONE METABOLISM, BONE MINERAL DENSITY, MRI IN EARLY RHEUMATOID ARTHRITIS
Diana Vershhynina, Varerij Ryzhyk, Olena Mikhalchenko, Iryna Golovach, Peter Dudij, Igor Semeniv, Olga Shevchuk
Bone biomechanics and quality
PP31
A GWAS in an extreme high bone mass population shows exess signal from genes associated with BMD in normal population
Celia L Gregson, Paul J Leo Leo, Graeme R Clark, George Davey Smith, Matthew A Brown, Jon H Tobias, Emma L Duncan Duncan
PP32
Vitamin D levels of greater than 85nmol/L in the presence of adequate dietary Ca minimise bone turnover and improve bone strength.
Peter O'Loughlin, Alice Lee, Paul Anderson, Roland Steck, Mark Forwood, Rebecca Sawyer, Howard Morris
PP33
Influence of the organic matrix of mineralized tissues on their dynamic mechanical properties assessed by scanning acoustic microscopy
Stéphane BLOUIN, Stephan PUCHEGGER, Klaus KLAUSHOFER, Paul ROSCHGER, Peter FRATZL
PP34
Obesity Induced by a Sucrose-Rich Diet Promotes Deficits in Bone Mineralization and Microarchitecture
Bruna Biffe, Maria Tereza Nunes, Antonio Augusto Carvalho, Vilma Colli, Rita Dornelles, Ana Claudia Nakamune, Pedro Florindo, Mario Jefferson Louzada
PP35
The Effect of Fluoride on the DEXA Score and Material Properties of Ex Vivo Emu Tibiae.
Sidney Omelon, Kevin Nhan, Gillian Reid-Schachter, Nicolas Lacroix, Malaika Miles-Rossouw, Fabio Variola
PP36
Regional heterogeneity of trabecular bone microdamage density in association with trabecular microarchitecture and bone resorption in whole human lumbar vertebrae
Vincent T. Carpentier, Helen Tsangari, Nick L. Fazzalari, Julia S. Kuliwaba
PP37
Microarchitectural decay and microdamage accumulation in vertebral trabecular bone: a comparative analysis of the iliac crest, proximal femur and vertebral body in the aged postmenopausal skeleton
Vincent T. Carpentier, Dzenita Muratovic, Ian H. Parkinson, Nick L. Fazzalari, Julia S. Kuliwaba
PP38
Bisphosphonate influence on bone quality at molecular level: study of human jaw bone sequesters by Raman microspectroscopy.
Cécile Olejnik, Guillaume Falgayrac, Alexandrine During, Marie-Hélène Vieillard, Jean Michel Maes, Bernard Cortet, Guillaume Penel
PP39
Glucose-dependent insulinotropic polypeptide receptor deletion results in a reduced bone strength and quality
Aleksandra Mieczkowska, Nigel Irwin, Peter R Flatt, Daniel Chappard, Guillaume Mabilleau
PP40
Prediction of Vertebral Body Stiffness in Patients with Multiple Myeloma using a Linear qCT-based Finite Element Model
Graeme Campbell, Christian Graeff, Sarah Giravent, Felix Thomsen, Jaime Pena, A. Wulff, A. Günther, Claus -C Glüer, Jan Borggrefe
PP41
Mechanical contrasts between osteons and interstitial bone measured by scanning acoustic microscopy
Dmitri Fix, Stephan Puchegger, Christine Pilz-Allen, Paul Roschger, Peter Fratzl, Richard Weinkamer
PP42
Bone quality in young thalassaemic patients
Alberto Argentiero, Nadia Agnello, Cosimo Neglia, Giovanna Chitano, Alessandra Della Rosa, Giovanni Quarta, Antonella Quarta, Prisco Piscitelli, Alessandro Distante
PP43
Protective effect of polyphenols from Aronia melanocarpa berries against cadmium-induced weakening of the femur biomechanical properties in rats
Malgorzata M. Brzóska, Alicja Roszczenko, Joanna Rogalska
PP44
2-oxoglutaric acid protects against side effects of maximal therapeutic doses of dexamethasone in piglets skeleton.
Piotr Dobrowolski, Ewa Tomaszewska, Paulina Kurlak, Stefan Pierzynowski
PP45
Analysis of the microarchitecutre of the human femoral head using micro-computertomography
Hyungmin Ji, Ye-Yeon Won, Ye-Soo Park
PP46
Low magnitude vibration signals attenuate the rapid bone mass induced by Lipopolysaccharide
In Sook Kim, Tae Hyung Cho, Beomseok Lee, Soon Jung Hwang
PP47
Osseous alterations in condylar head after directional change of functional loading in rabbit mandibular condyle
Soon Jung Hwang, Hoon Joo Yang, Tae Hyung Cho, Ji Hye Oh, In Sook Kim
PP48
Nano-structural signs of the cortical bone fragility: Atomic force microscopy study in the femoral neck of elderly hip fracture patients and healthy aged controls
Petar Milovanovic, Zlatko Rakocevic, Jelena Potocnik, Danijela Djonic, Vladimir Zivkovic, Slobodan Nikolic, Marija Djuric
PP49
Nano-structural and compositional basis of devitalized tooth fragility
Ksenija Zelic Mihajlovic, Petar Milovanovic, Zlatko Rakocevic, Sonja Askrabic, Jelena Potocnik, Miroslav Popovic, Marija Djuric
PP50
Micro-morphological properties of osteons reveal changes in cortical bone stability during aging, osteoporosis and bisphosphonate treatment in women
Andreas Bernhard, Petar Milovanovic, Michael Hahn, Danijela Djonic, Matthias Krause, Stefan Breer, Klaus Pueschel, Elizabeth A. Zimmermann, Marija Djuric, Michael Amling, Bjoern Busse
PP51
Microstructural adaptation of bone tissue of the facial skeleton to the distribution of occlusal load under physiological conditions
Aleksa Janovic, Petar Milovanovic, Igor Saveljic, Dalibor Nikolic, Michael Hahn, Bjoern Busse, Zoran Rakocevic, Nenad Filipovic, Michael Amling, Marija Djuric
PP52
Bone morphometry from human peripheral quantitative computer tomography scans is preserved by virtual high-resolution image reconstruction
Friederike Schulte, Sandro Badilatti, Ian Parkinson, Jörg Goldhahn, Ralph Müller
PP53
Strontium ranelate treatment improves bone material level properties in human transiliac bone biopsy specimens
Patrick Ammann, René Rizzoli
PP54
In vitro exposure of rat femur to Strontium chloride influences bone material level properties and increases bone strength
Patrick Ammann, René Rizzoli
PP55
In vivo microindentation for the assessment of bone material level properties
Patrick Ammann, Roberto Güerri, Paul Hansma, Xavier Nogués, Adolfo Diez-Perez
PP56
Quantitative assessment of bone remodelling and osteophytogenesis in murine Osteoarthritis
Patricia Borges, Tonia Vincent, Massimo Marenzana
PP57
Role of Receptor Activity Modifying Protein 3 in the Response of Bone to Mechanical Loading
Matthew Livesey, Suruchi Pacharne, Ning Wang, Peter Grabowski, Lang Yang, Gareth Richards, Tim Skerry
PP58
Diagnostic Discrimination of TBS and Spine BMD in Glucocorticoid-induced and Postmenopausal Osteoporosis
Margaret Paggiosi, Nicola Peel, Richard Eastell
Bone development/growth and fracture repair
PP59
The Effect of mTORC1 on Postnatal Skeletal Development
Mary Matthews, Andrew Zannettino, Stephen Fitter, Sally Martin
PP60
MEK inhibitors in fracture healing and NF1 pseudarthrosis
David Little, Jad El-Hoss, Mille Kollind, Nikita Deo, Michelle McDonald, Kate Sullivan, Chris Little, Aaron Schindeler
PP61
Vascularisation and progenitor cells of primary and secondary ossification centres in the human growth plate
Sonja M. Walzer, Erdal Cetin, Ruth Grübl-Barabas, Irene Sulzbacher, Beate Rüger, Werner Girsch, Reinhard Windhager, Michael B. Fischer
PP62
The intermittent administration of Parathyroid hormone (1-34) may induce the formation of cementum and bone: a histological study in rats.
Daniel Vasconcelos, Marcelo Marques, Silvana Barros, Any Carolina Vasconcelos, Bruno Benatti, Pedro Novaes
PP63
Microtomography analysis of bone formation in calvarial defects filled with gelatin sponge or fibrin glue
Thiago de Santana Santos, Helena Bacha Lopes, Adriana Luiza Almeida, Marcio Mateus Beloti, Adalberto Luiz Rosa
PP64
Effect of fluoride in bone repair of alveolus of mice with different bone density. Histological and morphometric analysis.
Rodrigo Oliveira, Andressa Sabino, Paula Herrera, Mileni Fernandes, Patrícia Germino, Danielle Ceolin, Tânia Cestari
PP65
A novel biocompatible BMP6 carrier device for bone regeneration
Lovorka Grgurevic, Igor Erjavec, Morana Jankolija, Irena Popek, Anamarija Olic, Smiljka Vikic Topic, Donatella Verbanac, Mihaela Peric, Hermann Oppermann, Slobodan Vukicevic
PP66
The P2Y2 receptor restrains BMD during development
Susanne Syberg, Maria Ellegaard, Peter Schwarz, Niklas Rye Jørgensen
PP67
Hip fracture induces a transient appearance of circulating mesenchymal stem cells
Terhi J. Heino, Bettina Sederquist, Hannu T. Aro
PP68
Long bone phenotypic analyzes of a RANK transgenic mouse line
Vanessa BAAROUN, Amélie COUDERT, Caroline MARTY, Beatriz CASTANEDA, Ariane BERDAL, Vianney DESCROIX
PP69
The sealing zone is not required for mineralized cartilage resorption during endochondral ossification and growth of long bone.
Heiani Touaitahuata, Gaelle Cres, Anne Blangy
PP70
A casein-based diet leads to a better bone status than a soy protein-based diet during moderate protein restriction in growing mice.
Emilien Rouy, Norbert Laroche, François Blachier, Daniel Tomé, Laurence Vico, Anne Blais
PP71
Accuracy Errors in Longitudinal QCT Measurements of Cortical Thickness Bone Mineral Density (BMD) and Bone Mineral Content (BMC) Using Different Segmentation Techniques: A Simulation Study
Bastian Gerner, Oleg Museyko, Dominique Töpfer, Klaus Engelke
PP72
Calcium phosphate cement /Strontium enhances bone formation in the metaphyseal osteoporotic fracture
Thaqif El Khassawna, Seemun Ray, Ulrich Thormann, Katrin Lips, Michael Gelinsky, Matthias Schumacher, Alexander Claus Langheinrich, Reinhard Schnettler, Volker Alt
PP73
Feasibility of local CD133+ cell transplantation to avoid non-unions in biological impaired bone healing
Anke Dienelt, Andrea F. Sass, Bernd Preininger, Katharina Schmidt-Bleek, Georg N. Duda
PP74
Metaphyseal Fracture Healing in a Sheep Model of Low Turnover Osteoporosis Induced by Hypothalamic-Pituitary Disconnection
Ronny Bindl, Ralf Oheim, Pia Pogoda, Frank Timo Beil, Katharina Gruchenberg, Sandra Reitmaier, Tim Wehner, Enrico Calcia, Peter Radermacher, Lutz Claes, Michael Amling, Anita Ignatius
PP75
Interplay of physical and biological cues in the regeneration of critical-sized bone defects
Amaia Cipitria, Johannes C. Reichert, Claudia Lange, Hanna Schell, Manav Mehta, Wolfgang Wagermaier, Paul Zaslansky, Peter Fratzl, Dietmar W. Hutmacher, Georg N. Duda
PP76
THE EFFECT OF POST-NATAL (CHILDHOOD) OBESITY ON SKELETAL DEVELOPMENT
Efrat Monsonego-Ornan, Stav Simsa-Maziel, Janna Zareski, Sergey Anpilov, Gili Solomon
PP77
Histologic Diagnosis of Aluminum Osteomalacia in Renal Failure Rats
Yoshimi Teraki
PP78
Sex-related differences of femur properties in silver foxes (Vulpes vulpes)
Marcin Tatara, Witold Krupski, Andrzej Jakubczak, Marek Bienko, Krzysztof Kostro
PP79
Interrelationships between morphometric, densitometric and mechanical properties of mandible in 5-month old Polish Merino sheep
Witold Krupski, Marcin Tatara, Anna Szabelska, Iwona Luszczewska-Sierakowska, Barbara Tymczyna
PP80
Bone metabolism is influenced by serum 25-hydroxyvitamin D in healthy children
Edyta Czekuc-Kryskiewicz, Elzbieta Karczmarewicz, Maciej Jaworski, Justyna Czech-Kowalska, Anna Gorska, Jerzy Konstantynowicz, Pawel Pludowski, Jaroslaw Piskorski, Roman Lorenc
PP81
Characterization of an Y1R antagonist as a drug for bone regeneration.
Inês Alencastre, Catarina Almeida, Diana Leite, Cecília Alves, Daniela Sousa, Estrela Neto, Meriem Lamghari
PP82
MEASUREMENT PROPERTIES OF RADIAL AND TIBIAL SPEED OF SOUND FOR SCREENING BONE HEALTH AND FRAGILITY IN 10 TO 12 YEARS OLD BOYS AND GIRLS
Lurdes Rebocho, Graça Cardadeiro, Vera Zymbal, Ezequiel M Gonçalves, Luís B Sardinha, Fátima Baptista
PP83
Trabecular micro-architecture of the proximal femur during post-natal growth
Marija Djuric, Petar Milovanovic, Danijela Djonic, Michael Hahn, Bjoern Busse, Michael Amling
PP84
Variations in osteotoxic effects of cadmium on femoral bone structure after different routes of exposure
Monika Martiniakova, Hana Chovancova, Radoslav Omelka, Ivana Bobonova, Robert Toman
PP85
The retention and bioactivity of rhBMP-2 released from a bisphosphonate-linked hyaluronan-based hydrogel
Gry Hulsart-Billström, Pik-Kwan Yuen, Richard Marsell, Jöns Hilborn, Sune Larsson, Dmitri Ossipov
PP86
The effect of incubation time of preformed injectable hydrogels on bone formation when used as carrier of rhBMP-2 
Sonya Piskounova, Gry Hulsart-Billström, Lars Gedda, Kristoffer Bergman, Jöns Hilborn, Sune Larsson, Tim Bowden
PP87
Premixed calcium phosphate cement as a carrier for bone morphogenetic protein 2 
Nick Walters, Gry Hulsart-Billström, Håkan Engqvist, Sune Larsson
PP88
Low calcium intake aggravates the deleterious effects of an isocaloric low protein diet on bone material level properties during growth
Carole Fournier, René Rizzoli, Patrick Ammann
PP89
Spirulina alga prevents impairment of peak bone mass acquisition induced by an isocaloric low protein diet
Carole Fournier, René Rizzoli, Patrick Ammann
PP90
The choice of fetal bovine serum (FBS) influences the degree of spontaneous mineralization on silk fibroin scaffolds in 3D cell cultures
Samantha Paulsen, Jolanda Vetsch, Ralph Müller, Sandra Hofmann
PP91
Pediatric differences in Bone Mineral Density according to ethnic background in children. The Generation R Study.
Carolina Medina-Gomez, Denise H.M Heppe, Albert Hofman, Vincent Jaddoe, André Uitterlinden, Fernando Rivadeneira
PP92
Identifying scoliosis in population-based cohorts: development and validation of a novel method based on total body dual energy X-ray absorptiometry scans
Hilary Taylor, Ian Harding, John Hutchinson, Ian Nelson, Ashley Blom, Jon Tobias, Emma Clark
PP93
Smaller bones at aged 10 predicts scoliosis at aged 15: Results from a population-based birth cohort
Hilary Taylor, Ashley Blom, Ian Harding, John Hutchinson, Ian Nelson, Jon Tobias, Emma Clark
PP94
The healing of fracture of mandible  against the chronic nitrate intoxication
David Aveticov, Vitaly Kostenko, Karine Neporada, Ekaterina Lokes, Stanislav Stavickiy
PP95
Osteometric parameters of mature rats mandible molars at implantation in the tibia of biogenic hydroxyapatite
Luzin Vladislav, Morozov Vitali, Morozova Helen
PP96
Macroelements composition of the dentin in rat’s mandibular incisors with implanted biogenic hydroxyapatite into the tibia
Luzin Vladyslav, Morozov Vitaly, Astrakhantsev Dmitry, Golubkov Pavel, Sokol Marina
PP97
Organometric parameters of rat′s bones under the effect of toluene vapor
Skorobogatov A, Luzin V, Morozov V, Shutov Ye
PP98
Identification and Characterization of a Mesenchymal Progenitor Cell Population Involved in Fracture Healing
Brya Matthews, Danka Grcevic, Liping Wang, Yusuke Hagiwara, Douglas Adams, Ivo Kalajzic
Calciotropic and phosphotropic hormones and mineral metabolism
PP99
INTERRELATIONSHIP BETWEEN OSTEOCALCIN (BGP) AND ENERGETIC METABOLISM IN TWO STRAINS OF RATS.
Clarisa Marotte, Gabriel Bryk, Magali Zeni Coronel, Paulina Abrego, Diego Martín Lucero, Laura Schreier, María Luz Portela, Susana Noemí Zeni
PP100
a mixture of GOS/FOS® ADDED TO A LOW CALCIUM (Ca) DIET IMPROVED  Ca, PHOSPHORUS (P) AND MAGNESIUM (Mg) ABSORPTION: EXPERIMENTAL MODEL IN NORMAL GROWING RATS
Gabriel Bryk, Macarena Gonzales Chaves, Clarisa Marotte, Daniela Medina, Magali Zeni Coronel, Maria Luz De Portela, Susana Noemi Zeni
PP101
Vasculature and Bone: Stages of Atherosclerosis come along with Changes in Gene Expression Levels of Calcification Regulators
Natascha Schweighofer, Ariane Aigelsreiter, Martina Graf-Rechberger, Nicole Hacker, Daniela Kniepeiss, Philipp Stiegler, Olivia Trummer, Thomas Pieber, Matthias Ulbing, Doris Wagner, Helmut Müller, Barbara Obermayer-Pietsch
PP102
A genetic polymorphism of osteocalcin is associated with BMI but not with parameters of glucose and lipid metabolism in women with polycystic ovary syndrome
Verena Schwetz, Olivia Trummer, Albrecht Giuliani, Thomas R. Pieber, Barbara Obermayer-Pietsch, Elisabeth Lerchbaum
PP103
State and metabolism of osseous tissue in people with postinfarction cardiosclerosis
Liudmila Yankouskaya, Irena Karpova
PP104
Neonatal neuroendocrine alterations impair tooth eruption, enamel mineralization, and leptin and corticosterone secretion in adulthood.
Wagner Garcez de Mello, Samuel Rodrigues Lourenço de Morais, Alberto Carlos Botazzo Delbem, Rita Cássia Menegati Dornelles, José Antunes-Rodrigues, João Cesar Bedran de Castro
PP105
α2CAR KO Mice Present Opposite Bone Phenotype in Femur and Vertebrae
Marilia Bianca Teixeira, Gisele Martins, Cristiane Costa, Patricia Brum, Cecília Gouveia
PP106
Bone microtomography and immunohistochemistry of acyclic rats post antiresorptive therapy and resistance training
Camila Stringhetta-Garcia, Samuel Morais, Mário Louzada, Edilson Ervolino, Rita Dornelles
PP107
A study of the correlation between femoral head iron content and BMD in postmenopausal women
Bing Wang
PP108
A sensitive assay for measuring circulating BMP6
Martina Pauk, Lovorka Grgurevic, Jelena Brkljacic, Vera Kufner, Tatjana Bordukalo-Niksic, Morana Jankolija, Hermann Oppermann, Slobodan Vukicevic
PP109
Biochemical bone markers of bone turnover in diabetics- a meta-analysis.
Jakob Starup-Linde, Stine Aistrup Eriksen, Peter Vestergaard
PP110
Short-term resveratrol supplementation stimulates serum levels of bone-specific alkaline phosphatase in obese non-diabetic men
Morten Møller Poulsen, Marie Juul Ornstrup, Torben Harsløf, Niels Jessen, Bente Lomholt Langdahl, Bjørn Richelsen, Jens Otto Lunde Jørgensen, Steen Bønløkke Pedersen
PP111
The effect of gastric bypass on hormones related to bone re-modeling and intestinal growth.
Bolette Hartmann, Henrik Vestergaard, Peter Bonfils, Marie Hansen, Nicolai Albrechtsen, Peter Eskildsen, Andrea Floyd, Annette Lykke Svenningsen, Jens Juul Holst
PP112
Plasma triiodothyronine (T3) levels are positively associated with BMD and bone strength: a cross-sectional study.
Emil Moser, Tanja Sikjaer, Leif Mosekilde, Lars Rejnmark
PP113
Lower bone turnover in obesity: Is there a link to energy metabolism?
Heli Viljakainen, Kaisa K. Ivaska, Marita Lipsanen-Nyman, Tero Saukkonen, Sture Andersson, Kalevi Laitinen, Outi Mäkitie
PP114
Pro-angiogenic and pro-survival Functions of Glucose in Human Mesenchymal Stem Cells Upon Transplantation
Mickael Deschepper, Joseph Paquet, Mathieu Manassero, Morad Bensidhoum, Karim Oudina, Delphine Logeart-Avramoglou, Herve Petite
PP115
On the Importance of Selenium for Bone Physiology
Nicole Pietschmann, Eddy Rijntjes, Antonia Hoeg, Lutz Schomburg
PP116
Effect of high doses of vitamin D on arterial properties, adiponectin, leptin and glucose homeostasis in type 2 diabetic patients.
Marina Shargorodsky
PP117
Relationship between bone mineral density, body composition, skin sclerosis and serum 25(OH) vitamin D levels in  systemic sclerosis
Addolorata Corrado, Anna Neve, Arcangela Marucci, Ripalta Colia, Angiola Mele, Francesco Paolo Cantatore
PP118
Role of estrogen replacement therapy in the control of immune system in postmenopausal osteoporosis.
PATRIZIA D'AMELIO, FRANCESCA SASSI, ILARIA BUONDONNO, GIORGIA FORNELLI, ELENA BONARDO, GIOVANNI CARLO ISAIA
PP119
VITAMIN D IN FRAGILE ELDERLY  WOMEN WITH SEVERE OSTEOPOROSIS AND  UNCONTROLLED HYPERTENSION Ferdinando D’Amico12, Francesco Caronzolo1, Giovanni Gaglio1, Antonino Granata1, Giuseppina Lombardo1, Tiziana Pipicella1,  Enzo Russo1, Pippo Spatola1, Alessandro Grippa1  Department of Geriatrics,   Hospital of Patti 1 - School  of Medicine, University of Messina 2   - Messina, Italy
Ferdinando D'Amico, Francesco Caronzolo, Giovanni Gaglio, Antonino Granata, Giuseppina Lombardo, Tiziana Pipicella, Pippo Spatola, Enzo Russo, Alessandro Grippa
PP120
Interaction between FGF23 R176W mutation and C716T nonsynonymous change (T239M, rs 7955866) in FGF23 on the clinical phenotype in a family with autosomal dominant hypophosphatemic rickets
Daniela Merlotti, Domenico Rendina, Luigi Gennari, Teresa Esposito, Sara Magliocca, Gianpaolo De Filippo, Pasquale Strazzullo, Ranuccio Nuti, Fernando Gianfrancesco
PP121
Calcium Dietary Intake in Southern Lebanese Women
Yasser Yaghi, Fatiha El Horr, Nancy Maan, Kinda Yaghi
PP122
Effects of long-term oral administration with methimazole on femur properties in male Wistar rats
Marcin Tatara, Marcin Golynski, Radoslaw Radzki, Marek Bienko, Witold Krupski
PP123
Vitamin D supplementation during lactation- effect on maternal and offspring's vitamin D status and bone mass - double-blind randomized control trial.
Justyna Czech-Kowalska, Maciej Jaworski, Julita Latka-Grot, Dorota Bulsiewicz, Pawel Pludowski, Bogdan Chazan, Beata Pawlus, Grazyna Wygledowska, Anna Zochowska, Maria K. Kornacka, Edyta Kryskiewicz, Elzbieta Karczmarewicz, Anna Dobrzanska
PP124
Polyphenols from berries of Aronia melanocarpa improve the antioxidative capacity of the bone tissue in cadmium-exposed rats
Joanna Rogalska, Malgorzata M. Brzóska, Alicja Roszczenko, Malgorzata Galazyn-Sidorczuk, Maria Jurczuk
PP125
The serum serotonin and 25-OH vitamin D levels: a study in 97 menopausal women
Mara Carsote, Mihaela Popescu, Ramona Samoila, Rene Baloescu, Madalina Muler, Adriana Gruia, Catalina Poiana
PP126
Vitamin D: Light side and best time of sunshine in Riyadh, Saudi Arabia
Fahad Alshahrani, Mussa Almalki, Naji Aljohani, Abdullah Alzahrani, Yossef Alsaleh, Michel Holick
PP127
Hypercalcemia following high vitamin D loading dose 
Paul Lips, Aegida Neradova, Natasja van Schoor, Mark Vervloet
PP128
Mass spectrometric immunoassay (MSIATM) for intact parathyroid hormone: correlation with immunoassay and application to clinical samples.
L Couchman, D Taylor, B Krystans, M Lopez, A Prakash, D Sarracino, A Garces, M Vogelsang, S Peterman, G Vadali, S Robinson, C Moniz
PP129
The Ellsworth-Howard Test Revisited
J. C. Y. Tang, C. J. Washbourne, H. Galitzer, T. Hiemstra, C. Meek, A. Chipchase, W. D. Fraser
PP130
CALCIUM-PHOSPHORUS METABOLISM AND CALCIUM-REGULATING HORMONES IN OSTEOPOROSIS WHICH ASSOCIATED WITH LIVER CIRRHOSIS
Iryna Golovach, Zinovij Mytnyk, Diana Vershynina
PP131
Effects of Zoledronic Acid (ZOL) on Hormone Levels in Premenopausal Women with Breast Cancer (BC) Receiving Neoadjuvant or Adjuvant Chemotherapy (CT) and Endocrine Therapy (ET): ProBONE II Study
Peyman Hadji, Anette Kauka, Thomas Bauer, May Ziller, Katrin Birkholz, Monika Baier, Mathias Muth, Peter Kann
Cancer and bone: basic, translational and clinical
PP132
The central role of the histone demethylase JHDM1D in the regulation of tumor associated genes in bone tumor related cells
Roman Thaler, Silvia Spitzer, Florian Haider, Heidrun Karlic, Klaus Klaushofer, Franz Varga
PP133
Identification of tumorigenic sarcoma cancer stem cells based on high aldehyde dehydrogenase 1 activity
Birgit Lohberger, Beate Rinner, Nicole Stuendl, Sonja Maria Walzer, Reinhard Windhager, Andreas Leithner
PP134
Isolation of ALDH1high Cells by Flow Cytometry and Investigation of the Expression Pattern of Wnt Pathway Genes in Primary Chordoma Cell Lines
Birgit Lohberger, Nicole Stuendl, Katharina Meditz, Bernadette Liegl, Andreas Leithner, Beate Rinner
PP135
Anti-RANKL Nanobody® ALX-0141 Shows Sustained Biomarker Inhibition in a Phase I Study in Healthy Postmenopausal Women
Pieter Schoen, Sandy Jacobs, Katrien Verschueren, Ingrid Ottevaere, Sigrid Sobry, Josefin-Beate Holz
PP136
Modulation of macrophage activation status by bisphosphonates and breast cancer cells.
Sofia Sousa, Jukka Mönkkönen, Jorma Määttä
PP137
Clusterin Inhibition using OGX-011 Synergistically Enhances Zoledronic Acid Activity in Osteosarcoma.
Francois Lamoureux, Marc Baud'huin, Benjamin Ory, Martin Gleave, Dominique Heymann, Francoise Redini
PP138
New chondrosarcoma cell lines and mouse models to study the link between chondrogenesis and chemoresistance
David Monderer, Alexandrine Luseau, Amélie Bellec, Emmanuelle David, Stéphanie Ponsolle, Soraya Saïagh, Sylvain Bercegeay, Philippe Piloquet, Marc Denis, Laurence Lodé, Françoise Rédini, Marine Biger, Dominique Heymann, Marie-Françoise Heymann, Ronan Le Bot, François Gouin, Frédéric Blanchard
PP139
New PI3Kalpha-specific inhibitor, BYL719: therapeutic interest in osteosarcoma
Bérengère Gobin, Marc Baud'huin, Céline Charrier, Soizic Hervouet, Frédéric Lezot, Frédéric Blanchard, Dominique Heymann
PP140
NVP-BEZ235, a dual PI3K/mTOR inhibitor, inhibits osteosarcoma cell proliferation and the tumor development in vivo
Bérengère Gobin, Séverine Battaglia, Julie Chesneau, Dominique Heymann
PP141
Therapeutic interest of Imatinib Mesylate in Osteosarcoma
Bérengère Gobin, Gatien Moriceau, Benjamin Ory, Régis Brion, Françoise Rédini, Dominique Heymann
PP142
Over-expression of Smad7 in osteosarcoma cells inhibits primary tumor growth, the associated bone osteolysis and the development of lung metastasis in murine xenograft model.
Audrey Lamora, Julie Talbot, Bérengère Gobin, Marion Leduc, Julien Taurelle, Régis Brion, Dominique Heymann, Françoise Rédini, Franck Verrecchia
PP143
Bone remodelling in patients with an IgM monoclonal gammopathy (Waldenström disease -MGUS)
Daniel Chappard, Béatrice Bouvard, Mathieu Royer, Emmanuel Hoppé, Erick Legrand, Norbert Ifrah, Maurice Audran
PP144
Selective BET bromodomains epigenetic signaling inhibition as a therapeutic strategy in primary bone tumors
Francois Lamoureux, Marc Baud'huin, Lidia Rodriguez, Camille Jacques, Martine Berreur, James E. Bradner, Francoise Redini, Dominique Heymann, Benjamin Ory
PP145
Synergistic anti-tumour effects on human breast cancer cells by mevalonate pathway inhibitors atorvastatin and zoledronic acid
Andy Göbel, Stefanie Thiele, Martina Rauner, Lorenz C. Hofbauer, Tilman D. Rachner
PP146
Metabolomics identifies plasma biomarkers of multiple myeloma development and progression
Elisabetta Mariani, Francesca Fontana, Silvia Mari, Jose Manuel Garcia Manteiga, Magda Marcatti, Nicola Napoli, Francesco Camnasio, Gianfranco Fraschini, Enrico Caneva, Roberto Sitia, Giovanna Musco, Fabio Ciceri, Simone Cenci
PP147
Involvement of the co-receptor RAMP2 in the progression of breast cancer-induced osteolytic lesions.
Alfredo Cappariello, Nadia Rucci, Mattia Capulli, Maurizio Muraca, Anna Teti
PP148
Direct administration of zoledronate acid improves bone structure in local osteoporotic lesion of ovariectomized rats
Yohei Matsuo, Masafumi Kashii, Tsuyoshi Sugiura, Tokimitsu Morimoto, Hirotsugu Honda, Takashi kaito, Motoki Iwasaki, Hideki Yoshikawa
PP149
Cytotoxicity of picocyanobacteria strains of the genera Cyanobium on Osteosarcoma Cells
Rosário Martins, Margarida Costa, Mónica Garcia, Piedade Barros, João Costa-Rodrigues, Vitor Vasconcelos, Maria Fernandes
PP150
Inhibition of osteoclastogenesis by proton pump inhibitors on co-cultures of human osteoclasts and breast cancer cells
Sara Reis, Maria Fernandes, João Costa-Rodrigues
PP151
Trolox Inhibits Breast Cancer Bone Metastasis and Bone Destruction Through Suppression of PGE2 Production
Jong-Ho Lee, Hyunil Ha, Won Jong Jin, Sun-Don Kim, Jin Suk Jung, Hong-Hee Kim, Zang Hee Lee
PP152
Carcinoid tumors and DXA assessment - a study in 222 menopausal women
Catalina Poiana, Mara Carsote, Rodica Petris, Raluca Trifanescu, Gabriela Voicu, Diana Paun
PP153
The DXA results in 41 patients with neuroendocrine tumors: a transversal study
Mara Carsote, Andreea Geleriu, Roxana Dusceac, Roxana Miron, Cristina Ene, Valentin Radoi, Gabriela Voicu, Catalina Poiana
PP154
miR-192 Impairs Invasion and Tumor-Induced Osteolysis by Repressing CCL2 in Bone Metastatic Colonization
Karmele Valencia, Diego Luis-Ravelo, Nicolas Bovy, Susana Martínez-Canarias, Cristina Ormazábal, Carolina Zandueta, Iker Antón, Ingrid Struman, Sébastien Tabruyn, Victor Segura, Javier De Las Rivas, Eva Bandrés
PP155
Influence of sex steroids on sclerostin levels in patients with prostate cancer
Manuel Muñoz-Torres, Rebeca Reyes-Garcia, Beatriz Garcia-Fontana, Sonia Morales-Santana, Mariela Varsavsky, Maria Dolores Aviles-Perez, Antonia Garcia-Martin
PP156
Vitamin D serum levels and breast cancer risk in a Mediterranean population: a case-control study.
Maria Rodriguez-Sanz, Natalia García-Giralt, Elisa Torres, Marta De Ramon, Antonio Cano-Sánchez, Miguel Ángel García-Pérez, Sonia Servitja, Laia Garrigós, María Martinez-García, Ignasi Tusquets, Joan Albanell, Adolfo Díez, Daniel Prieto-Alhambra, Xavier Nogués
PP157
Bone metastatic prostate cancer cells regulate their growth via impairing osteoblast differentiation
Marjolein van Driel, Iris Robbesom, Ruben Koster, Bianca Boers-Sijmons, Hideki Chiba, Hans van Leeuwen
PP158
Role of receptor activity modifying proteins (RAMPs) in skeletal regulation.
SURUCHI PACHARNE, GARETH RICHARDS, NING WANG, TIMOTHY SKERRY, KATHLEEN CARON
PP159
A novel antagonist of the canonical Wnt-signalling pathway, Sostdc1, is expressed in experimental models of myeloma and suppresses bone formation.
Clive Buckle, Zahra Faraahi, Michelle Lawson, Colby Eaton, Karin Vanderkerken, Peter Croucher
PP160
Glucose ceramide synthase inhibitors prevent osteoclast activation and limit myeloma induced osteolytic lesions
Adel Ersek, Ke Xu, Anastasios Karadimitris, Nicole J. Horwood
PP161
Effect of Zoledronic Acid (ZOL) on Bone Mineral Density (BMD) in Premenopausal Women Receiving Neoadjuvant or Adjuvant Therapies for Breast Cancer (BC): The ProBONE II Study
Peyman Hadji, Anette Kauka, Thomas Bauer, Katrin Birkholz, Monika Baier, Mathias Muth Muth, May Ziller
PP162
Effect of Zoledronic Acid (ZOL) on Bone Metabolism in Patients With Bone Metastases From Prostate or Breast Cancer (BC): The ZOTECT Study
Peyman Hadji, May Ziller, Tobias Maurer, Michael Autenrieth, Mathias Muth, Amelie Ruebel, Christoph May, Katrin Birkholz, Erhardt Diebel, Jochen Gleissneer, Peter Rothe, Juergen E Gschwend
Cell biology: osteoblasts and bone formation
PP163
Hepatic lipase is expressed by osteoblasts and modulates bone remodeling in obesity
Alexander Bartelt, F. Timo Beil, Brigitte Müller, Till Köhne, Markus Heine, Tayfun Yilmaz, Joerg Heeren, Thorsten Schinke, Andreas Niemeier
PP164
Histologic evaluation of direct pulp capping by the using of calcium hydroxide and octacalcium phosphate in dental pulp of cats
Fereydoon Sargolzaei-aval, Mohammad reza Arab, Eshagh Ali Saberi
PP165
Implantation of Octacalcium phosphate (OCP) enhances alveolar ridge in rat mandible
Fereydoon Sargolzaei Aval, Mohammad Reza Arab, Forough Sargolzaei Aval
PP166
ACTIVATED PROTEIN C (APC) INCREASES OSTEOBLAST PROLIFERATION AND BMP-2 INDUCED BONE FORMATION
Kaitlin Shen, Aaron J. Schindeler, Tegan L. Cheng, Meilang Xue, David G. Little, Chris J. Jackson
PP167
ADIPOGENESIS OCCURS AT THE EXPENSE OF OSTEOBLAST DIFFERENTIATION IN PRIMARY OSTEOBLASTS DEFICIENT IN PROTEASE-ACTIVATED RECEPTOR-2
Pamuditha Kularathna, Charles N. Pagel, John D. Hooper, Eleanor J. Mackie
PP168
Distinct Potential of Osteoblast Differentiation of Adipose Tissue- and Bone Marrow-Derived Mesenchymal Stem Cells
Rodrigo Abuna, Fabiola de Oliveira, Rogerio Kato, Adalberto Rosa, Marcio Beloti
PP169
Increase of mineral nodules and alkaline phosphatase levels in osteoblasts cultures by using disordered carbon nanotubes and titanium discs.
Daniela Cervelle Zancanela, Ana Maria Sper Simão, Elaine Yoshiko Matsubara, José Maurício Rosolen, Pietro Ciancaglini
PP170
Calcium transport and phosphomonohydrolase activity by proteoliposomes harboring Annexin V and Alkaline Phosphatase
Maytê Bolean, Ana Maria Simao, Tina Kiffer-Moreira, Marc Hoylaerts, José Luis Millán, Pietro Ciancaglini
PP171
In vitro effect of prolactin on the osteogenic potential of bone marrow mesenchymal stem cells of rats
Natália de Melo Ocarino, Silvia Silva Santos, Lorena Rocha, Juneo Freitas, Amanda Maria Sena Reis, Rogéria Serakides
PP172
Differential Gene Expression of Matrix Metalloproteinases (MMPs), MMP-inhibitors (TIMPs and RECK), and MMP-activator (EMMPRIN/CD147) During Osteogenic Differentiation from Human Dental Pulp Stem Cells (DPSCs).
Katiucia Paiva, Luiz Silva, Mari Sogayar
PP173
Exogenous polyphosphate is not readily utilized for mineralization in vitro
Marianne Ariganello, Sidney Omelon, Rima Wazen, Fabio Variola, Antonio Nanci
PP174
Elevated levels of serotonin decrease bone volume by direct effects on bone turnover in rats
Igor Erjavec, Tatjana Bordukalo-Niksic, Jelena Brkljacic, Martina Pauk, Lovorka Grgurevic, David D. Thompson, Vishwas M. Paralkar, Lipa Cicin-Sain, Slobodan Vukicevic
PP175
Identification of a small molecule kinase inhibitor that enhances osteoblast differentiation of human skeletal (mesenchymal) stem cells through regulation of TGFβ signaling
Majken Storm Siersbaek, Abbas Jafari, Walid Zaher, Li Chen, Moustapha Kassem
PP176
The effect of fibroblast growth factor 2 (FGF2) on mesenchymal stromal cell differentiation
Tiina Kähkönen, Kaisa, K. Ivaska, Pirkko Härkönen
PP177
Extracellular glucose alters mesenchymal stromal cell growth and differentiation
Anna-Reeta Virta, Kaisa K. Ivaska
PP178
Regulation and function of immunosuppressive molecule human leukocyte antigen G5 in human bone tissue
Frederic Deschaseaux, Julien Gaillard, Alain Langonné, Christophe Chauveau, Abderrahim Naji, Amina Bouacida, Philippe Rosset, Dominique Heymann, Gonzague de Pinieux, Nathalie Rouas-Freiss, Luc Sensébé
PP179
Mineralizing properties of DMP1 studied in vitro with cellular and acellular 3D collagen model systems mimicking the bone tissue
Jérémie Silvent, Nadine Nassif, Thierry Azaïs, Christophe Hélary, Sidney Delgado, Fabrice Soncin, Marie Madeleine Giraud-Guille, Jean-Yves Sire
PP180
N-Cadherin Governs Age-Related Determination in Mice Through Modulation of Wnt5a and Wnt10b.
Eric Haÿ, François-Xavier Dieudonné, Caroline Marty, Pierre J. Marie
PP181
The impairement of bone formation and mineralization in BSP-/- mouse calvaria cell cultures is partly rescued by increasing cell density
Guénaëlle Bouët, Wafa Bouleftour, Marchat David, Linossier Marie-Thérèse, Thomas Mireille, Aubin Jane E., Vico Laurence, Malaval Luc
PP182
Evaluation of bone formation capacities of human adipose-derived stromal cells cultured in platelet growth factor-enriched plasma medium.
Fabien Guilloton, Vahideh Rabani, Meadhbh Brennan, Giulio Bassi, Mauro Krampera, Pierre Layrolle, Luc Sensebé, Frédéric Deschaseaux
PP183
Development of mice models to study implant osseointegration and failure in alveolar bone 
Sylvain Mouraret, Claire Bardet, Dan J Hunter, Antoine Popelut, John B Brunski, Catherine Chaussain, Philippe Bouchard, Jill A Helms
PP184
Activation of β-Catenin Signalling Enhances the Osteogenic Gene Response to Mechanical Loading in Mesenchymal Stem Cells
Claudia Nemitz, Astrid Liedert, Franz Jakob, Anita Ignatius
PP185
DNA-Damage, Survival, Differentiation and Matrix Mineralization in vitro of a Murine Multipotent Mesenchymal Precursor Cell Line
Patrick Lau, Yueyuan Hu, Christine E. Hellweg, Christa Baumstark-Khan, Günther Reitz
PP186
Involvement of Runx2 in the differentiation process of osteoblastic precursor cells after radiation exposure
Yueyuan Hu, Patrick Lau, Christine Hellweg, Christa Baumstark-Khan, Guenther Reitz
PP187
  Implantation of Octacalcium Phosphate Enhances Long Bone's Repair in Rats
Mohammad Reza Arab, Fereydoon Sargolzaei Aval, Forugh Sargolzaei Aval
PP188
INTRACELLULAR CALCIUM FLUXES IN HUMAN BONE CELLS IN OSTEOPOROTIC AND OSTEOARTHRITIC  PATIENTS
Monica celi, Elena Gasbarra, Claudio Frank, Alessandro Cutarelli, Giulio Fioravanti Cinci, Umberto Tarantino
PP189
Integrins and cadherins in mesenchymal stem cells (MSCs) from dental tissues: possible implication in the osteogenic differentiation process
Adriana Di Benedetto, Claudia Carbone, Angela Oranger, Giacomina Brunetti, Lorenzo Lo Muzio, Silvia Colucci, Maria Grano, Giorgio Mori
PP190
ROLE OF VITAMIN D AND K ON HUMAN OSTEOBLASTS IN VITRO ON PRIMARY CULTURES DERIVED FROM OSTEOPOROTIC AND NORMAL PATIENTS
gianna roscetti, mario marini, emiliano arango, umberto tarantino
PP191
Nuclear translocation of oxytocin receptor mediates increased gene expression in osteoblasts
Adriana Di Benedetto, Concetta Cuscito, Graziana Colaianni, Roberto Tamma, Beatrice Nico, Damiana Calvano, Carlo Zambonin, Michelangelo Corcelli, Alberta Zallone
PP192
MODERATE HYPOTHERMIA INDUCES GROWTH ARREST IN NORMAL HUMAN OSTEOBLAST CELLS BUT RETAINED MITOCHONDRIAL METABOLISM IN VITRO
Mohd Din Aisha, Mohamed Noor Khan Nor-Ashikin, Ab. Rahim Sharaniza, Hapizah Nawawi, Marina Kapitonova, Gabriele Ruth Anisah Froemming
PP193
NORMAL HUMAN OSTEOBLAST CELLS EXERTS AN ADAPTIVE EFFECT TOWARDS MODERATE HYPOTHERMIA BY RETAINING BONE METABOLISM AND CELLULAR FUNCTION IN VITRO
Mohd Din Aisha, Mohamed Noor Khan Nor-Ashikin, Ab. Rahim Sharaniza, Hapizah Nawawi, Marina Kapitonova, Gabriele Ruth Anisah Froemming
PP194
Black Tea Polyphenols Suppress Adverse Effects of TNFα- Induced Inflammation in Osteoblast Cells
Husna Zulkipli, Aisha Mohd Din, Norita Salim, Gabriele Anisah Froemming, Aletza Mohd Ismail, Hapizah Nawawi
PP195
Microarray reveals positive effects of Green and Black Tea Polyphenols on TNF-α induced changes of gene expression
Husna Zulkipli, Norita Salim, Gabriele Anisah Froemming, Aletza Mohd Ismail, Hapizah Nawawi
PP196
The effect of enamel matrix derivative on human gingival fibroblasts cultured on zirconium disc surfaces
Heesu Lee, Ahran Pae, Yong-Dae Kwon, Seonghee Ko
PP197
EGF SUPPRESSES BMP2-INDUCED OSTEOGENIC DIFFERENTIATION THROUGH THE UP-REGULATION OF SMURF1 EXPRESSION
Hye-Lim Lee, Kyung Mi Woo, Hyun-Mo Ryoo, Gwan-Shik Kim, Jeong-Hwa Baek
PP198
Estrogen effect on the Sclerostin induction by BMP-2 in human mesenchymal stromal cells
In Sook Kim, Hoon Joo Yang, Yun Mi Song, Soo Jin Ryu, Ri Youn Kim, Soon Jung Hwang
PP199
Effect of beta-cryptoxanthin on the differentiation of human bone-marrow stromal stem-cells treated with pioglitazone
Antonio Casado-Díaz, Raquel Santiago-Mora, Gabriel Dorado, José Manuel Quesada-Gómez
PP200
Premixed acidic calcium phosphate cement with statin: stimulate osteoblast differetiation and decrease the inflammatory response
Maryam Montazerolghaem, Håkan Engqvist, Marjam Ott
PP201
Primary Human Bone Cells treated with Parathyroid Hormone or Dexamethasone show Effects on micro-RNA Expression Patterns Assessed by Second Generation Sequencing
Navya Laxman, Carl-Johan Rubin, Hans Mallmin, Olle Nilsson, Christian Tellgren-Roth, Andreas Kindmark
PP202
Expression and function of glutamate transporters in mouse primary osteoblasts
Wenjie Xie, Silvia Dolder, Mark Siegrist, Antoinette Wetterwald, Willy Hofstetter
PP203
Connectivity Map-based discovery of novel compounds that induce osteoblast differentiation
AM Brum, J van de Peppel, A van Kerkwijk, M Janssen, M Schreuders-Koedam, T Strini, M Eijken, JPTM van Leeuwen, BCJ van der Eerden
PP204
Non-canonical BMP signaling in bone healing
Gonzalo Sánchez-Duffhues, Amaya Garcia de Vinuesa, Peter Kloen, Marié-Jose Goumans, Peter ten Dijke
PP205
Thrombin receptor deficiency leads to osteopetrosis by decreasing the RANKL/OPG ratio
BCJ van der Eerden, K Tudpor, P Jongwattapapisan, TE Woudenberg-Vrenken, RJM Bindels, JGJ Hoenderop, JPTM van Leeuwen
PP206
Serum Sclerostin Does Not Reflect Its Expression In Bone, But Is Related To Bone Mineral Density.
Nathalie Bravenboer, Ruben Visser, Martin den Heijer, Annemieke Heijboer
PP207
In vitro 3D osteoblast-osteocyte co-culture mechanical loading model
Marisol Vazquez, Bronwen Evans, Sam Evans, Jim Ralphs, Daniela Riccardi, Deborah Mason
PP208
The positional origins of human osteoblasts dictate growth and differentiation potential and capacity for paracrine vascular cell cross-talk via VEGF.
Mittal Shah, Valentina Gburcik, Andrew Sankey, Peter Reilly, Roger Emery, Claire Clarkin, Andrew Pitsillides
PP209
Bone marrow stromal cells of female Bag-1 heterozygous mice exhibit reduced osteogenic potential
Joanna Greenhough, Paul Townsend, Richard Oreffo, Rahul Tare
PP210
Open source software for semi-automated histomorphometry of bone resorption and formation parameters.
Rob van 't Hof, Lorraine Rose, Anna Daroszewska
PP211
Rab27a is involved in bone formation by osteoblasts
Fraser Coxon, Angela Douglass, Alun Hughes, Miep Helfrich, Miguel Seabra, Tanya Tolmachova
PP212
Bone-forming cultures of rat and mouse calvarial osteoblasts: key differences in protocols
Isabel Orriss, Mark Hajjawi, Carmen Huesa, Vicky MacRae, Timothy Arnett
Cell biology: osteoclasts and bone resorption
PP213
Anti-dementia Acetylcholine esterase inhibitor inhibits osteoclastogenesis
Charles Inderjeeth, Jiake Xu, Bay Sie Lim, Dian Teguh
PP214
Is a network of collagen fibers and blood vessels supporting pre-osteoclast trafficking from the bone marrow to the bone surface?
Thomas Levin Andersen, Helene Bjørg Kristensen, Jean-Marie Delaisse
PP215
The F-actin modulator SWAP-70 is required for proper podosome dynamics in osteoclasts.
Anne Roscher, Martin Glösmann, Reinhold G Erben, Anne-Helen Lutter, Michael Chopin, Lorenz C Hofbauer, Rolf Jessberger, Annette Garbe
PP216
Glycosaminoglycan sulfation is a key regulator of osteoclast biology and osteogenic bone cell signaling
Juliane Salbach-Hirsch, Elena Tsourdi, Nicole Ziegler, Vera Hintze, Dieter Scharnweber, Stephanie Möller, Matthias Schnabelrauch, Martina Rauner, Lorenz Hofbauer
PP217
Collagen-induced arthritis reduces osteoclast differentiation potential and activity and impairs reactivity to neurotransmitter stimuli in an experimental arthritis rat model
Dominique Muschter, Nicole Schäfer, Rainer H. Straub, Joachim Grifka, Susanne Grässel
PP218
Protective effect of polyphenols from berries of Aronia melanocarpa against low exposure to cadmium-induced imbalance in the RANK/RANKL/OPG system in the bone tissue of rats
Joanna Rogalska, Malgorzata M. Brzóska
PP219
Negative modulation of human osteoclastogenesis by antiepileptic drugs
Sara Rocha, João Costa-Rodrigues, Ricardo Ferraz, Cristina Prudêncio, Maria Fernandes
PP220
Modulation of osteoclastogenesis by fluoroquinolones on nano- and micro-structurated hydroxyapatite surfaces
Sofia Ribeiro, João Costa-Rodrigues, Maria Fernandes
PP221
Modulation of osteoclastogenesis by antihypertensive drugs
Teresa Oliveira, João Costa-Rodrigues, Ricardo Ferraz, Cristina Prudêncio, Maria Fernandes
PP222
Mitogen- and stress-activated protein kinase 1 activates osteoclastogenesis in vitro and plays critical roles in bone destruction in vivo
Hong-Hee Kim, Jeongim Ha
PP223
Methylation is not involved in repression of ADRA2A in osteocytes
Vid Mlakar, Janja Zupan, Janja Marc, Simona Jurkovic Mlakar
PP224
POLYUNSATURATED FATTY ACIDS AND PHYTOESTROGENS MODULATE OSTEOCLASTOGENESIS AND BONE RESORPTION IN RAW 264.7 MACROPHAGES
Natalie Shepherd, Cassandre De Jager, Abe Kasonga, Sumari Marais, Yuko Tousen, Marlena Kruger, Magdalena Coetzee
PP225
Inhibition Of Lipopolysacharide Induced Osteoclast Formation And Bone Resorption In Vitro And In Vivo In Mice By Cystatin C
Strålberg Fredrik, Catharina Lindholm, Erik Lindström, Franciszek Kasprzykowski, Paul Saftig, Magnus Abrahamson, Anders Grubb, Ulf H Lerner
PP226
REGULATION OF OSTEOCLASTOGENESIS BY TOLL-LIKE RECEPTOR 5
Ali Kassem, Pernilla Lundberg, Catharina Lindholm, Pedro P.C. Souza, Ulf H. Lerner
PP227
RANKL immobilized on β-TCP induces and maintains osteoclast formation
John Choy, Wilhelm Hofstetter, Frank M. Klenke
PP228
Bisphosphonates differently affect jaw and long-bone marrow cells
Jenny A.F. Vermeer, Ineke D.C. Jansen, Greetje A.P. Renders, Teun J. de Vries, Vincent Everts
PP229
The D477N mutation in OPTN leads to increased bone turnover and enhanced osteoclast formation in OptnD477N/D477N mice
Sachin Wani, Rami Obaid, Ruth Jones, Philip Cohen, Stuart Ralston, Omar Albagha
PP230
Depletion of the autophagy adaptor OPTN leads to increased osteoclast formation, fusion and survival as well as increased NF-κB activation in vitro
Rami Obaid, Sachin Wani, Stuart ralston, Omar Albagha
PP231
Osteoclasts activity is affected by adenovirus infection
Ana Isabel Espirito Santo, Lynett Danks, David Mahoney, Youridies Vattakuzhi, Afsaneh Sabokbar, Nicole Horwood
PP232
The use of photo-activatable fluorophores to study the turnover of the receptor activator of NFkB receptor in health and disease.
David Mellis, Angela Duthie, Susan Clark, Julie Crockett
PP233
Investigating homozygous versus heterozygous expression of disease-causing receptor activator of NFkB mutations in vitro
David Mellis, Angela Duthie, Susan Clark, Julie Crockett
PP234
DO ECTO-NUCLEOTIDASES PLAY A ROLE IN THE REGULATION OF OSTEOCLAST FUNCTION?
Mark Hajjawi, Vicky MacRae, Carmen Huesa, José Luis Millán, Timothy Arnett, Isabel Orriss
PP235
Differential effects of nitrogen-containing bisphosphonates on human PBMCs and MUTZ-3 cells
AARON KWAASI, GUILLAUME MABILLEAU, JAMES DUNFORD, FRANK EBETINO, ALI ZAREI, MICHAEL PAZIANAS, AFSIE SABOKBAR, GRAHAM RUSSELL
PP236
Osteoclast resorptive surface: Correlation of structure and function
Kinga Szewczyk, Karen Fuller, Timothy Chambers
Cell Biology: osteocytes
PP237
Nucleotide and Mechanically Induced ATP Release Pathways in Osteocytes
Tina M. Kringelbach, Ivana Novak, Peter Schwarz, Niklas Rye Jorgensen
PP238
Calcium Sensing Receptor is expressed on/in osteocyte like MLOY4 culture and modulated by Strontium Ranelate
Priscilla C. Aveline, Hechmi Toumi, Eric Lespessailles, Cédric Boudot, Romuald Mentaverri, Gaël Y. Rochefort, Claude-Laurent Benhamou
PP239
Glycosaminoglycans and their sulfate derivates differentially regulate the osteocytic phenotype of murine and rat osteocyte-like cell lines
Fraser Coxon, Angela Douglass, Alun Hughes, Miep Helfrich, Miguel Seabra, Tanya Tolmachova
PP240
RANKL subcellular trafficking in osteocytes.
Masashi Honma, Yuki Ikebuchi, Yoshiaki Kariya, Madoka Hayashi, Naoki Hayashi, Shigeki Aoki, Hiroshi Suzuki
PP241
Inhibition of osteocyte-induced osteoclast precursor proliferation and migration by mechanical strain
Seong-Hee Ko, Heesu Lee
PP242
Activation of the Parathyroid Hormone-Receptor is Involved in the Pro-survival Effect of Hypotonic Shock in Osteocyte-like MLO-Y4 Cells
Marta Maycas, Juan. A Ardura, Luis Fernández de Castro, Arancha Gortázar, Pedro Esbrit
PP243
Single osteocyte gene expression in an in vivo model for load-induced bone adaptation
Robin Wilson, Andreas Trüssel, Duncan Webster, Felix Kurth, Petra Dittrich, Ralph Müller
PP244
Strontium ranelate and conditioned medium from mechanically-stimulated human bone cells both enhance osteogenic differentiation of mesenchymal stem cells
Astrid Bakker, Behrouz Zandieh-Doulabi, Jenneke Klein-Nulend
PP245
IGF-1 regulates MC-3T3 and human primary osteoblast to osteocyte differentiation in 3D culture
Nicole EE Scully, Deborah J Mason, Bronwen AJ Evans
PP246
Development of a novel 3D mineralising culture system to investigate the differentiation of osteoblasts to osteocytes
Nicole EE Scully, Sam L Evans, Deborah J Mason, Bronwen AJ Evans
Chondrocytes and cartilage
PP247
Expression of Novel Cartilage Genes during Maturation of Cultured Chondrocytes
Babatunde Awodele, Michiko Mirams, Charles Pagel, Eleanor Mackie
PP248
Intracellular calcium is influenced by the NuclearMagneticResonanceTherapy (NMRT) in Cal-78 chondrosarcoma cells
Bibiane Steinecker-Frohnwieser, Lukas Weigl, Werner Kullich
PP249
Impairment of endochondral ossification by Hoxa2 overexpression: a plausible molecular explanation of idiopathic proportionate short stature
Pierre M.L. Deprez, Miloud G. Nichane, Benoît Lengelé, René Rezsöhazy, Catherine Nyssen-Behets
PP250
IN VITRO EFFECTS OF CAFFEINE ON THE PROLIFERATION, APOPTOSIS AND GENE TRANSCRIPTS EXPRESSION OF CHONDROGENIC DIFFERENTIATION IN GROWTH CARTILAGE OF RATS
Amanda Maria Sena Reis, Raquel Viana Raad, Natália de Melo Ocarino, Rogéria Serakides
PP251
EFFECTS OF CAFFEINE ON FORMATION AND ENDOCHONDRAL BONE GROWTH OF RATS
Amanda Maria Sena Reis, Ana Cláudia Moura Batista, Natália de Melo ocarino, Rogéria Serakides
PP252
Modulation of c-Myb during chondrogenesis
Veronika Oralova, Marcela Buchtova, Eva Janeckova, Abigail Tucker, Eva Matalova
PP253
CAN ADRENOMEDULLIN BE A POTENTIAL OSTEOARTHRITIS TREATMENT?
Aurore CHATRON-COLLIET, Frédéric VELARD, Dominique CÔME, Hilène LIN, Hang Korng EA, Frédéric LIOTE
PP254
Oxygen tension-mediated regulation of chondrogenic differentiation: application to stem cells based osteochondral repair
Sophie PORTRON, Vincent HIVERNAUD, Christophe MERCERON, Julie LESOEUR, Martial MASSON, Olivier GAUTHIER, Claire VINATIER, Laurent BECK, Jerome GUICHEUX
PP255
Effects of an in vitro low-oxygen-tension preconditioning of adipose stem cells on their in vivo chondrogenic potential: application in cartilage tissue repair
Sophie PORTRON, Christophe MERCERON, Olivier GAUTHIER, Julie LESOEUR, Sophie SOURICE, Martial MASSON, Borhane FELLAH, Olivier GEFFROY, Elodie LALLEMAND, Pierre WEISS, Jérôme GUICHEUX, Claire VINATIER
PP256
Sclerostin preserves chondrocyte maintenance by modulating the crosstalk between canonical and non canonical Wnt pathways
Wafa Bouaziz, Thomas Funck-Brentano, Hilene Lin, Hang-Korng Ea, Eric Hay, Martine Cohen-Solal
PP257
Stress-induced matrix metalloproteinase (MMP) production in cartilage does not depend on NALP3-inflammasome in osteoarthritis.  
Carole Bougault, Marjolaine Gosset, Xavier Houard, Colette Salvat, Lars Godmann, Thomas Pap, Claire Jacques, Francis Berenbaum
PP258
Transcription factor Nkx3.2 plays crucial role in primary chondrogenesis by up-regulating type II collagen a1 transcription activity
Kosuke Ebina, Yoshitaka Kawato, Makoto Hirao, Yui Honjo, Tokimitsu Morimoto, Jun Hashimoto, Kenrin Shi, Hideki Yoshikawa
PP259
The influence of 2-oxoglutaric acid on articular cartilage of gastrectomised rats.
Piotr Dobrowolski, Ewa Tomaszewska, Paulina Kurlak, Stefan Pierzynowski
PP260
Dietary 2-oxoglutarate protects femoral cartilage of 9 months male pigs prenatally treated with dexamethasone.
Ewa Tomaszewska, Piotr Dobrowolski, Monika Hułas-Stasiak, Paulina Kurlak
PP261
Prenatally administered acrylamide programs a gut-bone axis of guinea pig newborns.
Ewa Tomaszewska, Piotr Dobrowolski, Paulina Kurlak, Barbara Badzian, Monika Hulas-Stasiak, Iwona Puzio, Krzysztof Kostro
PP262
Establishing an in vitro system to study chondrocyte phenotypes associated to human hereditary hemochromatosis and identify molecular players involved in chondrocyte related iron metabolism.
Marcio Simao, Paulo Gavaia, Jorge Pinto, Ea Korng, M. Leonor Cancela
PP263
Inflammatory Effects on Knee Joint Tissue by Indoxyl Sulfate
Ya-Yun Chen, Herng-Sheng Lee, Yu-Juei Hsu
PP264
Upregulation of GAP-43 is linked to the cartilage repair by microarray analysis
Chih-Shan Chang, Herng-Sheng Lee
PP265
Decrypting TGFβ signaling in age-induced osteoarthritis.
Amaya Garcia de Vinuesa, Esmeralda Blaney-Davidson, Gonzalo Sanchez-Duffhues, Arjan van Caam, Elly Vitters, Ingrid Meulenbelt, Marie Jose Goumans, Peter van der Kraan, Peter ten Dijke
PP266
The Rho/ROCK GTPase pathway differentially modulates chondrocyte and osteoblast differentiation from pluripotent stem cells.
Dalea M Bukhary, Fraser McDonald, Agamemnon E Grigoriadis
Genetics
PP267
A genetic determinant of vitamin D and its role in prostate cancer
Olivia Trummer, Eva Thurner, Tanja Langsenlehner, Uwe Langsenlehner, Sabine Krenn-Pilko, Winfried März, Thomas Pieber, Barbara Obermayer-Pietsch, Wilfried Renner
PP268
No Mutations in the serotonin related TPH1 and HTR1B genes in patients with monogenic sclerosing bone disorders.
Eveline Boudin, Karen Jennes, Fenna de Freitas, David Tegay, Geert Mortier, Wim Van Hul
PP269
Expression analysis of mesenchymal KS483 cells during differentiation towards osteoblasts.
Igor Fijalkowski, Eveline Boudin, Vere Borra, Wim Van Hul
PP270
SQSTM1/P392L post-zygotic mutations in unrelated patients with Paget's disease of bone
Sabrina Guay-Belanger, Edith Gagnon, Jean Morissette, Jacques P Brown, Laëtitia Michou
PP271
A familial case of Osteogenesis Imperfecta: study of genotype-phenotype correlation.
Alessandra Mihalich, Emanuela Ponti, Francesca Broggi, Anna Maria Di Blasio, Maria Luisa Bianchi
PP272
Comparison of gene expression in osteoblasts from patients of Polynesian and Caucasian ethnicity
Dorit Naot, Usha Bava, Ally Choi, Karen Callon, Rocco Pitto, Jarome Bentley, Greg Gamble, Jillian Cornish
PP273
Functional analysis of the two Runx3 promoters in osseous and non-osseous cells: implications for tissue/differentiation specific transcription of distinct isoforms
Natércia Conceição, Brigite Simões, M. Leonor Cancela
PP274
Association between polymorphisms in leptin, its receptor and beta adrenergic receptors genes and bone mineral density in postmenopausal Korean women
Hoon Kim, Seung-Yup Ku, Seok Hyun Kim, Young Min Choi, Jong Hak Kim, Jung Gu Kim
PP275
Genetic Aspects of Bone Remodeling Disturbance in Patients with Aggressive Periodontitis
Anastasia Zinovyeva, Victoria Atrushkevich, Alexander Polyakov
PP276
No association between the CYP1B1/Leu432Val polymorphism and osteoporosis-related traits in Slovak postmenopausal women
Radoslav Omelka, Vladimira Krajcovicova, Jana Spankova, Jana Durisova, Monika Martiniakova, Drahomir Galbavy, Maria Bauerova
PP277
A genomic and transcriptomic approach to the high bone mass phenotype: evidences of heterogeneity and of additive effects of TWIST1, IL6R, DLX3 and PPARG
Patricia Sarrión, Leonardo Mellibovsky, Roser Urreizti, Sergi Civit, Neus Cols, Natàlia García-Giralt, Guy Yoskovitz, Alvaro Aranguren, Jorge Malouf, Luís del Río, Roberto Güerri, Xavier Nogués, Adolfo Díez-Pérez, Daniel Grinberg, Susana Balcells
PP278
Gene-wide association study of RANK and RANKL genes in the bone context: Functional study of BMD-associated SNPs
Natalia Garcia-Giralt, Guy Yoskovitz, Maria Rodriguez-Sanz, Roser Urreizti, Roberto Guerri, Sergi Ariño-Ballester, Daniel Prieto-Alhambra, Leonardo Mellibovsky, Daniel Grinberg, Xavier Nogues, Susana Balcells, Adolfo Diez-Perez
PP279
Genome-Wide Association Study meta-analysis identifies the SOAT1/AXDND1 locus to be associated with hip and forearm fracture risk
Ulrika Pettersson-Kymmer, Andrea Lacroix, Joel Eriksson, Ulrica Bergström, Beatrice Melin, Carl Wibom, Liesbeth Vandenput, Preetha Rajaraman, Patricia Hartge, Stephen Chanock, Göran Hallmans, David Duggan, Charles Kooperberg, Samuel Handelman, Aaron Aragaki, Maria Nethander, Andre Uitterlinden, Fernando Rivadeneira, Rebecca Jackson, Claes Ohlsson
PP280
ASSOCIATION BETWEEN DENTINOGENESIS IMPERFECTA (DI) AND MUTATIONS IN COLIA1 AND COLIA2 GENES
Kristofer Andersson, Göran Dahllöf, Eva Åström, C-J Rubin, A Kindmark, Katarina Lindahl, Östen Ljunggren, Barbro Malmgren
PP281
Role of the functional Toll-like receptor-3 promoter polymorphism in the increased risk of Osteoarthritis
SUI-LUNG SU, Hsin-Yi Yang
PP282
Phenotypic dissection of bone mineral density facilitates the identification of skeletal site specificity on the genetic regulation of bone
John P Kemp, Carolina Medina-Gomez, Karol Estrada, Denise Heppe, Carola Zillikens, Nicholas Timpson, Beate Pourcain, Susan Ring, Albert Hofman, Vincent VW Jaddoe, George Davey Smith, Uitterlinden André G, Jonathan H Tobias, Fernando Rivadeneira, David M Evans
PP283
Discovery and Replication of Several Loci Significantly Associated with Lean Body Mass:  A Large Meta-Analysis of Genome Wide Association Studies (GWAS) from the "CHARGE" and "GEFOS" Consortia
Douglas Kiel, Laura Yerges, Yi-Hsiang Hsu, Lisette Stolk, David Karasik, Ruth Loos, Vilmundar Gudnason, Albert Smith, Jeffrey O'Connell, Mao Fu, Elizabeth Streeten, Jane Cauley, John Robbins, Bruce Psaty, Toby Johnson, Zoltan Kutalik, Gregory Livshits, Tamara Harris, Claes Ohlsson, M. Carola Zillikens
Muscle, physical activity and bone
PP284
RAISING CK: WHAT IT MEANS ACCORDING TO DIFFERENT CLINICAL LANDSCAPE?  Scali, J.; Visentini, S.; Berruezo, R ; Pacheco, G.; Sevilla, D.; Garcia, R,.Reumathology Unit - Carlos G. Durand Hospital - Buenos Aires, Argentina.
Juan Jose Scali, Susana Visentini, Ramiro Berruezo, Daniel Sevilla, Gonzalo Pacheco, Rodrigo Garcia
PP285
Prolonged Botulinum Toxin Type A-induced muscle paralysis results in loss of bone mineral density and bone strength in young female rats
Maria Ellegaard, Susanne Syberg, Niklas Rye Jørgensen, Peter Schwarz
PP286
Muscle function and quality of life in primary hyperparathyroidism.
Lars Rolighed, Anne Kristine Amstrup, Niels Frederik Breum Jakobsen, Tanja Sikjaer, Leif Mosekilde, Peer Christiansen, Lars Rejnmark
PP287
Muscle strength and peripheral fractures in osteoporotic patients
Hans-Christof Schober, Franka Hamann, Johanna Torner
PP288
Microgravity modulates nitric oxide homeostasis in vascular system
Pradeep Thagaraj, Suvro Chatterjee
PP289
The Outcomes and Costs of Falls in Elderly Women
Inga Tamulaityte-Morozoviene, Vidmantas Alekna, Rimantas Stukas, Marija Tamulaitiene
PP290
Response of mechanically strained tenocytes to different cell culture substrates
David Musson, JungJoo Kim, Karen Callon, Dorit Naot, Vickie Shim, Iain Anderson, Jillian Cornish
PP291
Physical activity, bone metabolism and inflammatory markers, and bone mineral density in elderly men: a preliminary investigation
Elisa Marques, Jorge Mota, João Viana, Pedro Figueiredo, João Guimarães, Joana Carvalho
PP292
SEX-SPECIFIC ASSOCIATION OF PHYSICAL ACTIVITY WITH BONE MASS DISTRIBUTION AT THE FEMORAL NECK AND TROCHANTER IN YOUNG ADULTS
Vera Zymbal, Lurdes Rebocho, Graça Cardadeiro, Fátima Baptista
PP293
Sarcopenia in patients with spondyloarthritis - is there any relation with radiological damage?
Renata Aguiar, Tiago Merinhos, Joana Sequeira, Catarina Ambrósio, Anabela Barcelos
PP294
INFLUENCE OF MECHANICAL LOADING AND SKELETON GEOMETRY IN BONE MASS AT THE PROXIMAL FEMUR IN 10-12 YEARS OLD CHILDREN- A LONGITUDINAL STUDY
Graça Cardadeiro, Fátima Baptista, Nicolleta Rosati, Vera Zymbal, Lurdes Rebocho, Paula M Bruno, Kathleen F Janz, Luís B Sardinha
PP295
PROXIMAL FEMUR GEOMETRY AS MODERATOR FACTOR FOR THE EFFECT OF MECHANICAL LOADING DURING GAIT - A BONE REMODELING ANALYSIS
Miguel M Machado, Paulo R Fernandes, Fátima Baptista
PP296
Body Composition Relationship in Korean Old People
Woong H. Choi, Sang M. Hong
PP297
Prevalence of sarcopenia & its association with osteporosis in Korean postmenopausalwomen.  Hyoung-Moo  Park1), Jin-Hee Kim1), Tak Kim2)   Dept. Ob & Gyn. College of Medicine Chungang University1), Korea University2) Seoul, Korea
Hyoung-Moo Park, Tak Kim
PP298
The effects of Vitamin D supplementation and fitness program for biochemistry, muscle mass and physical functions in elderly women
Byung Yeon Yu, Kyung Soo Kim, In Kyung Kim
PP299
Influence of gym high-intensity dynamic exercises and therapeutic exercises on functional status of patients with early rheumatoid arthritis
Evgeniya Orlova, Dmitry Karateev, Andrey Kochetkov, Tatiana Mozhar
PP300
Vitamin D deficiency is associated with nonspecific skeletal pain in Saudi Women
Khulood Hussein, Hanan Alkadi, Suzan Lanham-New, Mohamad Ardawi
PP301
Effect of vitamin D status on Muscle Function and Physical Performance among Saudi Postmenopausal Women: a cross-sectional study
khulood Hussein
PP302
Morphology of muscle attachment sites and microarhitecture of underlying bone as the markers of physical activities of past populations
Ksenija Djukic, Petar Milovanovic, Michael Hahn, Bjoern Busse, Michael Amling, Marija Djuric
PP303
The effect of different exercise modes on bone density in middle-aged and older men: A systematic review
Kate A Bolam, Jannique G Z van Uffelen, Dennis R Taaffe
PP304
Everyday activity, important factors and quality of life in children and youths with Osteogenesis Imperfecta
Kristina Lowing, Maude Hagberg, Eva Astrom
PP305
Associations of 25-hydroxyvitamin D concentrations with quality of life and self-rated health
Rachida Rafiq, Karin Swart, Natasja van Schoor, Dorly Deeg, Paul Lips, Renate de Jongh
PP306
Increased activity associated with exercise does not rescue aged bone’s impaired response to local mechanical loading
Lee Meakin, Chinedu Udeh, Toshihiro Sugiyama, Gabriel Galea, Lance Lanyon, Joanna Price
PP307
Muscle power and force may influence cortical bone strength via distinct mechanisms: findings from a cross sectional study of high bone mass cases and controls
Sarah A Hardcastle, Celia L Gregson, Jorn Rittweger, Kate A Ward, Jon H Tobias
PP308
SARCOPENIA IN UKRAINIAN WOMEN OF DIFFERENT AGE
Vladyslav Povoroznyuk, Nataliia Dzerovych
PP309
LEAN MASS, NOT OBESITY, IS RELATED TO TOTAL BODY BONE MINERAL CONTENT IN BOYS.
Tom Sanchez, Jingmei Wang, Felix Rajan, Terry Schwalenberg, Kathy Dudzek
Osteoporosis: evaluation and imaging
PP310
Osteoporosis and osteopenia of the spine in rheumatic patients, treated with glucocorticosteroids.
Armine Haroyan, Liana Ghukasyan
PP311
Appropriate Osteoporosis Treatment by Family Physicians in Response to FRAX versus CAROC Reporting: A Randomized Controlled Trial
Karen Beattie, George Ioannidis, Joy MacDermid, Ruby Grewal, Alexandra Papaioannou, Anthony Hodsman, Jonathan D. Adachi
PP312
Correlation of Bioelectrical Impendance Analysis and Dual Energy X-Ray Absorptiometry for bone mineral content and bone mineral density in young healthy humans
Erna Davidovic Cvetko, Nebojsa Nesic, Jasminka Milas-Ahic, Ines Drenjancevic
PP313
Microstructural alterations of femoral head articular cartilage and subchondral bone in osteoarthritis and osteoporosis
Dragica Bobinac, Tanja Celic, Marin Marinovic, Ivana Maric
PP314
Communication of fracture risk and treatment benefit in terms of "Bone Health Age" using FRAX or Qfracture.
Bo Abrahamsen, Katrine Hass Rubin, Carrinna Hansen, Kim Brixen
PP315
The stability of intact parathyroid hormone in human blood during different sampling conditions and long-term storage in serum tubes
Camilla Sand Andersen, Hans Christian Hoeck, Parisa Gazerani, Peter Vestergaard
PP316
Cortical and trabecular bone parameters from HR-pQCT images at the tibia: a local comparison with synchrotron radiation micro-computed tomography
Agnès OSTERTAG, Françoise PEYRIN, Sylvie FERNANDEZ, Jean-Denis LAREDO, Marie-Christine de VERNEJOUL, Christine CHAPPARD
PP317
A 3D QCT Technique of the Thoracic and Lumbar Spine: Integral Volume and Intervertebral Disc Space Increase and BMD decreases from T6 to L4
Oleg Museyko, Axel Heinemann, Mattias Krause, Reinhard Barkmann, Michael Amling, Claus Glüer, Klaus Püschel, Klaus Engelke
PP318
Binding kinetics of fluorescent bisphosphonates as a tool for monitoring bone dynamics in vivo
Robert Tower, Graeme Campbell, Marc Muller, Olga Will, Frederieka Grundmann, Christian Schem, Claus Gluer, Sanjay Tiwari
PP319
PREVALENCE OF FRAX CLINICAL RISK FACTORS- DIETARY CALCIUM INTAKE HABITS AND OSTEOPOROSIS SCREENING IN GREEK WOMEN
Sofoclis Bakides, George Sakellariadis, Stavroula Alevizou, Kleoniki Koussi, Anna Rapti, Panayiotis Tsiverdis, Konstantina Kavvadia, Kyriakos Drivas, Charilila-Loukia Ververeli
PP320
Quantitative ultrasound of os calcis BMD versus conventional DXA and peripheral QCT in interval assessment of BMD changes in adolescent females
William WK To, Margaret WN Wong
PP321
Use of os calcis quantitative ultrasound for bone mineral density screening in adolescents with menstrual dysfunction
William WK To, Margaret WN Wong
PP322
Comparative Assessment of Bone Mineral Density of the Femoral Neck between Dual-Energy X-Ray Absorptiometry and a New Ultrasonic Method
Francesco Conversano, Ernesto Casciaro, Antonio Greco, Paola Pisani, Roberto Franchini, Antonella Grimaldi, Eugenio Quarta, Maurizio Muratore, Sergio Casciaro
PP323
A New Ultrasonic Method for Diagnosis of Osteoporosis on Hip and Spine
Sergio Casciaro, Francesco Conversano, Ernesto Casciaro, Roberto Franchini, Maria Daniela Renna, Antonio Greco, Eugenio Quarta, Laura Quarta, Maurizio Muratore
PP324
Strong Diagnostic Agreement Between a Novel Ultrasound-Based Method for Lumbar Densitometry and Dual-Energy X-Ray Absorptiometry
Maurizio Muratore, Francesco Conversano, Ernesto Casciaro, Giulia Soloperto, Roberto Franchini, Antonio Greco, Eugenio Quarta, Sergio Casciaro
PP325
Relationship between quantitative ultrasound parameters at calcaneous and health-related quality of life domains in postmenopausal Italian women: the FEDRO study
Stefano Gonnelli, Carla Caffarelli, Giuseppe Guglielmi, Stefania Rossi, Silvano Adami, Ranuccio Nuti
PP326
FRAXture - does FRAX reflect the risk of fracture in real practice?
Renata Aguiar, Romeu Pinho, Tiago Merinhos, Catarina Ambrósio, Anabela Barcelos
PP327
BMA assessment standard curves for wrist and ankle in both sexes – data from EpiReumaPt 
Helena Canhao, Nelia Gouveia, Tania Rego, Ana Maria Rodrigues, Jaime Branco
PP328
Bone mineral density distribution in early osteoporotic bone
Saba Abdulghani, Luis Santos, Bruno Vidal, Rita Cascão, João Fonseca
PP329
Discordance of Z-score in healthy premenopausal women with BMD below the expected range of age and contributing factors: The Korea National Health and Nutrition Examination Survey 2008-9. 
Sung-Kil Lim, Kyeong Hye Park, Kyoung Min Kim, Jung Soo Lim, Yumie Rhee
PP330
Factors that affects on bone density in premenopausal women
Dong Ock Lee, Hoon Choi, Jung Gu Kim
PP331
May we screen with FRAX ® clinical factors?
Carmen Gabriela Barbu, Catalina Poiana, Dariana Ionita, Magda Gascan, Cristina Stefan, Aurelia Stefanopol, Simona Fica
PP332
Osteoporosis and bone fractures in elder women with rheumatoid arthritis
Kamalya Kasumova, Azamat Satybaldyev, Alexander Smirnov
PP333
Calcification of the coronary arteries among the males with coronary heart disease and osteoporosis
Еlena Malyuta, Tatiana Raskina, Olga Barbarash, Alexandr Kokov
PP334
Bone fragility in patients with alcoholic liver cirrhosis: can hip structure analysis better predict risk of hip fracture
Danijela Djonic, Djordje Culafic, Violeta Culafic-Vojinovic, Svetlana Ignjatovic, Ivan Soldatovic, Jelena Vasic, Marija Djuric
PP335
Usefulness of bone turnover markers in the evaluation of fracture risk in type 2 diabetes.
Pedro Rozas-Moreno, Rebeca Reyes-Garcia, Antonia Garcia-Martin, Gema Lopez-Gallardo, Beatriz Garcia-Fontana, Sonia Morales-Santana, Manuel Muñoz-Torres
PP336
TBS improves the detection of subjects at risk of fracture irrespectively to the BMD status: a Spanish population-based study
Silvana Di Gregorio, Renaud Winzenrieth, Luis Del Rio
PP337
Dietary calcium and vitamin D intake and serum 25-hydroxyvitamin D and parathyroid hormone levels in healthy elderly Spanish men: The relationship with calcaneal and phalangeal quantitative ultrasound and phalangeal dual energy X-ray absorptiometry
Alejo Leal, Maria Luz Canal-Macias, Julian Fernando Calderón-García, Raul Roncero-Martín, Trinidad Rodriguez-Dominguez, Jose M. Moran
PP338
Low testosterone levels are associated with poor peripheral bone mineral density and quantitative bone ultrasound at phalanges and calcaneus in healthy elderly men
Jesus Maria Lavado-Garcia, Purificación Rey-Sanchez, Carmen Costa-Fernandez, Mariana Martínez, Alejo Leal, Francisco Jose Rodriguez-Velasco, Juan Diego Pedrera-Zamorano
PP339
What is the performance in vertebral fracture discrimination by Bone mineral density (BMD), micro-architecture estimation (TBS), and FRAX in stand-alone, combined or adjusted approaches: The OsteoLaus Study
Olivier Lamy, Marc-Antoine Krieg, Delphine Stoll, Berengère Aubry-Rozier, Marie Metzger, Didier Hans
PP340
TRABECULAR BONE SCORE AND BONE MINERAL DENSITY OF LUMBAR SPINE IN HEALTHY WOMEN: PROS AND CONS
Vladyslav Povoroznyuk, O Lamy, Nataliia Dzerovych, Didier Hans
Steroid hormones and receptors
PP509
Prostate tumorigenesis in estrogen receptor β inactivated, prostate targeted fibroblast growth factor 8B transgenic mice
Teresa Elo, Lan Yu, Eeva Valve, Sari Mäkelä, Pirkko Härkönen
PP510
Glucocorticoids Inhibit Bone Formation Independent of miRNA Regulation
Peng Liu, Ulrike Baschant, Marco Groth, Mario Baumgart, Matthias Platzer, Hans-Martin Jäck, Jan Tuckermann
PP511
The survey perception by 85 specialist's physician of the corticosteroid adverse events
kawtar nassar, saadia janani, wafaa rachidi, ouafaa mkinsi
PP512
Positive regulation of osteogenesis by bile acid through FXR
Chan Soo Shin, Sun Wook Cho, Hyojung Park, Jae-Yeon Yang, Sang Wan Kim, Young Joo Park, Mijung Yim, Jung Eun Kim, Seong Yeon Kim, Jee Hyun An
PP513
Indole-3-carbonil and epigallocatechin-3-gallate for complex treatment of inflammatory periodontal diseases in female patients with gynecological pathologies.
Victoria Atrushkevich, Ella Zabalueva, Elena Zoryan
Abstract Code Title Authors Affiliations Category
PP1 10 years follow up after prenatal transplantation of fetal mesenchymal stem cell in a patient with severe osteogenesis imperfecta. Cecilia Götherström, Katarina Le Blanc, Eva Åström, Jahan Taslimi, Gail E Graham, Uwe Ewald, Magnus Westgren Paediatric bone disease
PP2 Osteonecrosis of the Jaw in a Patient with Rheumatoid Artritis treated with an oral aminobisphosphonate: a clinical case report Lorena Longato, Loredana Cavalli, Gemma Marcucci, Alessia Metozzi, Francesca Giusti, Maria Luisa Brandi, Prisco Piscitelli Osteoporosis: pathophysiology and epidemiology
PP3 The possibility rule of new mutations in juvenile Paget's disease (A rare case of mild JPD) Judit Donath, Gabor Speer, Janos Kosa, Peter Lakatos, Gyula Poor Other diseases of bone and mineral metabolism
PP4 The impact of calcimimetic treatment on bone turnover in a renal patient with high turnover hyperparathyroid bone disease Barbara Murray, Sinead Kinsella, Rory McQuillan, Alan Watson Other diseases of bone and mineral metabolism
PP5 Late onset autosomal dominant hypophosphatemic rickets; confirmation of the diagnosis with genomic analysis. Symeon Tournis, Ioannis Stathopoulos, Kalliopi Lampropoulou-Adamidou, Theodora Koromila, Nikolaos Chatzistamatas, Michail Droggaris, Christos Zafeiris, Konstantinos Makris, Helen Marketou, Nikolaos Papaioannou, Panagoula Kollia, Gazi Gazi Other diseases of bone and mineral metabolism
PP6 Diagnosis of Fibrous Dysplasia with DNA tests. Ioannis Stathopoulos, Alexia Balanika, Christos Baltas, Kalliopi Lampropoulou-Adamidou, Theodora Koromila, Panagoula Kollia, Symeon Tournis, Nikolaos Papaioannou, Aikaterini Katsalira Other diseases of bone and mineral metabolism
PP7 SEVERE PREGNANCY- AND LACTATION- ASSOCIATED OSTEOPOROSIS. Teriparatide treatment Kalliopi Lampropoulou-Adamidou, Christos Kosmidis, Ioannis P. Stathopoulos, Nikolaos A. Papaioannou, George Trovas Osteoporosis: treatment
PP8 Phenotypic change in a patient with hypophosphatasia with the onset of renal failure Tim Cundy, Toshimi Michigami, Kanako Tachikawa, Michael Dray, John Collins Other diseases of bone and mineral metabolism
PP9 FİBRODYSPLASIA OSSIFICANS PROGRESSIVA: CASE REPORT Firuzan Altın, Özer Burnaz, Levent Özgönenel, Nil Çağlar Other diseases of bone and mineral metabolism
PP10 Hajdu-Cheney syndrome: report of two cases in a family Georgina Terroso, Miguel Bernardes, Abelha Aleixo, Pedro Madureira, Romana Vieira, Rita Fonseca, Diana Goncalves, Lucia Costa Other diseases of bone and mineral metabolism
PP11 Gorham disease: description of a case with severe cervical spine involvement Georgina Terroso, André Rodrigues Pinho, Manuel Santos Carvalho, Joana Freitas, Francisco Serdoura, Vitorino Veludo Other diseases of bone and mineral metabolism
PP12 Severe osteoporosis associated with Hajdu-Cheney syndrome : follow-up after 2 years of teriparatide therapy Georgina Terroso, Miguel Bernardes, Abelha Aleixo, Romana Vieira, Pedro Madureira, Rita Fonseca, Diana Goncalves, Lucia Costa Osteoporosis: treatment
PP13 CLINICAL AND HISTOMORPHOMETRICAL ASSESSMENT OF BONE QUALITY IN HIP OSTEOARTHRITIS AND OSTEOPOROSIS Maurizio Feola, Cecilia Rao, Monica Celi, Elena Gasbarra, Umberto Tarantino Arthritis and other joint diseases: translational and clinical
PP14 PROPHYLAXIS OF GOUT FLARE WITH COLCHICINE AND VITAMIN C Simeon Monov, Daniela Monova, Rasho Rashkov Arthritis and other joint diseases: translational and clinical
PP15 Cartilage intermediate layer protein (CILP) is produced in synovial membrane of osteoarthritic joint and upregulated in osteoarthritis associated fibrosis Irina Kerna, Kalle Kisand, Ann Tamm, Agu Tamm Arthritis and other joint diseases: translational and clinical
PP16 Biomarker u-C2C in Estonian early knee OA cohort: progressive and non-progressive cases Agu Tamm, Ann Tamm, Jaanika Kumm, Maret Vija, Mare Lintrop Arthritis and other joint diseases: translational and clinical
PP17 Bone is the main target of activation of Canonical Wnt pathway in osteoarthritis Thomas Funck-Brentano, Wafa Bouaziz, Valerie Geoffroy, Didier Hannouche, Caroline Marty, Eric Hay, Martine Cohen-Solal Arthritis and other joint diseases: translational and clinical
PP18 Milk fat globule-epidermal growth factor 8 (MFG-E8) is a critical determinant of bone mass and alters the course of inflammation in arthritis Kathrin Sinningen, Sylvia Thiele, Sylvia Grossklaus, Mark Udey, Lorenz C Hofbauer, Triantafyllos Chavakis, Martina Rauner Arthritis and other joint diseases: translational and clinical
PP19 Vitamin K2 administration is associated with decreased disease activity in patients with rheumatoid arthritis Kosuke Ebina, Tokimitsu Morimoto, Kenrin Shi, Shoichi Kaneshiro, Kota Koizumi, Makoto Hirao, Jun Hashimoto, Hideki Yoshikawa Arthritis and other joint diseases: translational and clinical
PP20 Immunological profile of 110 rheumatoid arthritis kawtar nassar, saadia janani, wafaa rachidi, ouafaa mkinsi Arthritis and other joint diseases: translational and clinical
PP21 Monosodium urate crystals inhibit tenocyte viability and function: implications for periarticular involvement in chronic gout Ashika Chhana, Karen Callon, Michael Dray, Bregina Pool, Dorit Naot, Greg Gamble, Brendan Coleman, Fiona McQueen, Jillian Cornish, Nicola Dalbeth Arthritis and other joint diseases: translational and clinical
PP22 Generalized Long Term Bone Loss in Early Rheumatoid Arthritis in the Biologic Treatment Era - A 10 Year prospective Observational Study Anne Prøven, Knut Helgetveit, Glenn Haugeberg Arthritis and other joint diseases: translational and clinical
PP23 Ultrasound carotid plaque morphology in Rheumatoid Arthritis women without previous cardiovascular events Alice Castro, Diana Carmona-Fernandes, Maria José Santos, Luís Mendes-Pedro, Helena Canhão, João Eurico Fonseca Arthritis and other joint diseases: translational and clinical
PP24 bone mineral density changes after total knee replacement in women over the age of 65 Deog Yoon Kim Arthritis and other joint diseases: translational and clinical
PP25 Rehabilitation of patients with early rheumatoid arthritis, including cryotherapy, physical exercises, occupational therapy, orthoses and therapeutic education Evgeniya Orlova, Dmitry Karateev, Andrey Kochetkov, Lev Denisov Arthritis and other joint diseases: translational and clinical
PP26 THE FEMORAL NECK FRACTURES IN PATIENTS WITH RHEUMATOID ARTHRITIS Marina Podvorotova, Irina Dydykina Arthritis and other joint diseases: translational and clinical
PP27 Sclerostin/MEPE axis in OA: lessons from long bone development Katherine Staines, Blandine Poulet, Colin Farquharson, Andrew Pitsillides Arthritis and other joint diseases: translational and clinical
PP28 The glutamate receptor antagonist NBQX alleviates inflammation, pathology and gait abnormalities in rat antigen induced arthritis. Cleo Bonnet, Anwen Williams, Sophie Gilbert, Ann Harvey, Bronwen Evans, Deborah Mason Arthritis and other joint diseases: translational and clinical
PP29 A deletion mutation of the gene P58IPK, the cellular inhibitor of PKR and PERK, results in a degenerative joint phenotype in mice. Sophie Gilbert, Mari Nowell, Cleo Bonnet, Warren Ladiges, John Morton, Vic Duance, Debbie Mason Arthritis and other joint diseases: translational and clinical
PP30 CHANGES AND COMPARISON OF BONE METABOLISM, BONE MINERAL DENSITY, MRI IN EARLY RHEUMATOID ARTHRITIS Diana Vershhynina, Varerij Ryzhyk, Olena Mikhalchenko, Iryna Golovach, Peter Dudij, Igor Semeniv, Olga Shevchuk Arthritis and other joint diseases: translational and clinical
PP31 A GWAS in an extreme high bone mass population shows exess signal from genes associated with BMD in normal population Celia L Gregson, Paul J Leo Leo, Graeme R Clark, George Davey Smith, Matthew A Brown, Jon H Tobias, Emma L Duncan Duncan Bone biomechanics and quality
PP32 Vitamin D levels of greater than 85nmol/L in the presence of adequate dietary Ca minimise bone turnover and improve bone strength. Peter O'Loughlin, Alice Lee, Paul Anderson, Roland Steck, Mark Forwood, Rebecca Sawyer, Howard Morris Bone biomechanics and quality
PP33 Influence of the organic matrix of mineralized tissues on their dynamic mechanical properties assessed by scanning acoustic microscopy Stéphane BLOUIN, Stephan PUCHEGGER, Klaus KLAUSHOFER, Paul ROSCHGER, Peter FRATZL Bone biomechanics and quality
PP34 Obesity Induced by a Sucrose-Rich Diet Promotes Deficits in Bone Mineralization and Microarchitecture Bruna Biffe, Maria Tereza Nunes, Antonio Augusto Carvalho, Vilma Colli, Rita Dornelles, Ana Claudia Nakamune, Pedro Florindo, Mario Jefferson Louzada Bone biomechanics and quality
PP35 The Effect of Fluoride on the DEXA Score and Material Properties of Ex Vivo Emu Tibiae. Sidney Omelon, Kevin Nhan, Gillian Reid-Schachter, Nicolas Lacroix, Malaika Miles-Rossouw, Fabio Variola Bone biomechanics and quality
PP36 Regional heterogeneity of trabecular bone microdamage density in association with trabecular microarchitecture and bone resorption in whole human lumbar vertebrae Vincent T. Carpentier, Helen Tsangari, Nick L. Fazzalari, Julia S. Kuliwaba Bone biomechanics and quality
PP37 Microarchitectural decay and microdamage accumulation in vertebral trabecular bone: a comparative analysis of the iliac crest, proximal femur and vertebral body in the aged postmenopausal skeleton Vincent T. Carpentier, Dzenita Muratovic, Ian H. Parkinson, Nick L. Fazzalari, Julia S. Kuliwaba Bone biomechanics and quality
PP38 Bisphosphonate influence on bone quality at molecular level: study of human jaw bone sequesters by Raman microspectroscopy. Cécile Olejnik, Guillaume Falgayrac, Alexandrine During, Marie-Hélène Vieillard, Jean Michel Maes, Bernard Cortet, Guillaume Penel Bone biomechanics and quality
PP39 Glucose-dependent insulinotropic polypeptide receptor deletion results in a reduced bone strength and quality Aleksandra Mieczkowska, Nigel Irwin, Peter R Flatt, Daniel Chappard, Guillaume Mabilleau Bone biomechanics and quality
PP40 Prediction of Vertebral Body Stiffness in Patients with Multiple Myeloma using a Linear qCT-based Finite Element Model Graeme Campbell, Christian Graeff, Sarah Giravent, Felix Thomsen, Jaime Pena, A. Wulff, A. Günther, Claus -C Glüer, Jan Borggrefe Bone biomechanics and quality
PP41 Mechanical contrasts between osteons and interstitial bone measured by scanning acoustic microscopy Dmitri Fix, Stephan Puchegger, Christine Pilz-Allen, Paul Roschger, Peter Fratzl, Richard Weinkamer Bone biomechanics and quality
PP42 Bone quality in young thalassaemic patients Alberto Argentiero, Nadia Agnello, Cosimo Neglia, Giovanna Chitano, Alessandra Della Rosa, Giovanni Quarta, Antonella Quarta, Prisco Piscitelli, Alessandro Distante Bone biomechanics and quality
PP43 Protective effect of polyphenols from Aronia melanocarpa berries against cadmium-induced weakening of the femur biomechanical properties in rats Malgorzata M. Brzóska, Alicja Roszczenko, Joanna Rogalska Bone biomechanics and quality
PP44 2-oxoglutaric acid protects against side effects of maximal therapeutic doses of dexamethasone in piglets skeleton. Piotr Dobrowolski, Ewa Tomaszewska, Paulina Kurlak, Stefan Pierzynowski Bone biomechanics and quality
PP45 Analysis of the microarchitecutre of the human femoral head using micro-computertomography Hyungmin Ji, Ye-Yeon Won, Ye-Soo Park Bone biomechanics and quality
PP46 Low magnitude vibration signals attenuate the rapid bone mass induced by Lipopolysaccharide In Sook Kim, Tae Hyung Cho, Beomseok Lee, Soon Jung Hwang Bone biomechanics and quality
PP47 Osseous alterations in condylar head after directional change of functional loading in rabbit mandibular condyle Soon Jung Hwang, Hoon Joo Yang, Tae Hyung Cho, Ji Hye Oh, In Sook Kim Bone biomechanics and quality
PP48 Nano-structural signs of the cortical bone fragility: Atomic force microscopy study in the femoral neck of elderly hip fracture patients and healthy aged controls Petar Milovanovic, Zlatko Rakocevic, Jelena Potocnik, Danijela Djonic, Vladimir Zivkovic, Slobodan Nikolic, Marija Djuric Bone biomechanics and quality
PP49 Nano-structural and compositional basis of devitalized tooth fragility Ksenija Zelic Mihajlovic, Petar Milovanovic, Zlatko Rakocevic, Sonja Askrabic, Jelena Potocnik, Miroslav Popovic, Marija Djuric Bone biomechanics and quality
PP50 Micro-morphological properties of osteons reveal changes in cortical bone stability during aging, osteoporosis and bisphosphonate treatment in women Andreas Bernhard, Petar Milovanovic, Michael Hahn, Danijela Djonic, Matthias Krause, Stefan Breer, Klaus Pueschel, Elizabeth A. Zimmermann, Marija Djuric, Michael Amling, Bjoern Busse Bone biomechanics and quality
PP51 Microstructural adaptation of bone tissue of the facial skeleton to the distribution of occlusal load under physiological conditions Aleksa Janovic, Petar Milovanovic, Igor Saveljic, Dalibor Nikolic, Michael Hahn, Bjoern Busse, Zoran Rakocevic, Nenad Filipovic, Michael Amling, Marija Djuric Bone biomechanics and quality
PP52 Bone morphometry from human peripheral quantitative computer tomography scans is preserved by virtual high-resolution image reconstruction Friederike Schulte, Sandro Badilatti, Ian Parkinson, Jörg Goldhahn, Ralph Müller Bone biomechanics and quality
PP53 Strontium ranelate treatment improves bone material level properties in human transiliac bone biopsy specimens Patrick Ammann, René Rizzoli Bone biomechanics and quality
PP54 In vitro exposure of rat femur to Strontium chloride influences bone material level properties and increases bone strength Patrick Ammann, René Rizzoli Bone biomechanics and quality
PP55 In vivo microindentation for the assessment of bone material level properties Patrick Ammann, Roberto Güerri, Paul Hansma, Xavier Nogués, Adolfo Diez-Perez Bone biomechanics and quality
PP56 Quantitative assessment of bone remodelling and osteophytogenesis in murine Osteoarthritis Patricia Borges, Tonia Vincent, Massimo Marenzana Bone biomechanics and quality
PP57 Role of Receptor Activity Modifying Protein 3 in the Response of Bone to Mechanical Loading Matthew Livesey, Suruchi Pacharne, Ning Wang, Peter Grabowski, Lang Yang, Gareth Richards, Tim Skerry Bone biomechanics and quality
PP58 Diagnostic Discrimination of TBS and Spine BMD in Glucocorticoid-induced and Postmenopausal Osteoporosis Margaret Paggiosi, Nicola Peel, Richard Eastell Bone biomechanics and quality
PP59 The Effect of mTORC1 on Postnatal Skeletal Development Mary Matthews, Andrew Zannettino, Stephen Fitter, Sally Martin Bone development/growth and fracture repair
PP60 MEK inhibitors in fracture healing and NF1 pseudarthrosis David Little, Jad El-Hoss, Mille Kollind, Nikita Deo, Michelle McDonald, Kate Sullivan, Chris Little, Aaron Schindeler Bone development/growth and fracture repair
PP61 Vascularisation and progenitor cells of primary and secondary ossification centres in the human growth plate Sonja M. Walzer, Erdal Cetin, Ruth Grübl-Barabas, Irene Sulzbacher, Beate Rüger, Werner Girsch, Reinhard Windhager, Michael B. Fischer Bone development/growth and fracture repair
PP62 The intermittent administration of Parathyroid hormone (1-34) may induce the formation of cementum and bone: a histological study in rats. Daniel Vasconcelos, Marcelo Marques, Silvana Barros, Any Carolina Vasconcelos, Bruno Benatti, Pedro Novaes Bone development/growth and fracture repair
PP63 Microtomography analysis of bone formation in calvarial defects filled with gelatin sponge or fibrin glue Thiago de Santana Santos, Helena Bacha Lopes, Adriana Luiza Almeida, Marcio Mateus Beloti, Adalberto Luiz Rosa Bone development/growth and fracture repair
PP64 Effect of fluoride in bone repair of alveolus of mice with different bone density. Histological and morphometric analysis. Rodrigo Oliveira, Andressa Sabino, Paula Herrera, Mileni Fernandes, Patrícia Germino, Danielle Ceolin, Tânia Cestari Bone development/growth and fracture repair
PP65 A novel biocompatible BMP6 carrier device for bone regeneration Lovorka Grgurevic, Igor Erjavec, Morana Jankolija, Irena Popek, Anamarija Olic, Smiljka Vikic Topic, Donatella Verbanac, Mihaela Peric, Hermann Oppermann, Slobodan Vukicevic Bone development/growth and fracture repair
PP66 The P2Y2 receptor restrains BMD during development Susanne Syberg, Maria Ellegaard, Peter Schwarz, Niklas Rye Jørgensen Bone development/growth and fracture repair
PP67 Hip fracture induces a transient appearance of circulating mesenchymal stem cells Terhi J. Heino, Bettina Sederquist, Hannu T. Aro Bone development/growth and fracture repair
PP68 Long bone phenotypic analyzes of a RANK transgenic mouse line Vanessa BAAROUN, Amélie COUDERT, Caroline MARTY, Beatriz CASTANEDA, Ariane BERDAL, Vianney DESCROIX Bone development/growth and fracture repair
PP69 The sealing zone is not required for mineralized cartilage resorption during endochondral ossification and growth of long bone. Heiani Touaitahuata, Gaelle Cres, Anne Blangy Bone development/growth and fracture repair
PP70 A casein-based diet leads to a better bone status than a soy protein-based diet during moderate protein restriction in growing mice. Emilien Rouy, Norbert Laroche, François Blachier, Daniel Tomé, Laurence Vico, Anne Blais Bone development/growth and fracture repair
PP71 Accuracy Errors in Longitudinal QCT Measurements of Cortical Thickness Bone Mineral Density (BMD) and Bone Mineral Content (BMC) Using Different Segmentation Techniques: A Simulation Study Bastian Gerner, Oleg Museyko, Dominique Töpfer, Klaus Engelke Bone development/growth and fracture repair
PP72 Calcium phosphate cement /Strontium enhances bone formation in the metaphyseal osteoporotic fracture Thaqif El Khassawna, Seemun Ray, Ulrich Thormann, Katrin Lips, Michael Gelinsky, Matthias Schumacher, Alexander Claus Langheinrich, Reinhard Schnettler, Volker Alt Bone development/growth and fracture repair
PP73 Feasibility of local CD133+ cell transplantation to avoid non-unions in biological impaired bone healing Anke Dienelt, Andrea F. Sass, Bernd Preininger, Katharina Schmidt-Bleek, Georg N. Duda Bone development/growth and fracture repair
PP74 Metaphyseal Fracture Healing in a Sheep Model of Low Turnover Osteoporosis Induced by Hypothalamic-Pituitary Disconnection Ronny Bindl, Ralf Oheim, Pia Pogoda, Frank Timo Beil, Katharina Gruchenberg, Sandra Reitmaier, Tim Wehner, Enrico Calcia, Peter Radermacher, Lutz Claes, Michael Amling, Anita Ignatius Bone development/growth and fracture repair
PP75 Interplay of physical and biological cues in the regeneration of critical-sized bone defects Amaia Cipitria, Johannes C. Reichert, Claudia Lange, Hanna Schell, Manav Mehta, Wolfgang Wagermaier, Paul Zaslansky, Peter Fratzl, Dietmar W. Hutmacher, Georg N. Duda Bone development/growth and fracture repair
PP76 THE EFFECT OF POST-NATAL (CHILDHOOD) OBESITY ON SKELETAL DEVELOPMENT Efrat Monsonego-Ornan, Stav Simsa-Maziel, Janna Zareski, Sergey Anpilov, Gili Solomon Bone development/growth and fracture repair
PP77 Histologic Diagnosis of Aluminum Osteomalacia in Renal Failure Rats Yoshimi Teraki Bone development/growth and fracture repair
PP78 Sex-related differences of femur properties in silver foxes (Vulpes vulpes) Marcin Tatara, Witold Krupski, Andrzej Jakubczak, Marek Bienko, Krzysztof Kostro Bone development/growth and fracture repair
PP79 Interrelationships between morphometric, densitometric and mechanical properties of mandible in 5-month old Polish Merino sheep Witold Krupski, Marcin Tatara, Anna Szabelska, Iwona Luszczewska-Sierakowska, Barbara Tymczyna Bone development/growth and fracture repair
PP80 Bone metabolism is influenced by serum 25-hydroxyvitamin D in healthy children Edyta Czekuc-Kryskiewicz, Elzbieta Karczmarewicz, Maciej Jaworski, Justyna Czech-Kowalska, Anna Gorska, Jerzy Konstantynowicz, Pawel Pludowski, Jaroslaw Piskorski, Roman Lorenc Bone development/growth and fracture repair
PP81 Characterization of an Y1R antagonist as a drug for bone regeneration. Inês Alencastre, Catarina Almeida, Diana Leite, Cecília Alves, Daniela Sousa, Estrela Neto, Meriem Lamghari Bone development/growth and fracture repair
PP82 MEASUREMENT PROPERTIES OF RADIAL AND TIBIAL SPEED OF SOUND FOR SCREENING BONE HEALTH AND FRAGILITY IN 10 TO 12 YEARS OLD BOYS AND GIRLS Lurdes Rebocho, Graça Cardadeiro, Vera Zymbal, Ezequiel M Gonçalves, Luís B Sardinha, Fátima Baptista Bone development/growth and fracture repair
PP83 Trabecular micro-architecture of the proximal femur during post-natal growth Marija Djuric, Petar Milovanovic, Danijela Djonic, Michael Hahn, Bjoern Busse, Michael Amling Bone development/growth and fracture repair
PP84 Variations in osteotoxic effects of cadmium on femoral bone structure after different routes of exposure Monika Martiniakova, Hana Chovancova, Radoslav Omelka, Ivana Bobonova, Robert Toman Bone development/growth and fracture repair
PP85 The retention and bioactivity of rhBMP-2 released from a bisphosphonate-linked hyaluronan-based hydrogel Gry Hulsart-Billström, Pik-Kwan Yuen, Richard Marsell, Jöns Hilborn, Sune Larsson, Dmitri Ossipov Bone development/growth and fracture repair
PP86 The effect of incubation time of preformed injectable hydrogels on bone formation when used as carrier of rhBMP-2  Sonya Piskounova, Gry Hulsart-Billström, Lars Gedda, Kristoffer Bergman, Jöns Hilborn, Sune Larsson, Tim Bowden Bone development/growth and fracture repair
PP87 Premixed calcium phosphate cement as a carrier for bone morphogenetic protein 2  Nick Walters, Gry Hulsart-Billström, Håkan Engqvist, Sune Larsson Bone development/growth and fracture repair
PP88 Low calcium intake aggravates the deleterious effects of an isocaloric low protein diet on bone material level properties during growth Carole Fournier, René Rizzoli, Patrick Ammann Bone development/growth and fracture repair
PP89 Spirulina alga prevents impairment of peak bone mass acquisition induced by an isocaloric low protein diet Carole Fournier, René Rizzoli, Patrick Ammann Bone development/growth and fracture repair
PP90 The choice of fetal bovine serum (FBS) influences the degree of spontaneous mineralization on silk fibroin scaffolds in 3D cell cultures Samantha Paulsen, Jolanda Vetsch, Ralph Müller, Sandra Hofmann Bone development/growth and fracture repair
PP91 Pediatric differences in Bone Mineral Density according to ethnic background in children. The Generation R Study. Carolina Medina-Gomez, Denise H.M Heppe, Albert Hofman, Vincent Jaddoe, André Uitterlinden, Fernando Rivadeneira Bone development/growth and fracture repair
PP92 Identifying scoliosis in population-based cohorts: development and validation of a novel method based on total body dual energy X-ray absorptiometry scans Hilary Taylor, Ian Harding, John Hutchinson, Ian Nelson, Ashley Blom, Jon Tobias, Emma Clark Bone development/growth and fracture repair
PP93 Smaller bones at aged 10 predicts scoliosis at aged 15: Results from a population-based birth cohort Hilary Taylor, Ashley Blom, Ian Harding, John Hutchinson, Ian Nelson, Jon Tobias, Emma Clark Bone development/growth and fracture repair
PP94 The healing of fracture of mandible  against the chronic nitrate intoxication David Aveticov, Vitaly Kostenko, Karine Neporada, Ekaterina Lokes, Stanislav Stavickiy Bone development/growth and fracture repair
PP95 Osteometric parameters of mature rats mandible molars at implantation in the tibia of biogenic hydroxyapatite Luzin Vladislav, Morozov Vitali, Morozova Helen Bone development/growth and fracture repair
PP96 Macroelements composition of the dentin in rat’s mandibular incisors with implanted biogenic hydroxyapatite into the tibia Luzin Vladyslav, Morozov Vitaly, Astrakhantsev Dmitry, Golubkov Pavel, Sokol Marina Bone development/growth and fracture repair
PP97 Organometric parameters of rat′s bones under the effect of toluene vapor Skorobogatov A, Luzin V, Morozov V, Shutov Ye Bone development/growth and fracture repair
PP98 Identification and Characterization of a Mesenchymal Progenitor Cell Population Involved in Fracture Healing Brya Matthews, Danka Grcevic, Liping Wang, Yusuke Hagiwara, Douglas Adams, Ivo Kalajzic Bone development/growth and fracture repair
PP99 INTERRELATIONSHIP BETWEEN OSTEOCALCIN (BGP) AND ENERGETIC METABOLISM IN TWO STRAINS OF RATS. Clarisa Marotte, Gabriel Bryk, Magali Zeni Coronel, Paulina Abrego, Diego Martín Lucero, Laura Schreier, María Luz Portela, Susana Noemí Zeni Calciotropic and phosphotropic hormones and mineral metabolism
PP100 a mixture of GOS/FOS® ADDED TO A LOW CALCIUM (Ca) DIET IMPROVED  Ca, PHOSPHORUS (P) AND MAGNESIUM (Mg) ABSORPTION: EXPERIMENTAL MODEL IN NORMAL GROWING RATS Gabriel Bryk, Macarena Gonzales Chaves, Clarisa Marotte, Daniela Medina, Magali Zeni Coronel, Maria Luz De Portela, Susana Noemi Zeni Calciotropic and phosphotropic hormones and mineral metabolism
PP101 Vasculature and Bone: Stages of Atherosclerosis come along with Changes in Gene Expression Levels of Calcification Regulators Natascha Schweighofer, Ariane Aigelsreiter, Martina Graf-Rechberger, Nicole Hacker, Daniela Kniepeiss, Philipp Stiegler, Olivia Trummer, Thomas Pieber, Matthias Ulbing, Doris Wagner, Helmut Müller, Barbara Obermayer-Pietsch Calciotropic and phosphotropic hormones and mineral metabolism
PP102 A genetic polymorphism of osteocalcin is associated with BMI but not with parameters of glucose and lipid metabolism in women with polycystic ovary syndrome Verena Schwetz, Olivia Trummer, Albrecht Giuliani, Thomas R. Pieber, Barbara Obermayer-Pietsch, Elisabeth Lerchbaum Calciotropic and phosphotropic hormones and mineral metabolism
PP103 State and metabolism of osseous tissue in people with postinfarction cardiosclerosis Liudmila Yankouskaya, Irena Karpova Calciotropic and phosphotropic hormones and mineral metabolism
PP104 Neonatal neuroendocrine alterations impair tooth eruption, enamel mineralization, and leptin and corticosterone secretion in adulthood. Wagner Garcez de Mello, Samuel Rodrigues Lourenço de Morais, Alberto Carlos Botazzo Delbem, Rita Cássia Menegati Dornelles, José Antunes-Rodrigues, João Cesar Bedran de Castro Calciotropic and phosphotropic hormones and mineral metabolism
PP105 α2CAR KO Mice Present Opposite Bone Phenotype in Femur and Vertebrae Marilia Bianca Teixeira, Gisele Martins, Cristiane Costa, Patricia Brum, Cecília Gouveia Calciotropic and phosphotropic hormones and mineral metabolism
PP106 Bone microtomography and immunohistochemistry of acyclic rats post antiresorptive therapy and resistance training Camila Stringhetta-Garcia, Samuel Morais, Mário Louzada, Edilson Ervolino, Rita Dornelles Calciotropic and phosphotropic hormones and mineral metabolism
PP107 A study of the correlation between femoral head iron content and BMD in postmenopausal women Bing Wang Calciotropic and phosphotropic hormones and mineral metabolism
PP108 A sensitive assay for measuring circulating BMP6 Martina Pauk, Lovorka Grgurevic, Jelena Brkljacic, Vera Kufner, Tatjana Bordukalo-Niksic, Morana Jankolija, Hermann Oppermann, Slobodan Vukicevic Calciotropic and phosphotropic hormones and mineral metabolism
PP109 Biochemical bone markers of bone turnover in diabetics- a meta-analysis. Jakob Starup-Linde, Stine Aistrup Eriksen, Peter Vestergaard Calciotropic and phosphotropic hormones and mineral metabolism
PP110 Short-term resveratrol supplementation stimulates serum levels of bone-specific alkaline phosphatase in obese non-diabetic men Morten Møller Poulsen, Marie Juul Ornstrup, Torben Harsløf, Niels Jessen, Bente Lomholt Langdahl, Bjørn Richelsen, Jens Otto Lunde Jørgensen, Steen Bønløkke Pedersen Calciotropic and phosphotropic hormones and mineral metabolism
PP111 The effect of gastric bypass on hormones related to bone re-modeling and intestinal growth. Bolette Hartmann, Henrik Vestergaard, Peter Bonfils, Marie Hansen, Nicolai Albrechtsen, Peter Eskildsen, Andrea Floyd, Annette Lykke Svenningsen, Jens Juul Holst Calciotropic and phosphotropic hormones and mineral metabolism
PP112 Plasma triiodothyronine (T3) levels are positively associated with BMD and bone strength: a cross-sectional study. Emil Moser, Tanja Sikjaer, Leif Mosekilde, Lars Rejnmark Calciotropic and phosphotropic hormones and mineral metabolism
PP113 Lower bone turnover in obesity: Is there a link to energy metabolism? Heli Viljakainen, Kaisa K. Ivaska, Marita Lipsanen-Nyman, Tero Saukkonen, Sture Andersson, Kalevi Laitinen, Outi Mäkitie Calciotropic and phosphotropic hormones and mineral metabolism
PP114 Pro-angiogenic and pro-survival Functions of Glucose in Human Mesenchymal Stem Cells Upon Transplantation Mickael Deschepper, Joseph Paquet, Mathieu Manassero, Morad Bensidhoum, Karim Oudina, Delphine Logeart-Avramoglou, Herve Petite Calciotropic and phosphotropic hormones and mineral metabolism
PP115 On the Importance of Selenium for Bone Physiology Nicole Pietschmann, Eddy Rijntjes, Antonia Hoeg, Lutz Schomburg Calciotropic and phosphotropic hormones and mineral metabolism
PP116 Effect of high doses of vitamin D on arterial properties, adiponectin, leptin and glucose homeostasis in type 2 diabetic patients. Marina Shargorodsky Calciotropic and phosphotropic hormones and mineral metabolism
PP117 Relationship between bone mineral density, body composition, skin sclerosis and serum 25(OH) vitamin D levels in  systemic sclerosis Addolorata Corrado, Anna Neve, Arcangela Marucci, Ripalta Colia, Angiola Mele, Francesco Paolo Cantatore Calciotropic and phosphotropic hormones and mineral metabolism
PP118 Role of estrogen replacement therapy in the control of immune system in postmenopausal osteoporosis. PATRIZIA D'AMELIO, FRANCESCA SASSI, ILARIA BUONDONNO, GIORGIA FORNELLI, ELENA BONARDO, GIOVANNI CARLO ISAIA Calciotropic and phosphotropic hormones and mineral metabolism
PP119 VITAMIN D IN FRAGILE ELDERLY  WOMEN WITH SEVERE OSTEOPOROSIS AND  UNCONTROLLED HYPERTENSION Ferdinando D’Amico12, Francesco Caronzolo1, Giovanni Gaglio1, Antonino Granata1, Giuseppina Lombardo1, Tiziana Pipicella1,  Enzo Russo1, Pippo Spatola1, Alessandro Grippa1  Department of Geriatrics,   Hospital of Patti 1 - School  of Medicine, University of Messina 2   - Messina, Italy Ferdinando D'Amico, Francesco Caronzolo, Giovanni Gaglio, Antonino Granata, Giuseppina Lombardo, Tiziana Pipicella, Pippo Spatola, Enzo Russo, Alessandro Grippa Calciotropic and phosphotropic hormones and mineral metabolism
PP120 Interaction between FGF23 R176W mutation and C716T nonsynonymous change (T239M, rs 7955866) in FGF23 on the clinical phenotype in a family with autosomal dominant hypophosphatemic rickets Daniela Merlotti, Domenico Rendina, Luigi Gennari, Teresa Esposito, Sara Magliocca, Gianpaolo De Filippo, Pasquale Strazzullo, Ranuccio Nuti, Fernando Gianfrancesco Calciotropic and phosphotropic hormones and mineral metabolism
PP121 Calcium Dietary Intake in Southern Lebanese Women Yasser Yaghi, Fatiha El Horr, Nancy Maan, Kinda Yaghi Calciotropic and phosphotropic hormones and mineral metabolism
PP122 Effects of long-term oral administration with methimazole on femur properties in male Wistar rats Marcin Tatara, Marcin Golynski, Radoslaw Radzki, Marek Bienko, Witold Krupski Calciotropic and phosphotropic hormones and mineral metabolism
PP123 Vitamin D supplementation during lactation- effect on maternal and offspring's vitamin D status and bone mass - double-blind randomized control trial. Justyna Czech-Kowalska, Maciej Jaworski, Julita Latka-Grot, Dorota Bulsiewicz, Pawel Pludowski, Bogdan Chazan, Beata Pawlus, Grazyna Wygledowska, Anna Zochowska, Maria K. Kornacka, Edyta Kryskiewicz, Elzbieta Karczmarewicz, Anna Dobrzanska Calciotropic and phosphotropic hormones and mineral metabolism
PP124 Polyphenols from berries of Aronia melanocarpa improve the antioxidative capacity of the bone tissue in cadmium-exposed rats Joanna Rogalska, Malgorzata M. Brzóska, Alicja Roszczenko, Malgorzata Galazyn-Sidorczuk, Maria Jurczuk Calciotropic and phosphotropic hormones and mineral metabolism
PP125 The serum serotonin and 25-OH vitamin D levels: a study in 97 menopausal women Mara Carsote, Mihaela Popescu, Ramona Samoila, Rene Baloescu, Madalina Muler, Adriana Gruia, Catalina Poiana Calciotropic and phosphotropic hormones and mineral metabolism
PP126 Vitamin D: Light side and best time of sunshine in Riyadh, Saudi Arabia Fahad Alshahrani, Mussa Almalki, Naji Aljohani, Abdullah Alzahrani, Yossef Alsaleh, Michel Holick Calciotropic and phosphotropic hormones and mineral metabolism
PP127 Hypercalcemia following high vitamin D loading dose  Paul Lips, Aegida Neradova, Natasja van Schoor, Mark Vervloet Calciotropic and phosphotropic hormones and mineral metabolism
PP128 Mass spectrometric immunoassay (MSIATM) for intact parathyroid hormone: correlation with immunoassay and application to clinical samples. L Couchman, D Taylor, B Krystans, M Lopez, A Prakash, D Sarracino, A Garces, M Vogelsang, S Peterman, G Vadali, S Robinson, C Moniz Calciotropic and phosphotropic hormones and mineral metabolism
PP129 The Ellsworth-Howard Test Revisited J. C. Y. Tang, C. J. Washbourne, H. Galitzer, T. Hiemstra, C. Meek, A. Chipchase, W. D. Fraser Calciotropic and phosphotropic hormones and mineral metabolism
PP130 CALCIUM-PHOSPHORUS METABOLISM AND CALCIUM-REGULATING HORMONES IN OSTEOPOROSIS WHICH ASSOCIATED WITH LIVER CIRRHOSIS Iryna Golovach, Zinovij Mytnyk, Diana Vershynina Calciotropic and phosphotropic hormones and mineral metabolism
PP131 Effects of Zoledronic Acid (ZOL) on Hormone Levels in Premenopausal Women with Breast Cancer (BC) Receiving Neoadjuvant or Adjuvant Chemotherapy (CT) and Endocrine Therapy (ET): ProBONE II Study Peyman Hadji, Anette Kauka, Thomas Bauer, May Ziller, Katrin Birkholz, Monika Baier, Mathias Muth, Peter Kann Calciotropic and phosphotropic hormones and mineral metabolism
PP132 The central role of the histone demethylase JHDM1D in the regulation of tumor associated genes in bone tumor related cells Roman Thaler, Silvia Spitzer, Florian Haider, Heidrun Karlic, Klaus Klaushofer, Franz Varga Cancer and bone: basic, translational and clinical
PP133 Identification of tumorigenic sarcoma cancer stem cells based on high aldehyde dehydrogenase 1 activity Birgit Lohberger, Beate Rinner, Nicole Stuendl, Sonja Maria Walzer, Reinhard Windhager, Andreas Leithner Cancer and bone: basic, translational and clinical
PP134 Isolation of ALDH1high Cells by Flow Cytometry and Investigation of the Expression Pattern of Wnt Pathway Genes in Primary Chordoma Cell Lines Birgit Lohberger, Nicole Stuendl, Katharina Meditz, Bernadette Liegl, Andreas Leithner, Beate Rinner Cancer and bone: basic, translational and clinical
PP135 Anti-RANKL Nanobody® ALX-0141 Shows Sustained Biomarker Inhibition in a Phase I Study in Healthy Postmenopausal Women Pieter Schoen, Sandy Jacobs, Katrien Verschueren, Ingrid Ottevaere, Sigrid Sobry, Josefin-Beate Holz Cancer and bone: basic, translational and clinical
PP136 Modulation of macrophage activation status by bisphosphonates and breast cancer cells. Sofia Sousa, Jukka Mönkkönen, Jorma Määttä Cancer and bone: basic, translational and clinical
PP137 Clusterin Inhibition using OGX-011 Synergistically Enhances Zoledronic Acid Activity in Osteosarcoma. Francois Lamoureux, Marc Baud'huin, Benjamin Ory, Martin Gleave, Dominique Heymann, Francoise Redini Cancer and bone: basic, translational and clinical
PP138 New chondrosarcoma cell lines and mouse models to study the link between chondrogenesis and chemoresistance David Monderer, Alexandrine Luseau, Amélie Bellec, Emmanuelle David, Stéphanie Ponsolle, Soraya Saïagh, Sylvain Bercegeay, Philippe Piloquet, Marc Denis, Laurence Lodé, Françoise Rédini, Marine Biger, Dominique Heymann, Marie-Françoise Heymann, Ronan Le Bot, François Gouin, Frédéric Blanchard Cancer and bone: basic, translational and clinical
PP139 New PI3Kalpha-specific inhibitor, BYL719: therapeutic interest in osteosarcoma Bérengère Gobin, Marc Baud'huin, Céline Charrier, Soizic Hervouet, Frédéric Lezot, Frédéric Blanchard, Dominique Heymann Cancer and bone: basic, translational and clinical
PP140 NVP-BEZ235, a dual PI3K/mTOR inhibitor, inhibits osteosarcoma cell proliferation and the tumor development in vivo Bérengère Gobin, Séverine Battaglia, Julie Chesneau, Dominique Heymann Cancer and bone: basic, translational and clinical
PP141 Therapeutic interest of Imatinib Mesylate in Osteosarcoma Bérengère Gobin, Gatien Moriceau, Benjamin Ory, Régis Brion, Françoise Rédini, Dominique Heymann Cancer and bone: basic, translational and clinical
PP142 Over-expression of Smad7 in osteosarcoma cells inhibits primary tumor growth, the associated bone osteolysis and the development of lung metastasis in murine xenograft model. Audrey Lamora, Julie Talbot, Bérengère Gobin, Marion Leduc, Julien Taurelle, Régis Brion, Dominique Heymann, Françoise Rédini, Franck Verrecchia Cancer and bone: basic, translational and clinical
PP143 Bone remodelling in patients with an IgM monoclonal gammopathy (Waldenström disease -MGUS) Daniel Chappard, Béatrice Bouvard, Mathieu Royer, Emmanuel Hoppé, Erick Legrand, Norbert Ifrah, Maurice Audran Cancer and bone: basic, translational and clinical
PP144 Selective BET bromodomains epigenetic signaling inhibition as a therapeutic strategy in primary bone tumors Francois Lamoureux, Marc Baud'huin, Lidia Rodriguez, Camille Jacques, Martine Berreur, James E. Bradner, Francoise Redini, Dominique Heymann, Benjamin Ory Cancer and bone: basic, translational and clinical
PP145 Synergistic anti-tumour effects on human breast cancer cells by mevalonate pathway inhibitors atorvastatin and zoledronic acid Andy Göbel, Stefanie Thiele, Martina Rauner, Lorenz C. Hofbauer, Tilman D. Rachner Cancer and bone: basic, translational and clinical
PP146 Metabolomics identifies plasma biomarkers of multiple myeloma development and progression Elisabetta Mariani, Francesca Fontana, Silvia Mari, Jose Manuel Garcia Manteiga, Magda Marcatti, Nicola Napoli, Francesco Camnasio, Gianfranco Fraschini, Enrico Caneva, Roberto Sitia, Giovanna Musco, Fabio Ciceri, Simone Cenci Cancer and bone: basic, translational and clinical
PP147 Involvement of the co-receptor RAMP2 in the progression of breast cancer-induced osteolytic lesions. Alfredo Cappariello, Nadia Rucci, Mattia Capulli, Maurizio Muraca, Anna Teti Cancer and bone: basic, translational and clinical
PP148 Direct administration of zoledronate acid improves bone structure in local osteoporotic lesion of ovariectomized rats Yohei Matsuo, Masafumi Kashii, Tsuyoshi Sugiura, Tokimitsu Morimoto, Hirotsugu Honda, Takashi kaito, Motoki Iwasaki, Hideki Yoshikawa Cancer and bone: basic, translational and clinical
PP149 Cytotoxicity of picocyanobacteria strains of the genera Cyanobium on Osteosarcoma Cells Rosário Martins, Margarida Costa, Mónica Garcia, Piedade Barros, João Costa-Rodrigues, Vitor Vasconcelos, Maria Fernandes Cancer and bone: basic, translational and clinical
PP150 Inhibition of osteoclastogenesis by proton pump inhibitors on co-cultures of human osteoclasts and breast cancer cells Sara Reis, Maria Fernandes, João Costa-Rodrigues Cancer and bone: basic, translational and clinical
PP151 Trolox Inhibits Breast Cancer Bone Metastasis and Bone Destruction Through Suppression of PGE2 Production Jong-Ho Lee, Hyunil Ha, Won Jong Jin, Sun-Don Kim, Jin Suk Jung, Hong-Hee Kim, Zang Hee Lee Cancer and bone: basic, translational and clinical
PP152 Carcinoid tumors and DXA assessment - a study in 222 menopausal women Catalina Poiana, Mara Carsote, Rodica Petris, Raluca Trifanescu, Gabriela Voicu, Diana Paun Cancer and bone: basic, translational and clinical
PP153 The DXA results in 41 patients with neuroendocrine tumors: a transversal study Mara Carsote, Andreea Geleriu, Roxana Dusceac, Roxana Miron, Cristina Ene, Valentin Radoi, Gabriela Voicu, Catalina Poiana Cancer and bone: basic, translational and clinical
PP154 miR-192 Impairs Invasion and Tumor-Induced Osteolysis by Repressing CCL2 in Bone Metastatic Colonization Karmele Valencia, Diego Luis-Ravelo, Nicolas Bovy, Susana Martínez-Canarias, Cristina Ormazábal, Carolina Zandueta, Iker Antón, Ingrid Struman, Sébastien Tabruyn, Victor Segura, Javier De Las Rivas, Eva Bandrés Cancer and bone: basic, translational and clinical
PP155 Influence of sex steroids on sclerostin levels in patients with prostate cancer Manuel Muñoz-Torres, Rebeca Reyes-Garcia, Beatriz Garcia-Fontana, Sonia Morales-Santana, Mariela Varsavsky, Maria Dolores Aviles-Perez, Antonia Garcia-Martin Cancer and bone: basic, translational and clinical
PP156 Vitamin D serum levels and breast cancer risk in a Mediterranean population: a case-control study. Maria Rodriguez-Sanz, Natalia García-Giralt, Elisa Torres, Marta De Ramon, Antonio Cano-Sánchez, Miguel Ángel García-Pérez, Sonia Servitja, Laia Garrigós, María Martinez-García, Ignasi Tusquets, Joan Albanell, Adolfo Díez, Daniel Prieto-Alhambra, Xavier Nogués Cancer and bone: basic, translational and clinical
PP157 Bone metastatic prostate cancer cells regulate their growth via impairing osteoblast differentiation Marjolein van Driel, Iris Robbesom, Ruben Koster, Bianca Boers-Sijmons, Hideki Chiba, Hans van Leeuwen Cancer and bone: basic, translational and clinical
PP158 Role of receptor activity modifying proteins (RAMPs) in skeletal regulation. SURUCHI PACHARNE, GARETH RICHARDS, NING WANG, TIMOTHY SKERRY, KATHLEEN CARON Cancer and bone: basic, translational and clinical
PP159 A novel antagonist of the canonical Wnt-signalling pathway, Sostdc1, is expressed in experimental models of myeloma and suppresses bone formation. Clive Buckle, Zahra Faraahi, Michelle Lawson, Colby Eaton, Karin Vanderkerken, Peter Croucher Cancer and bone: basic, translational and clinical
PP160 Glucose ceramide synthase inhibitors prevent osteoclast activation and limit myeloma induced osteolytic lesions Adel Ersek, Ke Xu, Anastasios Karadimitris, Nicole J. Horwood Cancer and bone: basic, translational and clinical
PP161 Effect of Zoledronic Acid (ZOL) on Bone Mineral Density (BMD) in Premenopausal Women Receiving Neoadjuvant or Adjuvant Therapies for Breast Cancer (BC): The ProBONE II Study Peyman Hadji, Anette Kauka, Thomas Bauer, Katrin Birkholz, Monika Baier, Mathias Muth Muth, May Ziller Cancer and bone: basic, translational and clinical
PP162 Effect of Zoledronic Acid (ZOL) on Bone Metabolism in Patients With Bone Metastases From Prostate or Breast Cancer (BC): The ZOTECT Study Peyman Hadji, May Ziller, Tobias Maurer, Michael Autenrieth, Mathias Muth, Amelie Ruebel, Christoph May, Katrin Birkholz, Erhardt Diebel, Jochen Gleissneer, Peter Rothe, Juergen E Gschwend Cancer and bone: basic, translational and clinical
PP163 Hepatic lipase is expressed by osteoblasts and modulates bone remodeling in obesity Alexander Bartelt, F. Timo Beil, Brigitte Müller, Till Köhne, Markus Heine, Tayfun Yilmaz, Joerg Heeren, Thorsten Schinke, Andreas Niemeier Cell biology: osteoblasts and bone formation
PP164 Histologic evaluation of direct pulp capping by the using of calcium hydroxide and octacalcium phosphate in dental pulp of cats Fereydoon Sargolzaei-aval, Mohammad reza Arab, Eshagh Ali Saberi Cell biology: osteoblasts and bone formation
PP165 Implantation of Octacalcium phosphate (OCP) enhances alveolar ridge in rat mandible Fereydoon Sargolzaei Aval, Mohammad Reza Arab, Forough Sargolzaei Aval Cell biology: osteoblasts and bone formation
PP166 ACTIVATED PROTEIN C (APC) INCREASES OSTEOBLAST PROLIFERATION AND BMP-2 INDUCED BONE FORMATION Kaitlin Shen, Aaron J. Schindeler, Tegan L. Cheng, Meilang Xue, David G. Little, Chris J. Jackson Cell biology: osteoblasts and bone formation
PP167 ADIPOGENESIS OCCURS AT THE EXPENSE OF OSTEOBLAST DIFFERENTIATION IN PRIMARY OSTEOBLASTS DEFICIENT IN PROTEASE-ACTIVATED RECEPTOR-2 Pamuditha Kularathna, Charles N. Pagel, John D. Hooper, Eleanor J. Mackie Cell biology: osteoblasts and bone formation
PP168 Distinct Potential of Osteoblast Differentiation of Adipose Tissue- and Bone Marrow-Derived Mesenchymal Stem Cells Rodrigo Abuna, Fabiola de Oliveira, Rogerio Kato, Adalberto Rosa, Marcio Beloti Cell biology: osteoblasts and bone formation
PP169 Increase of mineral nodules and alkaline phosphatase levels in osteoblasts cultures by using disordered carbon nanotubes and titanium discs. Daniela Cervelle Zancanela, Ana Maria Sper Simão, Elaine Yoshiko Matsubara, José Maurício Rosolen, Pietro Ciancaglini Cell biology: osteoblasts and bone formation
PP170 Calcium transport and phosphomonohydrolase activity by proteoliposomes harboring Annexin V and Alkaline Phosphatase Maytê Bolean, Ana Maria Simao, Tina Kiffer-Moreira, Marc Hoylaerts, José Luis Millán, Pietro Ciancaglini Cell biology: osteoblasts and bone formation
PP171 In vitro effect of prolactin on the osteogenic potential of bone marrow mesenchymal stem cells of rats Natália de Melo Ocarino, Silvia Silva Santos, Lorena Rocha, Juneo Freitas, Amanda Maria Sena Reis, Rogéria Serakides Cell biology: osteoblasts and bone formation
PP172 Differential Gene Expression of Matrix Metalloproteinases (MMPs), MMP-inhibitors (TIMPs and RECK), and MMP-activator (EMMPRIN/CD147) During Osteogenic Differentiation from Human Dental Pulp Stem Cells (DPSCs). Katiucia Paiva, Luiz Silva, Mari Sogayar Cell biology: osteoblasts and bone formation
PP173 Exogenous polyphosphate is not readily utilized for mineralization in vitro Marianne Ariganello, Sidney Omelon, Rima Wazen, Fabio Variola, Antonio Nanci Cell biology: osteoblasts and bone formation
PP174 Elevated levels of serotonin decrease bone volume by direct effects on bone turnover in rats Igor Erjavec, Tatjana Bordukalo-Niksic, Jelena Brkljacic, Martina Pauk, Lovorka Grgurevic, David D. Thompson, Vishwas M. Paralkar, Lipa Cicin-Sain, Slobodan Vukicevic Cell biology: osteoblasts and bone formation
PP175 Identification of a small molecule kinase inhibitor that enhances osteoblast differentiation of human skeletal (mesenchymal) stem cells through regulation of TGFβ signaling Majken Storm Siersbaek, Abbas Jafari, Walid Zaher, Li Chen, Moustapha Kassem Cell biology: osteoblasts and bone formation
PP176 The effect of fibroblast growth factor 2 (FGF2) on mesenchymal stromal cell differentiation Tiina Kähkönen, Kaisa, K. Ivaska, Pirkko Härkönen Cell biology: osteoblasts and bone formation
PP177 Extracellular glucose alters mesenchymal stromal cell growth and differentiation Anna-Reeta Virta, Kaisa K. Ivaska Cell biology: osteoblasts and bone formation
PP178 Regulation and function of immunosuppressive molecule human leukocyte antigen G5 in human bone tissue Frederic Deschaseaux, Julien Gaillard, Alain Langonné, Christophe Chauveau, Abderrahim Naji, Amina Bouacida, Philippe Rosset, Dominique Heymann, Gonzague de Pinieux, Nathalie Rouas-Freiss, Luc Sensébé Cell biology: osteoblasts and bone formation
PP179 Mineralizing properties of DMP1 studied in vitro with cellular and acellular 3D collagen model systems mimicking the bone tissue Jérémie Silvent, Nadine Nassif, Thierry Azaïs, Christophe Hélary, Sidney Delgado, Fabrice Soncin, Marie Madeleine Giraud-Guille, Jean-Yves Sire Cell biology: osteoblasts and bone formation
PP180 N-Cadherin Governs Age-Related Determination in Mice Through Modulation of Wnt5a and Wnt10b. Eric Haÿ, François-Xavier Dieudonné, Caroline Marty, Pierre J. Marie Cell biology: osteoblasts and bone formation
PP181 The impairement of bone formation and mineralization in BSP-/- mouse calvaria cell cultures is partly rescued by increasing cell density Guénaëlle Bouët, Wafa Bouleftour, Marchat David, Linossier Marie-Thérèse, Thomas Mireille, Aubin Jane E., Vico Laurence, Malaval Luc Cell biology: osteoblasts and bone formation
PP182 Evaluation of bone formation capacities of human adipose-derived stromal cells cultured in platelet growth factor-enriched plasma medium. Fabien Guilloton, Vahideh Rabani, Meadhbh Brennan, Giulio Bassi, Mauro Krampera, Pierre Layrolle, Luc Sensebé, Frédéric Deschaseaux Cell biology: osteoblasts and bone formation
PP183 Development of mice models to study implant osseointegration and failure in alveolar bone  Sylvain Mouraret, Claire Bardet, Dan J Hunter, Antoine Popelut, John B Brunski, Catherine Chaussain, Philippe Bouchard, Jill A Helms Cell biology: osteoblasts and bone formation
PP184 Activation of β-Catenin Signalling Enhances the Osteogenic Gene Response to Mechanical Loading in Mesenchymal Stem Cells Claudia Nemitz, Astrid Liedert, Franz Jakob, Anita Ignatius Cell biology: osteoblasts and bone formation
PP185 DNA-Damage, Survival, Differentiation and Matrix Mineralization in vitro of a Murine Multipotent Mesenchymal Precursor Cell Line Patrick Lau, Yueyuan Hu, Christine E. Hellweg, Christa Baumstark-Khan, Günther Reitz Cell biology: osteoblasts and bone formation
PP186 Involvement of Runx2 in the differentiation process of osteoblastic precursor cells after radiation exposure Yueyuan Hu, Patrick Lau, Christine Hellweg, Christa Baumstark-Khan, Guenther Reitz Cell biology: osteoblasts and bone formation
PP187   Implantation of Octacalcium Phosphate Enhances Long Bone's Repair in Rats Mohammad Reza Arab, Fereydoon Sargolzaei Aval, Forugh Sargolzaei Aval Cell biology: osteoblasts and bone formation
PP188 INTRACELLULAR CALCIUM FLUXES IN HUMAN BONE CELLS IN OSTEOPOROTIC AND OSTEOARTHRITIC  PATIENTS Monica celi, Elena Gasbarra, Claudio Frank, Alessandro Cutarelli, Giulio Fioravanti Cinci, Umberto Tarantino Cell biology: osteoblasts and bone formation
PP189 Integrins and cadherins in mesenchymal stem cells (MSCs) from dental tissues: possible implication in the osteogenic differentiation process Adriana Di Benedetto, Claudia Carbone, Angela Oranger, Giacomina Brunetti, Lorenzo Lo Muzio, Silvia Colucci, Maria Grano, Giorgio Mori Cell biology: osteoblasts and bone formation
PP190 ROLE OF VITAMIN D AND K ON HUMAN OSTEOBLASTS IN VITRO ON PRIMARY CULTURES DERIVED FROM OSTEOPOROTIC AND NORMAL PATIENTS gianna roscetti, mario marini, emiliano arango, umberto tarantino Cell biology: osteoblasts and bone formation
PP191 Nuclear translocation of oxytocin receptor mediates increased gene expression in osteoblasts Adriana Di Benedetto, Concetta Cuscito, Graziana Colaianni, Roberto Tamma, Beatrice Nico, Damiana Calvano, Carlo Zambonin, Michelangelo Corcelli, Alberta Zallone Cell biology: osteoblasts and bone formation
PP192 MODERATE HYPOTHERMIA INDUCES GROWTH ARREST IN NORMAL HUMAN OSTEOBLAST CELLS BUT RETAINED MITOCHONDRIAL METABOLISM IN VITRO Mohd Din Aisha, Mohamed Noor Khan Nor-Ashikin, Ab. Rahim Sharaniza, Hapizah Nawawi, Marina Kapitonova, Gabriele Ruth Anisah Froemming Cell biology: osteoblasts and bone formation
PP193 NORMAL HUMAN OSTEOBLAST CELLS EXERTS AN ADAPTIVE EFFECT TOWARDS MODERATE HYPOTHERMIA BY RETAINING BONE METABOLISM AND CELLULAR FUNCTION IN VITRO Mohd Din Aisha, Mohamed Noor Khan Nor-Ashikin, Ab. Rahim Sharaniza, Hapizah Nawawi, Marina Kapitonova, Gabriele Ruth Anisah Froemming Cell biology: osteoblasts and bone formation
PP194 Black Tea Polyphenols Suppress Adverse Effects of TNFα- Induced Inflammation in Osteoblast Cells Husna Zulkipli, Aisha Mohd Din, Norita Salim, Gabriele Anisah Froemming, Aletza Mohd Ismail, Hapizah Nawawi Cell biology: osteoblasts and bone formation
PP195 Microarray reveals positive effects of Green and Black Tea Polyphenols on TNF-α induced changes of gene expression Husna Zulkipli, Norita Salim, Gabriele Anisah Froemming, Aletza Mohd Ismail, Hapizah Nawawi Cell biology: osteoblasts and bone formation
PP196 The effect of enamel matrix derivative on human gingival fibroblasts cultured on zirconium disc surfaces Heesu Lee, Ahran Pae, Yong-Dae Kwon, Seonghee Ko Cell biology: osteoblasts and bone formation
PP197 EGF SUPPRESSES BMP2-INDUCED OSTEOGENIC DIFFERENTIATION THROUGH THE UP-REGULATION OF SMURF1 EXPRESSION Hye-Lim Lee, Kyung Mi Woo, Hyun-Mo Ryoo, Gwan-Shik Kim, Jeong-Hwa Baek Cell biology: osteoblasts and bone formation
PP198 Estrogen effect on the Sclerostin induction by BMP-2 in human mesenchymal stromal cells In Sook Kim, Hoon Joo Yang, Yun Mi Song, Soo Jin Ryu, Ri Youn Kim, Soon Jung Hwang Cell biology: osteoblasts and bone formation
PP199 Effect of beta-cryptoxanthin on the differentiation of human bone-marrow stromal stem-cells treated with pioglitazone Antonio Casado-Díaz, Raquel Santiago-Mora, Gabriel Dorado, José Manuel Quesada-Gómez Cell biology: osteoblasts and bone formation
PP200 Premixed acidic calcium phosphate cement with statin: stimulate osteoblast differetiation and decrease the inflammatory response Maryam Montazerolghaem, Håkan Engqvist, Marjam Ott Cell biology: osteoblasts and bone formation
PP201 Primary Human Bone Cells treated with Parathyroid Hormone or Dexamethasone show Effects on micro-RNA Expression Patterns Assessed by Second Generation Sequencing Navya Laxman, Carl-Johan Rubin, Hans Mallmin, Olle Nilsson, Christian Tellgren-Roth, Andreas Kindmark Cell biology: osteoblasts and bone formation
PP202 Expression and function of glutamate transporters in mouse primary osteoblasts Wenjie Xie, Silvia Dolder, Mark Siegrist, Antoinette Wetterwald, Willy Hofstetter Cell biology: osteoblasts and bone formation
PP203 Connectivity Map-based discovery of novel compounds that induce osteoblast differentiation AM Brum, J van de Peppel, A van Kerkwijk, M Janssen, M Schreuders-Koedam, T Strini, M Eijken, JPTM van Leeuwen, BCJ van der Eerden Cell biology: osteoblasts and bone formation
PP204 Non-canonical BMP signaling in bone healing Gonzalo Sánchez-Duffhues, Amaya Garcia de Vinuesa, Peter Kloen, Marié-Jose Goumans, Peter ten Dijke Cell biology: osteoblasts and bone formation
PP205 Thrombin receptor deficiency leads to osteopetrosis by decreasing the RANKL/OPG ratio BCJ van der Eerden, K Tudpor, P Jongwattapapisan, TE Woudenberg-Vrenken, RJM Bindels, JGJ Hoenderop, JPTM van Leeuwen Cell biology: osteoblasts and bone formation
PP206 Serum Sclerostin Does Not Reflect Its Expression In Bone, But Is Related To Bone Mineral Density. Nathalie Bravenboer, Ruben Visser, Martin den Heijer, Annemieke Heijboer Cell biology: osteoblasts and bone formation
PP207 In vitro 3D osteoblast-osteocyte co-culture mechanical loading model Marisol Vazquez, Bronwen Evans, Sam Evans, Jim Ralphs, Daniela Riccardi, Deborah Mason Cell biology: osteoblasts and bone formation
PP208 The positional origins of human osteoblasts dictate growth and differentiation potential and capacity for paracrine vascular cell cross-talk via VEGF. Mittal Shah, Valentina Gburcik, Andrew Sankey, Peter Reilly, Roger Emery, Claire Clarkin, Andrew Pitsillides Cell biology: osteoblasts and bone formation
PP209 Bone marrow stromal cells of female Bag-1 heterozygous mice exhibit reduced osteogenic potential Joanna Greenhough, Paul Townsend, Richard Oreffo, Rahul Tare Cell biology: osteoblasts and bone formation
PP210 Open source software for semi-automated histomorphometry of bone resorption and formation parameters. Rob van 't Hof, Lorraine Rose, Anna Daroszewska Cell biology: osteoblasts and bone formation
PP211 Rab27a is involved in bone formation by osteoblasts Fraser Coxon, Angela Douglass, Alun Hughes, Miep Helfrich, Miguel Seabra, Tanya Tolmachova Cell biology: osteoblasts and bone formation
PP212 Bone-forming cultures of rat and mouse calvarial osteoblasts: key differences in protocols Isabel Orriss, Mark Hajjawi, Carmen Huesa, Vicky MacRae, Timothy Arnett Cell biology: osteoblasts and bone formation
PP213 Anti-dementia Acetylcholine esterase inhibitor inhibits osteoclastogenesis Charles Inderjeeth, Jiake Xu, Bay Sie Lim, Dian Teguh Cell biology: osteoclasts and bone resorption
PP214 Is a network of collagen fibers and blood vessels supporting pre-osteoclast trafficking from the bone marrow to the bone surface? Thomas Levin Andersen, Helene Bjørg Kristensen, Jean-Marie Delaisse Cell biology: osteoclasts and bone resorption
PP215 The F-actin modulator SWAP-70 is required for proper podosome dynamics in osteoclasts. Anne Roscher, Martin Glösmann, Reinhold G Erben, Anne-Helen Lutter, Michael Chopin, Lorenz C Hofbauer, Rolf Jessberger, Annette Garbe Cell biology: osteoclasts and bone resorption
PP216 Glycosaminoglycan sulfation is a key regulator of osteoclast biology and osteogenic bone cell signaling Juliane Salbach-Hirsch, Elena Tsourdi, Nicole Ziegler, Vera Hintze, Dieter Scharnweber, Stephanie Möller, Matthias Schnabelrauch, Martina Rauner, Lorenz Hofbauer Cell biology: osteoclasts and bone resorption
PP217 Collagen-induced arthritis reduces osteoclast differentiation potential and activity and impairs reactivity to neurotransmitter stimuli in an experimental arthritis rat model Dominique Muschter, Nicole Schäfer, Rainer H. Straub, Joachim Grifka, Susanne Grässel Cell biology: osteoclasts and bone resorption
PP218 Protective effect of polyphenols from berries of Aronia melanocarpa against low exposure to cadmium-induced imbalance in the RANK/RANKL/OPG system in the bone tissue of rats Joanna Rogalska, Malgorzata M. Brzóska Cell biology: osteoclasts and bone resorption
PP219 Negative modulation of human osteoclastogenesis by antiepileptic drugs Sara Rocha, João Costa-Rodrigues, Ricardo Ferraz, Cristina Prudêncio, Maria Fernandes Cell biology: osteoclasts and bone resorption
PP220 Modulation of osteoclastogenesis by fluoroquinolones on nano- and micro-structurated hydroxyapatite surfaces Sofia Ribeiro, João Costa-Rodrigues, Maria Fernandes Cell biology: osteoclasts and bone resorption
PP221 Modulation of osteoclastogenesis by antihypertensive drugs Teresa Oliveira, João Costa-Rodrigues, Ricardo Ferraz, Cristina Prudêncio, Maria Fernandes Cell biology: osteoclasts and bone resorption
PP222 Mitogen- and stress-activated protein kinase 1 activates osteoclastogenesis in vitro and plays critical roles in bone destruction in vivo Hong-Hee Kim, Jeongim Ha Cell biology: osteoclasts and bone resorption
PP223 Methylation is not involved in repression of ADRA2A in osteocytes Vid Mlakar, Janja Zupan, Janja Marc, Simona Jurkovic Mlakar Cell biology: osteoclasts and bone resorption
PP224 POLYUNSATURATED FATTY ACIDS AND PHYTOESTROGENS MODULATE OSTEOCLASTOGENESIS AND BONE RESORPTION IN RAW 264.7 MACROPHAGES Natalie Shepherd, Cassandre De Jager, Abe Kasonga, Sumari Marais, Yuko Tousen, Marlena Kruger, Magdalena Coetzee Cell biology: osteoclasts and bone resorption
PP225 Inhibition Of Lipopolysacharide Induced Osteoclast Formation And Bone Resorption In Vitro And In Vivo In Mice By Cystatin C Strålberg Fredrik, Catharina Lindholm, Erik Lindström, Franciszek Kasprzykowski, Paul Saftig, Magnus Abrahamson, Anders Grubb, Ulf H Lerner Cell biology: osteoclasts and bone resorption
PP226 REGULATION OF OSTEOCLASTOGENESIS BY TOLL-LIKE RECEPTOR 5 Ali Kassem, Pernilla Lundberg, Catharina Lindholm, Pedro P.C. Souza, Ulf H. Lerner Cell biology: osteoclasts and bone resorption
PP227 RANKL immobilized on β-TCP induces and maintains osteoclast formation John Choy, Wilhelm Hofstetter, Frank M. Klenke Cell biology: osteoclasts and bone resorption
PP228 Bisphosphonates differently affect jaw and long-bone marrow cells Jenny A.F. Vermeer, Ineke D.C. Jansen, Greetje A.P. Renders, Teun J. de Vries, Vincent Everts Cell biology: osteoclasts and bone resorption
PP229 The D477N mutation in OPTN leads to increased bone turnover and enhanced osteoclast formation in OptnD477N/D477N mice Sachin Wani, Rami Obaid, Ruth Jones, Philip Cohen, Stuart Ralston, Omar Albagha Cell biology: osteoclasts and bone resorption
PP230 Depletion of the autophagy adaptor OPTN leads to increased osteoclast formation, fusion and survival as well as increased NF-κB activation in vitro Rami Obaid, Sachin Wani, Stuart ralston, Omar Albagha Cell biology: osteoclasts and bone resorption
PP231 Osteoclasts activity is affected by adenovirus infection Ana Isabel Espirito Santo, Lynett Danks, David Mahoney, Youridies Vattakuzhi, Afsaneh Sabokbar, Nicole Horwood Cell biology: osteoclasts and bone resorption
PP232 The use of photo-activatable fluorophores to study the turnover of the receptor activator of NFkB receptor in health and disease. David Mellis, Angela Duthie, Susan Clark, Julie Crockett Cell biology: osteoclasts and bone resorption
PP233 Investigating homozygous versus heterozygous expression of disease-causing receptor activator of NFkB mutations in vitro David Mellis, Angela Duthie, Susan Clark, Julie Crockett Cell biology: osteoclasts and bone resorption
PP234 DO ECTO-NUCLEOTIDASES PLAY A ROLE IN THE REGULATION OF OSTEOCLAST FUNCTION? Mark Hajjawi, Vicky MacRae, Carmen Huesa, José Luis Millán, Timothy Arnett, Isabel Orriss Cell biology: osteoclasts and bone resorption
PP235 Differential effects of nitrogen-containing bisphosphonates on human PBMCs and MUTZ-3 cells AARON KWAASI, GUILLAUME MABILLEAU, JAMES DUNFORD, FRANK EBETINO, ALI ZAREI, MICHAEL PAZIANAS, AFSIE SABOKBAR, GRAHAM RUSSELL Cell biology: osteoclasts and bone resorption
PP236 Osteoclast resorptive surface: Correlation of structure and function Kinga Szewczyk, Karen Fuller, Timothy Chambers Cell biology: osteoclasts and bone resorption
PP237 Nucleotide and Mechanically Induced ATP Release Pathways in Osteocytes Tina M. Kringelbach, Ivana Novak, Peter Schwarz, Niklas Rye Jorgensen Cell Biology: osteocytes
PP238 Calcium Sensing Receptor is expressed on/in osteocyte like MLOY4 culture and modulated by Strontium Ranelate Priscilla C. Aveline, Hechmi Toumi, Eric Lespessailles, Cédric Boudot, Romuald Mentaverri, Gaël Y. Rochefort, Claude-Laurent Benhamou Cell Biology: osteocytes
PP239 Glycosaminoglycans and their sulfate derivates differentially regulate the osteocytic phenotype of murine and rat osteocyte-like cell lines Fraser Coxon, Angela Douglass, Alun Hughes, Miep Helfrich, Miguel Seabra, Tanya Tolmachova Cell Biology: osteocytes
PP240 RANKL subcellular trafficking in osteocytes. Masashi Honma, Yuki Ikebuchi, Yoshiaki Kariya, Madoka Hayashi, Naoki Hayashi, Shigeki Aoki, Hiroshi Suzuki Cell Biology: osteocytes
PP241 Inhibition of osteocyte-induced osteoclast precursor proliferation and migration by mechanical strain Seong-Hee Ko, Heesu Lee Cell Biology: osteocytes
PP242 Activation of the Parathyroid Hormone-Receptor is Involved in the Pro-survival Effect of Hypotonic Shock in Osteocyte-like MLO-Y4 Cells Marta Maycas, Juan. A Ardura, Luis Fernández de Castro, Arancha Gortázar, Pedro Esbrit Cell Biology: osteocytes
PP243 Single osteocyte gene expression in an in vivo model for load-induced bone adaptation Robin Wilson, Andreas Trüssel, Duncan Webster, Felix Kurth, Petra Dittrich, Ralph Müller Cell Biology: osteocytes
PP244 Strontium ranelate and conditioned medium from mechanically-stimulated human bone cells both enhance osteogenic differentiation of mesenchymal stem cells Astrid Bakker, Behrouz Zandieh-Doulabi, Jenneke Klein-Nulend Cell Biology: osteocytes
PP245 IGF-1 regulates MC-3T3 and human primary osteoblast to osteocyte differentiation in 3D culture Nicole EE Scully, Deborah J Mason, Bronwen AJ Evans Cell Biology: osteocytes
PP246 Development of a novel 3D mineralising culture system to investigate the differentiation of osteoblasts to osteocytes Nicole EE Scully, Sam L Evans, Deborah J Mason, Bronwen AJ Evans Cell Biology: osteocytes
PP247 Expression of Novel Cartilage Genes during Maturation of Cultured Chondrocytes Babatunde Awodele, Michiko Mirams, Charles Pagel, Eleanor Mackie Chondrocytes and cartilage
PP248 Intracellular calcium is influenced by the NuclearMagneticResonanceTherapy (NMRT) in Cal-78 chondrosarcoma cells Bibiane Steinecker-Frohnwieser, Lukas Weigl, Werner Kullich Chondrocytes and cartilage
PP249 Impairment of endochondral ossification by Hoxa2 overexpression: a plausible molecular explanation of idiopathic proportionate short stature Pierre M.L. Deprez, Miloud G. Nichane, Benoît Lengelé, René Rezsöhazy, Catherine Nyssen-Behets Chondrocytes and cartilage
PP250 IN VITRO EFFECTS OF CAFFEINE ON THE PROLIFERATION, APOPTOSIS AND GENE TRANSCRIPTS EXPRESSION OF CHONDROGENIC DIFFERENTIATION IN GROWTH CARTILAGE OF RATS Amanda Maria Sena Reis, Raquel Viana Raad, Natália de Melo Ocarino, Rogéria Serakides Chondrocytes and cartilage
PP251 EFFECTS OF CAFFEINE ON FORMATION AND ENDOCHONDRAL BONE GROWTH OF RATS Amanda Maria Sena Reis, Ana Cláudia Moura Batista, Natália de Melo ocarino, Rogéria Serakides Chondrocytes and cartilage
PP252 Modulation of c-Myb during chondrogenesis Veronika Oralova, Marcela Buchtova, Eva Janeckova, Abigail Tucker, Eva Matalova Chondrocytes and cartilage
PP253 CAN ADRENOMEDULLIN BE A POTENTIAL OSTEOARTHRITIS TREATMENT? Aurore CHATRON-COLLIET, Frédéric VELARD, Dominique CÔME, Hilène LIN, Hang Korng EA, Frédéric LIOTE Chondrocytes and cartilage
PP254 Oxygen tension-mediated regulation of chondrogenic differentiation: application to stem cells based osteochondral repair Sophie PORTRON, Vincent HIVERNAUD, Christophe MERCERON, Julie LESOEUR, Martial MASSON, Olivier GAUTHIER, Claire VINATIER, Laurent BECK, Jerome GUICHEUX Chondrocytes and cartilage
PP255 Effects of an in vitro low-oxygen-tension preconditioning of adipose stem cells on their in vivo chondrogenic potential: application in cartilage tissue repair Sophie PORTRON, Christophe MERCERON, Olivier GAUTHIER, Julie LESOEUR, Sophie SOURICE, Martial MASSON, Borhane FELLAH, Olivier GEFFROY, Elodie LALLEMAND, Pierre WEISS, Jérôme GUICHEUX, Claire VINATIER Chondrocytes and cartilage
PP256 Sclerostin preserves chondrocyte maintenance by modulating the crosstalk between canonical and non canonical Wnt pathways Wafa Bouaziz, Thomas Funck-Brentano, Hilene Lin, Hang-Korng Ea, Eric Hay, Martine Cohen-Solal Chondrocytes and cartilage
PP257 Stress-induced matrix metalloproteinase (MMP) production in cartilage does not depend on NALP3-inflammasome in osteoarthritis.   Carole Bougault, Marjolaine Gosset, Xavier Houard, Colette Salvat, Lars Godmann, Thomas Pap, Claire Jacques, Francis Berenbaum Chondrocytes and cartilage
PP258 Transcription factor Nkx3.2 plays crucial role in primary chondrogenesis by up-regulating type II collagen a1 transcription activity Kosuke Ebina, Yoshitaka Kawato, Makoto Hirao, Yui Honjo, Tokimitsu Morimoto, Jun Hashimoto, Kenrin Shi, Hideki Yoshikawa Chondrocytes and cartilage
PP259 The influence of 2-oxoglutaric acid on articular cartilage of gastrectomised rats. Piotr Dobrowolski, Ewa Tomaszewska, Paulina Kurlak, Stefan Pierzynowski Chondrocytes and cartilage
PP260 Dietary 2-oxoglutarate protects femoral cartilage of 9 months male pigs prenatally treated with dexamethasone. Ewa Tomaszewska, Piotr Dobrowolski, Monika Hułas-Stasiak, Paulina Kurlak Chondrocytes and cartilage
PP261 Prenatally administered acrylamide programs a gut-bone axis of guinea pig newborns. Ewa Tomaszewska, Piotr Dobrowolski, Paulina Kurlak, Barbara Badzian, Monika Hulas-Stasiak, Iwona Puzio, Krzysztof Kostro Chondrocytes and cartilage
PP262 Establishing an in vitro system to study chondrocyte phenotypes associated to human hereditary hemochromatosis and identify molecular players involved in chondrocyte related iron metabolism. Marcio Simao, Paulo Gavaia, Jorge Pinto, Ea Korng, M. Leonor Cancela Chondrocytes and cartilage
PP263 Inflammatory Effects on Knee Joint Tissue by Indoxyl Sulfate Ya-Yun Chen, Herng-Sheng Lee, Yu-Juei Hsu Chondrocytes and cartilage
PP264 Upregulation of GAP-43 is linked to the cartilage repair by microarray analysis Chih-Shan Chang, Herng-Sheng Lee Chondrocytes and cartilage
PP265 Decrypting TGFβ signaling in age-induced osteoarthritis. Amaya Garcia de Vinuesa, Esmeralda Blaney-Davidson, Gonzalo Sanchez-Duffhues, Arjan van Caam, Elly Vitters, Ingrid Meulenbelt, Marie Jose Goumans, Peter van der Kraan, Peter ten Dijke Chondrocytes and cartilage
PP266 The Rho/ROCK GTPase pathway differentially modulates chondrocyte and osteoblast differentiation from pluripotent stem cells. Dalea M Bukhary, Fraser McDonald, Agamemnon E Grigoriadis Chondrocytes and cartilage
PP267 A genetic determinant of vitamin D and its role in prostate cancer Olivia Trummer, Eva Thurner, Tanja Langsenlehner, Uwe Langsenlehner, Sabine Krenn-Pilko, Winfried März, Thomas Pieber, Barbara Obermayer-Pietsch, Wilfried Renner Genetics
PP268 No Mutations in the serotonin related TPH1 and HTR1B genes in patients with monogenic sclerosing bone disorders. Eveline Boudin, Karen Jennes, Fenna de Freitas, David Tegay, Geert Mortier, Wim Van Hul Genetics
PP269 Expression analysis of mesenchymal KS483 cells during differentiation towards osteoblasts. Igor Fijalkowski, Eveline Boudin, Vere Borra, Wim Van Hul Genetics
PP270 SQSTM1/P392L post-zygotic mutations in unrelated patients with Paget's disease of bone Sabrina Guay-Belanger, Edith Gagnon, Jean Morissette, Jacques P Brown, Laëtitia Michou Genetics
PP271 A familial case of Osteogenesis Imperfecta: study of genotype-phenotype correlation. Alessandra Mihalich, Emanuela Ponti, Francesca Broggi, Anna Maria Di Blasio, Maria Luisa Bianchi Genetics
PP272 Comparison of gene expression in osteoblasts from patients of Polynesian and Caucasian ethnicity Dorit Naot, Usha Bava, Ally Choi, Karen Callon, Rocco Pitto, Jarome Bentley, Greg Gamble, Jillian Cornish Genetics
PP273 Functional analysis of the two Runx3 promoters in osseous and non-osseous cells: implications for tissue/differentiation specific transcription of distinct isoforms Natércia Conceição, Brigite Simões, M. Leonor Cancela Genetics
PP274 Association between polymorphisms in leptin, its receptor and beta adrenergic receptors genes and bone mineral density in postmenopausal Korean women Hoon Kim, Seung-Yup Ku, Seok Hyun Kim, Young Min Choi, Jong Hak Kim, Jung Gu Kim Genetics
PP275 Genetic Aspects of Bone Remodeling Disturbance in Patients with Aggressive Periodontitis Anastasia Zinovyeva, Victoria Atrushkevich, Alexander Polyakov Genetics
PP276 No association between the CYP1B1/Leu432Val polymorphism and osteoporosis-related traits in Slovak postmenopausal women Radoslav Omelka, Vladimira Krajcovicova, Jana Spankova, Jana Durisova, Monika Martiniakova, Drahomir Galbavy, Maria Bauerova Genetics
PP277 A genomic and transcriptomic approach to the high bone mass phenotype: evidences of heterogeneity and of additive effects of TWIST1, IL6R, DLX3 and PPARG Patricia Sarrión, Leonardo Mellibovsky, Roser Urreizti, Sergi Civit, Neus Cols, Natàlia García-Giralt, Guy Yoskovitz, Alvaro Aranguren, Jorge Malouf, Luís del Río, Roberto Güerri, Xavier Nogués, Adolfo Díez-Pérez, Daniel Grinberg, Susana Balcells Genetics
PP278 Gene-wide association study of RANK and RANKL genes in the bone context: Functional study of BMD-associated SNPs Natalia Garcia-Giralt, Guy Yoskovitz, Maria Rodriguez-Sanz, Roser Urreizti, Roberto Guerri, Sergi Ariño-Ballester, Daniel Prieto-Alhambra, Leonardo Mellibovsky, Daniel Grinberg, Xavier Nogues, Susana Balcells, Adolfo Diez-Perez Genetics
PP279 Genome-Wide Association Study meta-analysis identifies the SOAT1/AXDND1 locus to be associated with hip and forearm fracture risk Ulrika Pettersson-Kymmer, Andrea Lacroix, Joel Eriksson, Ulrica Bergström, Beatrice Melin, Carl Wibom, Liesbeth Vandenput, Preetha Rajaraman, Patricia Hartge, Stephen Chanock, Göran Hallmans, David Duggan, Charles Kooperberg, Samuel Handelman, Aaron Aragaki, Maria Nethander, Andre Uitterlinden, Fernando Rivadeneira, Rebecca Jackson, Claes Ohlsson Genetics
PP280 ASSOCIATION BETWEEN DENTINOGENESIS IMPERFECTA (DI) AND MUTATIONS IN COLIA1 AND COLIA2 GENES Kristofer Andersson, Göran Dahllöf, Eva Åström, C-J Rubin, A Kindmark, Katarina Lindahl, Östen Ljunggren, Barbro Malmgren Genetics
PP281 Role of the functional Toll-like receptor-3 promoter polymorphism in the increased risk of Osteoarthritis SUI-LUNG SU, Hsin-Yi Yang Genetics
PP282 Phenotypic dissection of bone mineral density facilitates the identification of skeletal site specificity on the genetic regulation of bone John P Kemp, Carolina Medina-Gomez, Karol Estrada, Denise Heppe, Carola Zillikens, Nicholas Timpson, Beate Pourcain, Susan Ring, Albert Hofman, Vincent VW Jaddoe, George Davey Smith, Uitterlinden André G, Jonathan H Tobias, Fernando Rivadeneira, David M Evans Genetics
PP283 Discovery and Replication of Several Loci Significantly Associated with Lean Body Mass:  A Large Meta-Analysis of Genome Wide Association Studies (GWAS) from the "CHARGE" and "GEFOS" Consortia Douglas Kiel, Laura Yerges, Yi-Hsiang Hsu, Lisette Stolk, David Karasik, Ruth Loos, Vilmundar Gudnason, Albert Smith, Jeffrey O'Connell, Mao Fu, Elizabeth Streeten, Jane Cauley, John Robbins, Bruce Psaty, Toby Johnson, Zoltan Kutalik, Gregory Livshits, Tamara Harris, Claes Ohlsson, M. Carola Zillikens Genetics
PP284 RAISING CK: WHAT IT MEANS ACCORDING TO DIFFERENT CLINICAL LANDSCAPE?  Scali, J.; Visentini, S.; Berruezo, R ; Pacheco, G.; Sevilla, D.; Garcia, R,.Reumathology Unit - Carlos G. Durand Hospital - Buenos Aires, Argentina. Juan Jose Scali, Susana Visentini, Ramiro Berruezo, Daniel Sevilla, Gonzalo Pacheco, Rodrigo Garcia Muscle, physical activity and bone
PP285 Prolonged Botulinum Toxin Type A-induced muscle paralysis results in loss of bone mineral density and bone strength in young female rats Maria Ellegaard, Susanne Syberg, Niklas Rye Jørgensen, Peter Schwarz Muscle, physical activity and bone
PP286 Muscle function and quality of life in primary hyperparathyroidism. Lars Rolighed, Anne Kristine Amstrup, Niels Frederik Breum Jakobsen, Tanja Sikjaer, Leif Mosekilde, Peer Christiansen, Lars Rejnmark Muscle, physical activity and bone
PP287 Muscle strength and peripheral fractures in osteoporotic patients Hans-Christof Schober, Franka Hamann, Johanna Torner Muscle, physical activity and bone
PP288 Microgravity modulates nitric oxide homeostasis in vascular system Pradeep Thagaraj, Suvro Chatterjee Muscle, physical activity and bone
PP289 The Outcomes and Costs of Falls in Elderly Women Inga Tamulaityte-Morozoviene, Vidmantas Alekna, Rimantas Stukas, Marija Tamulaitiene Muscle, physical activity and bone
PP290 Response of mechanically strained tenocytes to different cell culture substrates David Musson, JungJoo Kim, Karen Callon, Dorit Naot, Vickie Shim, Iain Anderson, Jillian Cornish Muscle, physical activity and bone
PP291 Physical activity, bone metabolism and inflammatory markers, and bone mineral density in elderly men: a preliminary investigation Elisa Marques, Jorge Mota, João Viana, Pedro Figueiredo, João Guimarães, Joana Carvalho Muscle, physical activity and bone
PP292 SEX-SPECIFIC ASSOCIATION OF PHYSICAL ACTIVITY WITH BONE MASS DISTRIBUTION AT THE FEMORAL NECK AND TROCHANTER IN YOUNG ADULTS Vera Zymbal, Lurdes Rebocho, Graça Cardadeiro, Fátima Baptista Muscle, physical activity and bone
PP293 Sarcopenia in patients with spondyloarthritis - is there any relation with radiological damage? Renata Aguiar, Tiago Merinhos, Joana Sequeira, Catarina Ambrósio, Anabela Barcelos Muscle, physical activity and bone
PP294 INFLUENCE OF MECHANICAL LOADING AND SKELETON GEOMETRY IN BONE MASS AT THE PROXIMAL FEMUR IN 10-12 YEARS OLD CHILDREN- A LONGITUDINAL STUDY Graça Cardadeiro, Fátima Baptista, Nicolleta Rosati, Vera Zymbal, Lurdes Rebocho, Paula M Bruno, Kathleen F Janz, Luís B Sardinha Muscle, physical activity and bone
PP295 PROXIMAL FEMUR GEOMETRY AS MODERATOR FACTOR FOR THE EFFECT OF MECHANICAL LOADING DURING GAIT - A BONE REMODELING ANALYSIS Miguel M Machado, Paulo R Fernandes, Fátima Baptista Muscle, physical activity and bone
PP296 Body Composition Relationship in Korean Old People Woong H. Choi, Sang M. Hong Muscle, physical activity and bone
PP297 Prevalence of sarcopenia & its association with osteporosis in Korean postmenopausalwomen.  Hyoung-Moo  Park1), Jin-Hee Kim1), Tak Kim2)   Dept. Ob & Gyn. College of Medicine Chungang University1), Korea University2) Seoul, Korea Hyoung-Moo Park, Tak Kim Muscle, physical activity and bone
PP298 The effects of Vitamin D supplementation and fitness program for biochemistry, muscle mass and physical functions in elderly women Byung Yeon Yu, Kyung Soo Kim, In Kyung Kim Muscle, physical activity and bone
PP299 Influence of gym high-intensity dynamic exercises and therapeutic exercises on functional status of patients with early rheumatoid arthritis Evgeniya Orlova, Dmitry Karateev, Andrey Kochetkov, Tatiana Mozhar Muscle, physical activity and bone
PP300 Vitamin D deficiency is associated with nonspecific skeletal pain in Saudi Women Khulood Hussein, Hanan Alkadi, Suzan Lanham-New, Mohamad Ardawi Muscle, physical activity and bone
PP301 Effect of vitamin D status on Muscle Function and Physical Performance among Saudi Postmenopausal Women: a cross-sectional study khulood Hussein Muscle, physical activity and bone
PP302 Morphology of muscle attachment sites and microarhitecture of underlying bone as the markers of physical activities of past populations Ksenija Djukic, Petar Milovanovic, Michael Hahn, Bjoern Busse, Michael Amling, Marija Djuric Muscle, physical activity and bone
PP303 The effect of different exercise modes on bone density in middle-aged and older men: A systematic review Kate A Bolam, Jannique G Z van Uffelen, Dennis R Taaffe Muscle, physical activity and bone
PP304 Everyday activity, important factors and quality of life in children and youths with Osteogenesis Imperfecta Kristina Lowing, Maude Hagberg, Eva Astrom Muscle, physical activity and bone
PP305 Associations of 25-hydroxyvitamin D concentrations with quality of life and self-rated health Rachida Rafiq, Karin Swart, Natasja van Schoor, Dorly Deeg, Paul Lips, Renate de Jongh Muscle, physical activity and bone
PP306 Increased activity associated with exercise does not rescue aged bone’s impaired response to local mechanical loading Lee Meakin, Chinedu Udeh, Toshihiro Sugiyama, Gabriel Galea, Lance Lanyon, Joanna Price Muscle, physical activity and bone
PP307 Muscle power and force may influence cortical bone strength via distinct mechanisms: findings from a cross sectional study of high bone mass cases and controls Sarah A Hardcastle, Celia L Gregson, Jorn Rittweger, Kate A Ward, Jon H Tobias Muscle, physical activity and bone
PP308 SARCOPENIA IN UKRAINIAN WOMEN OF DIFFERENT AGE Vladyslav Povoroznyuk, Nataliia Dzerovych Muscle, physical activity and bone
PP309 LEAN MASS, NOT OBESITY, IS RELATED TO TOTAL BODY BONE MINERAL CONTENT IN BOYS. Tom Sanchez, Jingmei Wang, Felix Rajan, Terry Schwalenberg, Kathy Dudzek Muscle, physical activity and bone
PP310 Osteoporosis and osteopenia of the spine in rheumatic patients, treated with glucocorticosteroids. Armine Haroyan, Liana Ghukasyan Osteoporosis: evaluation and imaging
PP311 Appropriate Osteoporosis Treatment by Family Physicians in Response to FRAX versus CAROC Reporting: A Randomized Controlled Trial Karen Beattie, George Ioannidis, Joy MacDermid, Ruby Grewal, Alexandra Papaioannou, Anthony Hodsman, Jonathan D. Adachi Osteoporosis: evaluation and imaging
PP312 Correlation of Bioelectrical Impendance Analysis and Dual Energy X-Ray Absorptiometry for bone mineral content and bone mineral density in young healthy humans Erna Davidovic Cvetko, Nebojsa Nesic, Jasminka Milas-Ahic, Ines Drenjancevic Osteoporosis: evaluation and imaging
PP313 Microstructural alterations of femoral head articular cartilage and subchondral bone in osteoarthritis and osteoporosis Dragica Bobinac, Tanja Celic, Marin Marinovic, Ivana Maric Osteoporosis: evaluation and imaging
PP314 Communication of fracture risk and treatment benefit in terms of "Bone Health Age" using FRAX or Qfracture. Bo Abrahamsen, Katrine Hass Rubin, Carrinna Hansen, Kim Brixen Osteoporosis: evaluation and imaging
PP315 The stability of intact parathyroid hormone in human blood during different sampling conditions and long-term storage in serum tubes Camilla Sand Andersen, Hans Christian Hoeck, Parisa Gazerani, Peter Vestergaard Osteoporosis: evaluation and imaging
PP316 Cortical and trabecular bone parameters from HR-pQCT images at the tibia: a local comparison with synchrotron radiation micro-computed tomography Agnès OSTERTAG, Françoise PEYRIN, Sylvie FERNANDEZ, Jean-Denis LAREDO, Marie-Christine de VERNEJOUL, Christine CHAPPARD Osteoporosis: evaluation and imaging
PP317 A 3D QCT Technique of the Thoracic and Lumbar Spine: Integral Volume and Intervertebral Disc Space Increase and BMD decreases from T6 to L4 Oleg Museyko, Axel Heinemann, Mattias Krause, Reinhard Barkmann, Michael Amling, Claus Glüer, Klaus Püschel, Klaus Engelke Osteoporosis: evaluation and imaging
PP318 Binding kinetics of fluorescent bisphosphonates as a tool for monitoring bone dynamics in vivo Robert Tower, Graeme Campbell, Marc Muller, Olga Will, Frederieka Grundmann, Christian Schem, Claus Gluer, Sanjay Tiwari Osteoporosis: evaluation and imaging
PP319 PREVALENCE OF FRAX CLINICAL RISK FACTORS- DIETARY CALCIUM INTAKE HABITS AND OSTEOPOROSIS SCREENING IN GREEK WOMEN Sofoclis Bakides, George Sakellariadis, Stavroula Alevizou, Kleoniki Koussi, Anna Rapti, Panayiotis Tsiverdis, Konstantina Kavvadia, Kyriakos Drivas, Charilila-Loukia Ververeli Osteoporosis: evaluation and imaging
PP320 Quantitative ultrasound of os calcis BMD versus conventional DXA and peripheral QCT in interval assessment of BMD changes in adolescent females William WK To, Margaret WN Wong Osteoporosis: evaluation and imaging
PP321 Use of os calcis quantitative ultrasound for bone mineral density screening in adolescents with menstrual dysfunction William WK To, Margaret WN Wong Osteoporosis: evaluation and imaging
PP322 Comparative Assessment of Bone Mineral Density of the Femoral Neck between Dual-Energy X-Ray Absorptiometry and a New Ultrasonic Method Francesco Conversano, Ernesto Casciaro, Antonio Greco, Paola Pisani, Roberto Franchini, Antonella Grimaldi, Eugenio Quarta, Maurizio Muratore, Sergio Casciaro Osteoporosis: evaluation and imaging
PP323 A New Ultrasonic Method for Diagnosis of Osteoporosis on Hip and Spine Sergio Casciaro, Francesco Conversano, Ernesto Casciaro, Roberto Franchini, Maria Daniela Renna, Antonio Greco, Eugenio Quarta, Laura Quarta, Maurizio Muratore Osteoporosis: evaluation and imaging
PP324 Strong Diagnostic Agreement Between a Novel Ultrasound-Based Method for Lumbar Densitometry and Dual-Energy X-Ray Absorptiometry Maurizio Muratore, Francesco Conversano, Ernesto Casciaro, Giulia Soloperto, Roberto Franchini, Antonio Greco, Eugenio Quarta, Sergio Casciaro Osteoporosis: evaluation and imaging
PP325 Relationship between quantitative ultrasound parameters at calcaneous and health-related quality of life domains in postmenopausal Italian women: the FEDRO study Stefano Gonnelli, Carla Caffarelli, Giuseppe Guglielmi, Stefania Rossi, Silvano Adami, Ranuccio Nuti Osteoporosis: evaluation and imaging
PP326 FRAXture - does FRAX reflect the risk of fracture in real practice? Renata Aguiar, Romeu Pinho, Tiago Merinhos, Catarina Ambrósio, Anabela Barcelos Osteoporosis: evaluation and imaging
PP327 BMA assessment standard curves for wrist and ankle in both sexes – data from EpiReumaPt  Helena Canhao, Nelia Gouveia, Tania Rego, Ana Maria Rodrigues, Jaime Branco Osteoporosis: evaluation and imaging
PP328 Bone mineral density distribution in early osteoporotic bone Saba Abdulghani, Luis Santos, Bruno Vidal, Rita Cascão, João Fonseca Osteoporosis: evaluation and imaging
PP329 Discordance of Z-score in healthy premenopausal women with BMD below the expected range of age and contributing factors: The Korea National Health and Nutrition Examination Survey 2008-9.  Sung-Kil Lim, Kyeong Hye Park, Kyoung Min Kim, Jung Soo Lim, Yumie Rhee Osteoporosis: evaluation and imaging
PP330 Factors that affects on bone density in premenopausal women Dong Ock Lee, Hoon Choi, Jung Gu Kim Osteoporosis: evaluation and imaging
PP331 May we screen with FRAX ® clinical factors? Carmen Gabriela Barbu, Catalina Poiana, Dariana Ionita, Magda Gascan, Cristina Stefan, Aurelia Stefanopol, Simona Fica Osteoporosis: evaluation and imaging
PP332 Osteoporosis and bone fractures in elder women with rheumatoid arthritis Kamalya Kasumova, Azamat Satybaldyev, Alexander Smirnov Osteoporosis: evaluation and imaging
PP333 Calcification of the coronary arteries among the males with coronary heart disease and osteoporosis Еlena Malyuta, Tatiana Raskina, Olga Barbarash, Alexandr Kokov Osteoporosis: evaluation and imaging
PP334 Bone fragility in patients with alcoholic liver cirrhosis: can hip structure analysis better predict risk of hip fracture Danijela Djonic, Djordje Culafic, Violeta Culafic-Vojinovic, Svetlana Ignjatovic, Ivan Soldatovic, Jelena Vasic, Marija Djuric Osteoporosis: evaluation and imaging
PP335 Usefulness of bone turnover markers in the evaluation of fracture risk in type 2 diabetes. Pedro Rozas-Moreno, Rebeca Reyes-Garcia, Antonia Garcia-Martin, Gema Lopez-Gallardo, Beatriz Garcia-Fontana, Sonia Morales-Santana, Manuel Muñoz-Torres Osteoporosis: evaluation and imaging
PP336 TBS improves the detection of subjects at risk of fracture irrespectively to the BMD status: a Spanish population-based study Silvana Di Gregorio, Renaud Winzenrieth, Luis Del Rio Osteoporosis: evaluation and imaging
PP337 Dietary calcium and vitamin D intake and serum 25-hydroxyvitamin D and parathyroid hormone levels in healthy elderly Spanish men: The relationship with calcaneal and phalangeal quantitative ultrasound and phalangeal dual energy X-ray absorptiometry Alejo Leal, Maria Luz Canal-Macias, Julian Fernando Calderón-García, Raul Roncero-Martín, Trinidad Rodriguez-Dominguez, Jose M. Moran Osteoporosis: evaluation and imaging
PP338 Low testosterone levels are associated with poor peripheral bone mineral density and quantitative bone ultrasound at phalanges and calcaneus in healthy elderly men Jesus Maria Lavado-Garcia, Purificación Rey-Sanchez, Carmen Costa-Fernandez, Mariana Martínez, Alejo Leal, Francisco Jose Rodriguez-Velasco, Juan Diego Pedrera-Zamorano Osteoporosis: evaluation and imaging
PP339 What is the performance in vertebral fracture discrimination by Bone mineral density (BMD), micro-architecture estimation (TBS), and FRAX in stand-alone, combined or adjusted approaches: The OsteoLaus Study Olivier Lamy, Marc-Antoine Krieg, Delphine Stoll, Berengère Aubry-Rozier, Marie Metzger, Didier Hans Osteoporosis: evaluation and imaging
PP340 TRABECULAR BONE SCORE AND BONE MINERAL DENSITY OF LUMBAR SPINE IN HEALTHY WOMEN: PROS AND CONS Vladyslav Povoroznyuk, O Lamy, Nataliia Dzerovych, Didier Hans Osteoporosis: evaluation and imaging
PP341 VITAMIN D LEVELS IN IMMOBILIZED SPANISH ADULTS. THE CAMARGO COHORT STUDY.  José M. Olmos, Pilar García Velasco, José L. Hernández, Josefina Martínez, Verónica Cabrero, Carmen Valero, Jesús González-Macías Osteoporosis: pathophysiology and epidemiology
PP342 BONE MINERAL DENSITY IN STATIN USERS: ANALYSIS OF A POPULATION-BASED COHORT FROM SPAIN José L. Hernández, José M. Olmos, Galo Romaña, Josefina Martínez, Irina Yezerska, Julia de Juan, Jesús González-Macías Osteoporosis: pathophysiology and epidemiology
PP343 Fracture risk among men, in relation to osteopenia and osteoporosis defined by areal bone mineral density. Julie Pasco, Stephen Lane, Sharon Brennan, Elizabeth Timney, Gosia Bucki-Smith, Amelia Dobbins, Mark Kotowicz Osteoporosis: pathophysiology and epidemiology
PP344 BONE TURNOVER MARKERS IN OLD OLD VS POSTMENOPAUSAL WOMEN Charles Inderjeeth, Kien Chan, Preeti Nair, Pang Wee Yang, Anupham Chauhan, EEmun Lim Osteoporosis: pathophysiology and epidemiology
PP345 Mortality after osteoporosis-related hip fractures in Austria 2008-2010 Wolfgang Brozek, Berthold Reichardt, Oliver Kimberger, Daniela Kritsch, Klaus Klaushofer, Elisabeth Zwettler Osteoporosis: pathophysiology and epidemiology
PP346 Association of osteoprotegerin gene polymorphisms with bone mineral density and bone turnover markers in postmenopausal women and elderly men. Martina Smolic, Selma Cvijetic, Tomislav Kizivat, Robert Smolic, Ivana Maric, Teuta Opacak-Bernardi, Hrvoje Roguljic, Antun Tucak Osteoporosis: pathophysiology and epidemiology
PP347 Acute effects of glucocorticoids on CRP and bone markers Jan Stepan, Kristyna Brabnikova Maresova, Karel Pavelka Osteoporosis: pathophysiology and epidemiology
PP348 Variation in osteoporosis patients' service utilization in general practice clinics Troels Kristensen, Kim Rose Olsen, Charlotte Ejersted, Anders Halling Osteoporosis: pathophysiology and epidemiology
PP349 Women with hormone sensitive breast cancer who have received chemotherapy including prednisolone have reduced bone mass Sofie Rønn, Jannie D Hald, Marianne Thisted, Louise Andersen, Louise Grønhøj, Anders Bonde Jensen, Bente L Langdahl Osteoporosis: pathophysiology and epidemiology
PP350 The risk of fractures in cirrhosis and chronic pancreatitis. A Danish nationwide retrospective matched cohort study Ulrich Christian Bang, Thomas Benfield, Flemming Bendtsen, Lars Hyldstrup, Jens-Erik Beck Jensen Osteoporosis: pathophysiology and epidemiology
PP351 Cytokine levels in the bone marrow are not just a reflection of the levels in serum - suggesting that bone marrow constitutes an independent compartment Torben Harsløf, Lotte Sørensen, Steen Pedersen, Bente Langdahl Osteoporosis: pathophysiology and epidemiology
PP352 The relationship between urban-rural migration and bone mineral density in an urban-rural adult population: cross sectional findings from the Hyderabad Indian Migration study Heli Viljakainen, Yoav Ben-Shlomo, Sanjay Kinra, Shah Ebrahim, Hannah Kuper, KV Radhakrishna, Bharathi Kulkarni, Jon Tobias Osteoporosis: pathophysiology and epidemiology
PP353 Apolipoprotein-E (ApoE) deficiency prevents obesity but predisposes to the development of osteoporosis following long-term exposure to Western-type diet, in mice Nicholaos Papachristou, Elena Kalyvioti, Irene-Eva Triantaphyllidou, Eleni Karavia, Eva Plakoula, Harry Blair, Kyriakos Kypreos, Dionysios Papachristou Osteoporosis: pathophysiology and epidemiology
PP354 Apolipoprotein A-I deficiency is associated with decreased expression of osteoblast-specific regulators in mice  Elena Kalyvioti, Nicholaos Papachristou, Irene-Eva Triantaphyllidou, Eleni Karavia, Eva Plakoula, Harry Blair, Kyriakos Kypreos, Dionysios Papachristou Osteoporosis: pathophysiology and epidemiology
PP355 Diabetes and obesity as independent risk factors for osteoporosis in postmenopausal women: a population study of 3.354 people. First results of the PROF Project (Prevention of Osteoporosis and Fractures). Cosimo Neglia, Alberto Argentiero, Giovanna Chitano, Nadia Agnello, Giuseppe Quarta, Vincenzo Caiaffa, Alessandro Distante, Prisco Piscitelli Osteoporosis: pathophysiology and epidemiology
PP356 MICROGRAVITY-INDUCED OSTEOPOROSIS: A CHALLENGE FOR THE FUTURE OF SPACE PROGRAMS Prisco Piscitelli, Alberto Argentiero, Giovanna Chitano, Cosimo Neglia, Emiliano Sordi, Giovanni Iolascon, Alessandro Distante, Maria Luisa Brandi Osteoporosis: pathophysiology and epidemiology
PP357 THE PREVALENCE OF OSTEOPOROSIS AND RISK FACTORS FOR BONE DEMINERALIZATION IN ITALY: FIRST RESULTS FROM THE FIRMO STUDY Caterina Fossi, Loredana Cavalli, Francesca Giusti, Alessia Metozzi, Simone Parri, Andrea Guazzini, Maria Luisa Brandi Osteoporosis: pathophysiology and epidemiology
PP358 OSTEOPOROSIS AND "FRAGILITY FRACTURES" IN 110 CENTENARIANS LIVING AT THE NURSING HOME OF MILAN Ivana Santi, Monica Gianotto, Valentina Guercio, Francesco Cetta, Massimo Monti Osteoporosis: pathophysiology and epidemiology
PP359 Ten Years of Increasing Hip Fractures Incidence in Italy but First Good News from the Analysis of National Hospitalizations Records 2000-2009 Prisco Piscitelli, Maurizio Feola, Cecilia Rao, Monica Celi, Eleonora Piccirilli, Elena Gasbarra, Simone Parri, Giovanni Iolascon, Maria Luisa Brandi, Umberto Tarantino Osteoporosis: pathophysiology and epidemiology
PP360 Osteoporosis risk factor correlation with BMD in Latvia Inese Pavlina, Ingvars Rasa, Inara Adamsone, Ilze Daukste, Sandra Jaundzeikare, Dainis Kaneps, Ingrida Kaze, Agita Medne, Signe Zelca Osteoporosis: pathophysiology and epidemiology
PP361 Referral Rate of Lebanese Males for Osteodensitimetry Yasser Yaghi, Ghassan Maalouf, Ahmad Ghazzawi, Kinda Yaghi Osteoporosis: pathophysiology and epidemiology
PP362 Asssesment of Osteoporosis Knowledge among Lebanese Physicians Yasser Yaghi, Fatiha El Horr, Yousef Mousa, Kinda Yaghi, Nancy Maan Osteoporosis: pathophysiology and epidemiology
PP363 Adolescents´lifestyle and bone health - what about the young bones in Norway? Anne Winther, Elaine Dennison, Luai Awad Ahmed, Anne-Sofie Furberg, Guri Grimnes, Rolf Jorde, Clara Gram Gjesdal, Nina Emaus Osteoporosis: pathophysiology and epidemiology
PP364 Osteoporosis an Independent Predictor of Mortality in Hip Fracture Patients Andreas P. Diamantopoulos, Mari Hoff, Marc Hochberg, Glenn Haugeberg Osteoporosis: pathophysiology and epidemiology
PP365 Effect of sitagliptin on bone growth and remodeling in non-ovariectomized and ovariectomized rats Maria Pytlik, Joanna Folwarczna, Justyna Fronczek-Sokół, Adam Smyła, Patrycja Więcek, Maria Zych Osteoporosis: pathophysiology and epidemiology
PP366 Caffeine at a moderate dose favorably affected bone mechanical properties in ovariectomized rats Joanna Folwarczna, Maria Pytlik, Maria Zych, Urszula Cegieła, Ilona Kaczmarczyk-Sedlak, Barbara Nowińska, Leszek Śliwiński Osteoporosis: pathophysiology and epidemiology
PP367 Estimated glomerular filtration rate is associated with bone fragility in the elderly Maria João Gonçalves, Ana Rodrigues, Joana Caetano-Lopes, Emilia Raquel, Ana Lopes, Bruno Vidal, Ana Catarina Vale, Marco Sarmento, Maria Fátima Vaz, Jacinto Monteiro, João Eurico Fonseca, Helena Canhão Osteoporosis: pathophysiology and epidemiology
PP368 Portuguese and Spanish FRAX® tool versions: a comparative analysis from EpiReumaPt Nelia Gouveia, Helena Canhao, Tania Rego, Susana Sousa, Jaime Branco Osteoporosis: pathophysiology and epidemiology
PP369 Change in Bone Mineral Density of the proximal femur after Total Knee Replacement KwnagKyoun Kim Osteoporosis: pathophysiology and epidemiology
PP370 Up-regulation of inhibitors of DNA binding/differentiation gene during alendronate-induced osteoblast differentiation Heung Yeol Kim, Hoon Choi Osteoporosis: pathophysiology and epidemiology
PP371 Comparative Analysis of Vitamin D level with or without Osteoporotic Spinal Compression Fracture in Korean Elderly Patients Ye-Soo Park, Hong-Sik Kim, Dong-Yi Kong, Ye-Yeon Won, Byung-Moon Kang Osteoporosis: pathophysiology and epidemiology
PP372 Decreased bone mineral density is associated with coronoary atherosclerosis in healthy postmenopausal women Mihyun Jo, SiHyun Cho, Young Sik Choi, Byung Seok Lee, Seok Kyo Seo Osteoporosis: pathophysiology and epidemiology
PP373 Prevalence of vitamin D deficiency and low bone mineral density in healthy Saudi Women Khulood Hussein, Hanan Alkadi, Susan Lanham-New, Mohamad Ardawi Osteoporosis: pathophysiology and epidemiology
PP374 Effect of two types of bariatric surgery (gastrojejunal bypass and sleeve gastroplasty) on gene expression of bone remodeling markers in Goto-Kakizaki rats José-Luis Pérez-Castrillon, José-Antonio Riancho, Daniel DeLuis, Manuel Gonzalez-Sagrado, Marta Ruiz-Mambrilla, María Domingo-Anfres, Rosa Conde, David Primo, Antonio Dueñas-Laita Osteoporosis: pathophysiology and epidemiology
PP375 25-hydroxyvitamin D values in liver transplant candidates. Ana Monegal, Pilar Peris, Andrea Cuervo, Africa Muxi, Laia Gifre, Nuria Guañabens Osteoporosis: pathophysiology and epidemiology
PP376 URSODEOXYCHOLIC ACID PROTECTS OSTEOBLASTIC CELLS FROM BILIRUBIN AND LITHOCHOLIC ACID INDUCED APOPTOSIS. Silvia Ruiz-Gaspà, Marta Dubreuil, Andrés Combalia, Pilar Peris, Ana Monegal, Albert Parés, Nuria Guañabens Osteoporosis: pathophysiology and epidemiology
PP377 Effect of glucocorticoid treatment on Wnt signalling antagonists (sclerostin and Dkk-1) and their relationship to bone turnover and bone mass. Laia Gifre, Pilar Peris, Silvia Ruiz-Gaspà, Ana Monegal, Benet Nomdedeu, Núria Guañabens Osteoporosis: pathophysiology and epidemiology
PP378 Role of Wnt antagonists (sclerostin and Dkk-1) on bone turnover markers and bone mass, in patients with complete spinal cord injury. Preliminary results. Laia Gifre, Joan Vidal, Silvia Ruiz-Gaspà, Enric Portell, Ana Monegal, Africa Muxi, Núria Guañabens, Pilar Peris Osteoporosis: pathophysiology and epidemiology
PP379 Where and when do hip fractures occur? A population-based study Breiffni Leavy, Anna Cristina Åberg, Håkan Melhus, Hans Mallmin, Karl Michaëlsson, Liisa Byberg Osteoporosis: pathophysiology and epidemiology
PP380 Hip Fracture Trends in Denmark 1980-2010 with Age-Period-Cohort-effects Bjorn Rosengren, Jonas Björk, Cyrus Cooper, Bo Abrahamsen Osteoporosis: pathophysiology and epidemiology
PP381 Impact of hip fracture on mortality and life expectancy Karl Michaëlsson, Peter Nordström, Anna Nordström, Hans Garmo, Liisa Byberg, Nancy Pedersen, Håkan Melhus Osteoporosis: pathophysiology and epidemiology
PP382 The relationship between cardiovascular risk and bone mineral density: an important role for anthropometry. Renate de Jongh, Karen Jameson, Holly Syddall, Avan Sayer, Martin den Heijer, Cyrus Cooper, Elaine Dennison Osteoporosis: pathophysiology and epidemiology
PP383 Detection of autoantibodies to osteoprotegerin in patients with rheumatoid arthritis and their association with disease activity Barbara Hauser, Philip Riches, Tamara Gilchrist, Jim F Wilson, William D Fraser, Stuart H Ralston Osteoporosis: pathophysiology and epidemiology
PP384 Does Vitamin D status impact on hip fracture incidence? - evidence of fracture variation with latitude and season in Sweden Eugene McCloskey, Helena Johansson, Anders Oden, John Kanis Osteoporosis: pathophysiology and epidemiology
PP385 Fracture Risk Assessment in a Primary Care Population: Case Finding Using Routine GP Data, FRAX® and RAIDR® in the United Kingdom Terry Aspray, Erica Whalley, Mike Scott, Steve Summers, Steve Turley, Rachel Wright, Valerie Maddison, Sharon Abdy, Lesley Kay Osteoporosis: pathophysiology and epidemiology
PP386 Effect of thymogen injections on dentinogenesis in mandibular incisors after thymectomy A.A. Kochubey, V.I. Luzin, A.V. Yeryomin Osteoporosis: pathophysiology and epidemiology
PP387 Sclerostin associated with vertebral bone marrow fat in older men but not women Vivian Ma, Xiaojuan Li, Sigurdur Sigurdsson, Gudny Eriksdottir, Alda Hauksdottir, Lisa Palermo, Trisha Hue, Thomas Lang, Tamara Harris, Clifford Rosen, Eric Vittinghoff, Kristin Siggeirsdottir, Gunnar Sigurdsson, Diana Oskarsdottir, Vilmundur Gudnason, Ann Schwartz Osteoporosis: pathophysiology and epidemiology
PP388 The association of leptin-adiponectin ratio with bone in overweight and obese postmenopausal women Yi-Chih Chi, Pei-Yang Liu, Maria Spicer, Jasminka Ilich Osteoporosis: pathophysiology and epidemiology
PP389 Serum leptin and adiponectin in overweight and obese postmenopausal women after the 6-month weight loss program and their relationship with BMD Yi-Chih Chi, Pei-Yang Liu, Maria Spicer, Jasminka Ilich Osteoporosis: pathophysiology and epidemiology
PP390 Cathepsin K Inhibition as a Therapeutic Target in Osteoporosis John Eisman Osteoporosis: treatment
PP391 Electronic clinical decision support for the management of osteoporosis in primary care. Yvonne Selecki, Jaqui Center, Tuan Nguyen, John Eisman Osteoporosis: treatment
PP392 Anti-osteoporosis treatment amongst Austrian hip fracture patients: Status quo, and effects on mortality and subsequent fracture risk Wolfgang Brozek, Berthold Reichardt, Oliver Kimberger, Daniela Kritsch, Klaus Klaushofer, Elisabeth Zwettler Osteoporosis: treatment
PP393 Remarkable bone mineral density increases on teriparatide in patients with glucocorticoid-induced osteoporosis and Crohn's disease Danny Ko-Wu Kuo, Kenny To, David Kendler Osteoporosis: treatment
PP394 Effects of a new conjugate drug in a rat model of postmenopausal osteoporosis Careesa Liu, Robert Young, Marc Grynpas Osteoporosis: treatment
PP395 Renal function and safety result after one year treatment of Zoledronic Acid in Chinese women with postmenopausal osteoporosis Huiyong Shen, Yue Sun, Xun Liu Osteoporosis: treatment
PP396 Characterization and Risk Factors of Acute-Phase Response Following a First-dose Administration of Zoledronic Acid for Treatment of Osteoporosis DECAI CHEN Osteoporosis: treatment
PP397 Intact heparin inhibits BMP6 osteogenic activity Jelena Brkljacic, Martina Pauk, Igor Erjavec, Slobodan Vukicevic Osteoporosis: treatment
PP398 Health economic consequences of fractures in patients with osteoporosis: A national register based study of total and incremental health costs following fracture. Kim Rose Olsen, Carrinna Hansen, Bo Abrahamsen Osteoporosis: treatment
PP399 Assessment of serum 25-Hydroxyvitamin D concentrations in postmenopausal osteoporotic women: a retrospective study to evaluate long-term treatment with vitamin D3 Camilla Sand Andersen, Peter Vestergaard, Parisa Gazerani, Hans Christian Hoeck Osteoporosis: treatment
PP400 Osteonecrosis of the jaw and non-malignant disease Amélie COUDERT, Géraldine LESCAILLE, Vanessa BAAROUN, Jean AZERAD, Martine COHEN-SOLAL, Ariane BERDAL, Vianney DESCROIX Osteoporosis: treatment
PP401 Effectiveness of Strontium Renalate therapy for osteoporosis in men.  National Association of Osteoporosis in Georgia Lali Kilasonia, Medea Kopaliani, Nana Kirvalidze, Luba Lagvilava, Neriman Tsintsadze Osteoporosis: treatment
PP402 Do Bisphosphonates remain basic drugs for the treatment of osteoporosis? Lali Kilasonia, Luba Lagvilava, Nana Kirvalidze, Medea Kopaliani, Neriman Tsartsidze Osteoporosis: treatment
PP403 Parathyroid hormone changes following denosumab treatment in postmenopausal osteoporosis Polyzois Makras, Stergios Polyzos, Athanasios Papatheodorou, Panagiotis Kokkoris, Daniel Chatzifotiadis, Athanasios Anastasilakis Osteoporosis: treatment
PP404 Sequential therapy after PTH 1-84 treatment: comparison among bisphosphonates and strontium ranelate Renato Pastore, Daniela Mentuccia, Patrizio Pasqualetti, Gaetano Frajese Osteoporosis: treatment
PP405 Adherence to therapy: outcomes after seven years of treatment with Bisphosphonates Renato Pastore, Daniela Mentuccia Osteoporosis: treatment
PP406 IN REAL CLINICAL PRACTICE OSTEOPOROSIS DRUGS ARE TAKEN  FOR A VERY SHORT PERIOD: ANALYSIS OF PERSISTENCE IN THE CAMPANIA REGION Giovanni Iolascon, Annarita Capaldo, Valentina Orlando, Enrica Menditto, Francesca Gimigliano Osteoporosis: treatment
PP407 EFFECT OF A MIXTURE OF CALCIUM, VITAMIN D, INULIN AND SOY ISOFLAVONES ON BONE METABOLISM IN POST-MENOPAUSAL WOMEN: A RETROSPECTIVE ANALYSIS Maurizio Bevilacqua, Vellela Righini, Diana Certan, Matteo Alemanni, Giorgio Gandolini Osteoporosis: treatment
PP408 Vertebroplasty versus Kyphoplasty in Osteoporotic Vertebral Fractures: a Finite Element Comparative Analysis. Luca Pietrogrande, Claudia Ottardi, Luigi La Barbera, Emanuela Raimondo, Tomaso Villa Osteoporosis: treatment
PP409 25-OH vitamin D and γ-δ TCR lymphocyte interplay in the pathogenesis of acute phase reaction after zoledronic acid infusion for osteoporosis treatment Chiara Crotti, Francesca Cavaciocchi, Maria De Santis, Angela Ceribelli, Gianluigi Fabbriciani, Carlo Selmi Osteoporosis: treatment
PP410 BONE TURNOVER MARKERS AND RADIOGRAPHIC PROGRESSION OF VERTEBRAL COMPRESSION FRACTURES DURING ANTI-OSTEOPOROTIC THERAPY Costantino Corradini, Vittorio Macchi, Stefano Pasqualotto, Francesca Boisio, Daniele Tradati, Calogero Crapanzano, Cesare Verdoia Osteoporosis: treatment
PP411 Changes in low back pain and upper gastrointestinal symptoms in Japanese osteoporotic patients after switching to once-monthly oral minodronate from daily or weekly bisphosphonates   Nobukazu Okimoto, Akinori Sakai, Satoshi Ikeda, Toru Yoshioka, Kitau Teshima, Hidehiro Matsumoto, Hiroshi Tsurukami, Yuichi Okazaki, Masato Nagashima, Fumio Fukuda, Shinobu Arita Osteoporosis: treatment
PP412 Preoperative bisphosphonate treatment in patients with neuromuscular scoliosis improves bone strength of vertebral body Masafumi Kashii, Yukitaka Nagamoto, Takahito Fujimori, Hirotsugu Honda, Takashi Kaito, Hideki Yoshikawa, Motoki Iwasaki Osteoporosis: treatment
PP413 Early response to once-monthly oral minodronate after switching from daily or weekly bisphosphonates in Japanese osteoporotic patients Akinori Sakai, Satoshi Ikeda, Nobukazu Okimoto, Kitau Teshima, Shinobu Arita, Hidehiro Matsumoto, Hiroshi Tsurukami, Yuichi Okazaki, Masato Nagashima, Fumio Fukuda, Toru Yoshioka Osteoporosis: treatment
PP414 Treatment with eldecalcitol (ED-71) and raloxifene combined increases cancellous and cortical bone strength in ovariectomized rats. Sadaoki Sakai, Satoshi Takeda, Ayako Shiraishi, Nobuo Koike, Masahiko Mihara, Koichi Endo Osteoporosis: treatment
PP415 Patient preference and adherence to once-monthly oral minodronate in Japanese osteoporotic patients previously using daily or weekly bisphosphonates Satoshi Ikeda, Akinori Sakai, Nobukazu Okimoto, Kitau Teshima, Shinobu Arita, Hidehiro Matsumoto, Hiroshi Tsurukami, Yuichi Okazaki, Masato Nagashima, Fumio Fukuda, Toru Yoshioka Osteoporosis: treatment
PP416 Meta-Analysis of the Effects of Vitamin D Supplements on Bone Mineral Density in Adults Ian R Reid, Mark Bolland, Andrew Grey Osteoporosis: treatment
PP417 A case of Atypical Femoral Fracture with Abnormal Cortical Bone characterized by Impaired Mineralization and Pyrophosphate Accumulation Maziar Shabestari, Erik Fink Eriksen, Paul Roschger, Eleftherios Paschalis, Adolfo Diez-Perez Osteoporosis: treatment
PP418 Myricetin suppress LPS-induced MMP expression in human periodontal ligament fibroblasts and inhibit osteoclastogenesis by downregulating NFATc1 in LPS-induced RAW 264.7 cells Seon-Yle Ko, Young-Joo Jang Osteoporosis: treatment
PP419 Analysis of clinical assessment and efficacy of once-yearly intravenous zoledronic acid for osteoporosis Ye-Soo Park, Hong-Sik Kim, Jung-Hwan Lee, Ye-Yeon Won, Byung-Moon Kang Osteoporosis: treatment
PP420 Subsequent Hip Fracture in Inchon and Bucheon area of Korea (Cohort study) Kyoung Ho Moon, Ju Young Kim, Kee haeng Lee Osteoporosis: treatment
PP421 The efficiency of  bisphosphonates (alendronate, risedronate, ibandronate) for postmenopausal osteoporosis after 1 year of therapy Diana Paun, Nicoleta Totolici, Monica Chirita, Rodica Petris, Constantin Dumitrache Osteoporosis: treatment
PP422 Bisphosphonates poisonous action Buyko Maria, Atrushkevich Victoria Osteoporosis: treatment
PP423 Three years' experience of zoledronic acid use in the treatment of postmenopausal osteoporosis Svetlana Yureneva, Oksana Yakushevskaya, Sergey Kuznetsov, Tatyana Ivanets, Vera Smetnik, Gennady Sukchich Osteoporosis: treatment
PP424 Acute phase response and zoledronic acid therapy Svetlana Yureneva, Oksana Yakushevskaya, Vera Smetnik, Gennady Sukchich Osteoporosis: treatment
PP425 EVALUATION WITH DENSITOMETRY OF PATIENTS WITH BREAST CANCER AND LOW BONE MINERAL DENSITY (LBMD) AFTER 2 YEARS OF TREATMENT. Sonia Muñoz Gil, Tomás Mut Dólera, Belén C Garrido López, MD Torregrosa Maicas, R Gironés Sarrió, P López Tendero, MD García Armario, Pascual Muñoz Mira Osteoporosis: treatment
PP426 CHARACTERIZATION AND INCIDENCE ON ACUTE PHASE REACTION IN PAGET'S DISEASE AFTER ZOLEDRONIC ACID INFUSION A. Conesa Mateos, D. Rotés Sala, J. Carbonell Abelló Osteoporosis: treatment
PP427 Risk factors for the development of  vertebral fractures after percutaneous vertebroplasty.   Àngels Martinez-Ferrer, Jordi Blasco, Laia Gifre, Ana Monegal, Nuria Guañabens, Pilar Peris Osteoporosis: treatment
PP428 Persistence with different anti-osteoporosis medications: a population-based cohort study. Aina Pagès-Castellà, Cristina Carbonell-Abella, Xavier Nogués, M Kassim Javaid, Nigel K Arden, Cirus Cooper, Adolfo Díez-Pérez, Daniel Prieto-Alhambra Osteoporosis: treatment
PP429 STUDY DESCRIPTION AND BASELINE CHARACTERISTICS OF THE POPULATION ENROLLED IN THE EXTENDED FORSTEO® OBSERVATIONAL STUDY (ExFOS) Bente Langdahl, Claude Benhamou, Erik Lindh, Joannes Dekker, Giorgios Kapetanos, Tomaz Kocjan, Östen Ljunggren, Nicola Napoli, Helmut Petto, Tatjana Nicolic Osteoporosis: treatment
PP430 First in Man Study of a Novel and Highly Selective Cathepsin K Inhibitor MIV-711 - Safety, Pharmacokinetics and Pharmacodynamics of Single Ascending Oral Doses in Healthy Subjects Urszula Grabowska, Erik Lindström, Markus Jerling, Torbjörn Larsson, Disa Böttiger, Kerstin Danielson, Jens D Kristensen, Charlotte Edenius Osteoporosis: treatment
PP431 Bisphosphonate treatment of painful vertebral fractures due to osteoporosis in five boys with Duchenne muscular dystrophy Eva Åström Osteoporosis: treatment
PP432 Effects of a mutated sclerostin peptide on bone and lean mass in mice. Maude Gerbaix, Dominique Pierroz, Nicolas Bonnet, Verena Boschert, Thomas Mueller, Serge Ferrari Osteoporosis: treatment
PP433 Denosumab is associated with progressive improvements in hip cortical mass and thickness K Poole, G Treece, A Gee, JP Brown, MR McClung, A Wang, C Libanati Osteoporosis: treatment
PP434 Bone histology and histomorphometry: effects of 5 years of denosumab (DMAb) in the FREEDOM extension Jacques P Brown, Rachel Wagman, David W Dempster, David Kendler, Paul Miller, Michael Bolognese, Ivo Valter, Jens-Erik Beck Jensen, Cristiano Zerbini, Jose R Zanchetta, Nadia Daizadeh, Ian Reid Osteoporosis: treatment
PP435 Denosumab's dynamic CTX profile is maintained over 6 years of treatment: first 3 years of the FREEDOM extension study C Roux, MR McClung, N Franchimont, S Adami, PR Ebeling, IR Reid, H Resch, G Weryha, N Daizadeh, A Wang, RB Wagman, R Eastell Osteoporosis: treatment
PP436 Bone mineral density (BMD) changes in patients with prior fracture suboptimally treated with a bisphosphonate (BP): results from denosumab (DMAb)/ibandronate (IBN) and DMAb/risedronate (RIS) trials Christopher Recknor, Christian Roux, Pei-Ran Ho, Jesse Hall, Henry Bone, Sydney Bonnick, Joop van den Bergh, Irene Ferreira, Rachel Wagman, Jacques P Brown Osteoporosis: treatment
PP437 The spatial relationship between bone formation and bone resorption in healthy and ovariectomized mice treated with PTH, bisphosphonate or mechanical loading Davide Ruffoni, Claudia Weigt, Elisa Fattorini, Alina Levchuk, Friederike Schulte, Gisela Kuhn, Ralph Müller Osteoporosis: treatment
PP438 OPTIMIZING FRACTURE PREVENTION: THE FRACTURE LIAISON SERVICE, AN OBSERVATIONAL STUDY Danielle Eekman, Sven van Helden, Margriet Huisman, Harald Verhaar, Irene Bultink, Piet Geusens, Paul Lips, Willem Lems Osteoporosis: treatment
PP439 THE DIRECT AND INDIRECT COSTS OF AN OSTEOPOROTIC FRACTURE: A PROSPECTIVE EVALUATION OF ELDERLY PATIENTS WITH A CLINICAL FRACTURE Danielle Eekman, Marieke ter Wee, Veerle Coupé, Seher Erisek-Demirtas, Mark Kramer, Willem Lems Osteoporosis: treatment
PP440 Strontium potently inhibits mineralisation in bone-forming osteoblast cultures while osteoclast formation from marrow mononuclear cells is moderately reduced.    Daniel Wornham, Mark Hajjawi, Isabel Orriss, Timothy Arnett Osteoporosis: treatment
PP441 Reducing the risk of hypocalcaemia with parenteral antiresorptive therapies: an audit. Wei Xu, Kenneth Baker, Rachel Reavley, Emily Oates, Terry Aspray Osteoporosis: treatment
PP442 Design of a prospective observational study to evaluate persistence and adherence during denosumab treatment, and patient characteristics in postmenopausal women with osteoporosis in routine clinical practice Maurille Feudjo Tepie,, Gerd Möller, Peyman Hadji, Irene Ferreira, Suresh Siddhanti, Stephen Boonen, Astrid Fahrleitner-Pammer, Nikos Papaioannou Osteoporosis: treatment
PP443 Zoledronic acid versus Alendronate in the Management of Osteoporosis Lyn Ferguson, Maurizio Panarelli, Rosemary Dargie Osteoporosis: treatment
PP444 CORRECTION OF VITAMIN D DEFICIENCY IN WOMEN WITH POSTMENOPAUSAL OSTEOPOROSIS Vladyslav Povoroznyuk, Nataliya Balatska Osteoporosis: treatment
PP445 EFFECTIVENESS OF THE ACTIVE METABOLITE OF VITAMIN D IN THE TREATMENT OF POSTMENOPAUSAL OSTEOPOROSIS Fedir Klimovitskiy, Vladyslav Povoroznyuk, Nataliya Balatska Osteoporosis: treatment
PP446 Effects of Odanacatib on BMD and Safety in the Treatment of Osteoporosis in Postmenopausal Women Previously Treated with Alendronate- A Randomized Placebo-Controlled trial Roland Chapurlat, Tobias De Villiers, Sydney Bonnick, Alberto Odio, Santiago Palacios, Boyd Scott, Celine Le Bailly De Tilleghem, Carolyn DaSilva, Albert Leung, Deborah Gurner Osteoporosis: treatment
PP447 Effects of Sclerostin Antibody and Maintenance of New Bone Induced by Sclerostin Antibody in Animal Models Xiaodong Li, Michael S Ominsky, Min Liu, Rogely W Boyce, Hua Zhu Ke Osteoporosis: treatment
PP448 Resolution of Effects on Bone Turnover Markers and Bone Mineral Density after Discontinuation of Long-term Bisphosphonate Use  Claude Benhamou, Tobias De Villiers, C Conrad Johnston, Bente Langdahl, Kenneth Saag, Andrew Denker, Annpey Pong, John P McGinnis II, Elizabeth Rosenberg, Arthur Santora Osteoporosis: treatment
PP449 Odanacatib Treatment Reduces Remodeling- and Stimulates Modeling-based Bone Formation in Adult OVX Monkeys C Chen, M Shih, H Zheng, L Duong Osteoporosis: treatment
PP450 Transdermal Delivery of BA058, A Novel Analog of hPTHrP (1-34), with a Short Wear Time Patch in Preclinical and Clinical Studies Gary Hattersley, Kris Hansen, Amy Determan, Ken Brown, Kate Mckay, Jonathan Guerriero, Dan McCarthy, C Richard Lyttle, Louis St L O'Dea Osteoporosis: treatment
PP451 Estimation of Vertebral and Femoral Strength During the First Three Years of Denosumab Therapy Using an Alternative Smooth Non-linear Finite Element Methodology Philippe Zysset, Dieter Pahr, Klaus Engelke, Harry Genant, Michael McClung, David Kendler, Christopher Recknor, Michael Kinzl, Jakob Schwiedrzik, Oleg Museyko, Andrea Wang, Cesar Libanati Osteoporosis: treatment
PP452 Curbing Our Enthusiasm When Prescribing Strenuous Exercises in Osteopenia/Osteoporosis, When Fracture May Occur Under Good Intensions Mehrsheed Sinaki Osteoporosis: treatment
PP453 Factors Influencing Levels of Bone Resorption During Denosumab Dosing Richard Eastell, Ethel Siris, Christian Roux, Dennis M. Black, Nathalie Franchimont, Graham Jang, Nadia Daizadeh, Rachel B. Wagman, Matt Austin Osteoporosis: treatment
PP454 Long bone fragility in NF1 is due to deficiency of architecture, micro-structure and matrix mineralization. Jirko Kühnisch, Jong Seto, Claudia Lange, Susanne Schrof, Sabine Stumpp, Karolina Kobus, Julia Grohmann, Nadine Kossler, Peter Varga, Monika Osswald, Sigrid Tinschert, Wenke Seifert, Thaqif el Khassawna, David Stevenson, Florent Elefteriou, Uwe Kornak, Kay Raum, Peter Fratzl, Mateusz Kolanczyk, Stefan Mundlos Other diseases of bone and mineral metabolism
PP455 Cortical and Trabecular Alterations in Patients with Bone Marrow Edema of the Lower Limb Afrodite Zendeli, Christian Muschitz, Roland Kocijan, Lukas Fischer, Daniela Suess, Heinrich Resch Other diseases of bone and mineral metabolism
PP456 Altered bone material properties in HLA-B27 rats, an animal model for arthritis, ankylosing spondylitis, and gastrointestinal inflammation Sonja Gamsjaeger, Eleftherios P. Paschalis, Ruth Zoehrer, Klaus Klaushofer, Dimitris N. Tatakis Other diseases of bone and mineral metabolism
PP457 DPP4 inhibition attenuates bone loss in diabetic rats Lorenzo Glorie, Geert Behets, Lesley Baerts, Ingrid De Meester, Patrick D'Haese, Anja Verhulst Other diseases of bone and mineral metabolism
PP458 EVALUATION OF BONE AND MINERAL METABOLISM IN PATIENTS WITH THE SYNDROME OF RESISTANCE TO THYROID HORMONE Ludmilla Cardoso, Francisco de Paula, Lea Maciel Other diseases of bone and mineral metabolism
PP459 Correlates of tissue mineral density (TMD) of bone samples from total hip arthroplasty patients with type 2 diabetes: an ex vivo study Janet Pritchard, Alexandra Papaioannou, Mark Hurtig, Lora Giangregorio, Stephanie Atkinson, Karen Beattie, J.D. Adachi, Justin DeBeer, Mitchell Winemaker, Victoria Avram, Henry Schwarcz Other diseases of bone and mineral metabolism
PP460 Osteopontin ASARM Peptide Binding to Crystal Faces of Hydroxyapatite - Computational Simulations Ahmad Mansouri, David Masica, Jeffrey Gray, Marc McKee Other diseases of bone and mineral metabolism
PP461 QTc INTERVAL IN HYPERCALCEMIC KIDNEY TRANSPLANT RECIPIENTS Ruzica Smalcelj, Anton Smalcelj Other diseases of bone and mineral metabolism
PP462 EXPRESSION OF RANKL/RANK/OPG IN COLON DURING EXPERIMENTAL INFLAMMATORY BOWEL DISEASE Ivana Maric, Ivana Smoljan, Tamara Turk Wensveen, Andrica Lekic, Sanja Zoricic Cvek, Tanja Celic, Zeljka Crncevic Orlic, Dragica Bobinac Other diseases of bone and mineral metabolism
PP463 Bone morphogenetic protein-7 reduces kidney cold ischemic injury by maintaining epithelial phenotype of tubular cells Tanja Celic, Josip Spanjol, Ivana Maric, Olga Cvijanovic, Dragica Bobinac Other diseases of bone and mineral metabolism
PP464 Effects of add on PTH(1-84) substitution therapy in hypoparathyroidism: results from 2.5 years of PTH treatment Tanja Sikjaer, Emil Moser, Lars Rolighed, Leif Mosekilde, Lars Rejnmark Other diseases of bone and mineral metabolism
PP465 Post-surgical hypoparathyroidism and the risk of fractures Line Underbjerg, Tanja Sikjaer, Leif Mosekilde, Lars Rejnmark Other diseases of bone and mineral metabolism
PP466 Bone cross-sectional geometry in adult patients with hypophosphatemic rickets: a hip structural analysis study Charlotte Ejersted, Signe Beck-Nielsen, Jeppe Gram, Kim Brixen Other diseases of bone and mineral metabolism
PP467 Bone Marrow Fat Is Metabolically Distinct Fat Depot Riku Kiviranta, Tam Pham, Jarna Hannukainen, Juho Järvelin, Anna Karmi, Minna Soinio, Pauliina Salminen, Pirjo Nuutila Other diseases of bone and mineral metabolism
PP468 Miglustat therapy normalizes bone mass in a mouse model of cystic fibrosis Carole Le Henaff, Eric Haÿ, Frédéric Velard, Caroline Marty, Pierre J. Marie, Jacky P. Jacquot Other diseases of bone and mineral metabolism
PP469 MEPE-derived ASARM peptide impairs mineralization in tooth models of X-linked hypophosphatemia Benjamin Salmon, Claire Bardet, Mayssam Khaddam, Brigitte Baroukh, Julie Lesieur, Dominique Le Denmat, Antonino Nicoletti, Anne Poliard, Peter S Rowe, Agnes Linglart, Marc D McKee, Catherine Chaussain Other diseases of bone and mineral metabolism
PP470 DETERMINANTS OF BONE LOSS IN CYSTIC FIBROSIS Déborah GENSBURGER, Roland CHAPURLAT, Raphaele NOVE-JOSSERAND, Muriel RABILLOUD, Isabelle DURIEU Other diseases of bone and mineral metabolism
PP471 Long term energy deficiency in mice induces bone alterations reversed by long term recovery Sara ZGHEIB, Stéphanie LUCAS, Mathieu MEQUINION, Odile BROUX, Damien LETERME, Pierre HARDOUIN, Odile VILTART, Christophe CHAUVEAU Other diseases of bone and mineral metabolism
PP472 Monocytic expression of osteoclast-associated receptor (OSCAR) is induced in atherosclerotic mice and regulated by oxidized low-density lipoprotein in vitro Kathrin Sinningen, Martina Rauner, Nadia Al-Fakhri, Michael Schoppet, Lorenz Hofbauer Other diseases of bone and mineral metabolism
PP473 Evidence of increased bone resorption in early post menopausal women with Idiopathic Hypercalciuria. Study with biochemical markers and pQCT of the tibia. Konstantinos Stathopoulos, Ilias Bournazos, Pelagia Katsimbri, Andonios Partsinevelos, Aristeides B. Zoubos, Panagiotis Papaggelopoulos, Erato Atsali, Grigoris Skarandavos Other diseases of bone and mineral metabolism
PP474 Insertion of the clcn7 gene mutation pG213R in mouse induces Autosomal Dominant Osteopetrosis Type II (ADO2). Andrea Del Fattore, Amie K. Gray, Shoji Ichikawa, Kang Chu, Khalid S. Mohammad, Marta Capannolo, Maurizio Muraca, Anna Teti, Michael J. Econs, Imranul Alam Other diseases of bone and mineral metabolism
PP475 MULTIDISCIPLINARY STUDIES OF ANCIENT CALCIFIED TISSUES: I-RENAL STONES FROM MUMMIES Mattia Capulli, Lorenzo Arrizza, Nadia Rucci, Sara Gemini Piperni, Raimondo Quaresima, Valentina Giuffra, Gino Fornaciari, Anna Teti, Luca Ventura Other diseases of bone and mineral metabolism
PP476 MULTIDISCIPLINARY STUDIES OF ANCIENT CALCIFIED TISSUES: II - CONTENTS FROM EGYPTIAN CANOPIC JARS Nadia Rucci, Lorenzo Arrizza, Mattia Capulli, Antonio Maurizi, Cinzia Mercurio, Maria Cristina Guidotti, Gino Fornaciari, Anna Teti, Luca Ventura Other diseases of bone and mineral metabolism
PP477 A OPTN variant (rs1561570) interacts with TNFRSF11A polymorphism (rs1805034) on the clinical phenotype of sporadic Paget’s disease of bone. Daniela Merlotti, Luigi Gennari, Fernando Gianfrancesco, Domenico Rendina, Marco Di Stefano, Teresa Esposito, Giuseppina Divisato, Giovanna Morello, Riccardo Muscariello, Giancarlo Isaia, Pasquale Strazzullo, Ranuccio Nuti Other diseases of bone and mineral metabolism
PP478 Circulating Sclerostin level in Patients with Ossification of the Posterior Longitudinal Ligament of the Spine Masafumi Kashii, Yohei Matsuo, Tsuyoshi Sugiura, Takahito Fujimori, Yukitaka Nagamoto, Hirotsugu Honda, Takashi Kaito, Motoki Iwasaki, Hideki Yoshikawa Other diseases of bone and mineral metabolism
PP479 The activation of RANK/RANKL/OPG system in normal pregnancy and pre-eclampsia.Dorota Dorota Darmochwal-Kolarz Other diseases of bone and mineral metabolism
PP480 Effect of polyphenolic compounds from Aronia melanocarpa berries on cadmium accumulation in the bone tissue Malgorzata M. Brzóska, Malgorzata Galazyn-Sidorczuk, Maria Jurczuk Other diseases of bone and mineral metabolism
PP481 Single nucleotide polymorphisms identification and functional analysis in PDB6 locus – A target locus for Paget’s Disease of Bone Iris Silva, Natércia Conceição, Laetitia Michou, M. Leonor Cancela Other diseases of bone and mineral metabolism
PP482 ZOLEDRONATE EFFICACY AND SAFETY IN ACTIVE PAGET'S DISEASE Long-term follow-up and retreatment in clinical practice Elsa Vieira-Sousa, Ana Rodrigues, Joana Caetano-Lopes, Susana Capela, Filipa Ramos, Ricardo Figueira, Joaquim Polido-Pereira1, Cristina Ponte, Raquel Campanilho-Marques1, Rita Barros, José Carlos Romeu, José Alberto Pereira da Silva Other diseases of bone and mineral metabolism
PP483 Did Paget's Bone Disease Changed Over the Last Decade? Susana Fernandes, Joana Borges, Inês Gonçalves, Luís Cunha Miranda, Rui Leitão, Alexandra Cardoso, Manuela Micaelo, Eugénia Simões, Augusto Faustino, Filipe Barcelos, Candida Silva, Miguel Sousa, Manuela Parente, Margarida Silva, Helena Madeira, Vera Las, Sara Cortes, José Melo Gomes, José Vaz Patto Other diseases of bone and mineral metabolism
PP484 Osteocyte metabolism on post-menopausal bone loss and role of hormone replacement therapy Ana Maria Silva, Ana Carolina Moreira, Maria Sancha Santos, Anabela Albuquerque, Izilda Ferreira, Paulo Gil, Jorge Isidoro, Romeu Videira, Rui Carvalho, Vilma Sardão Other diseases of bone and mineral metabolism
PP485 The effect of hormone therapy on the change of bone mineral density in women with early menopause from pelvic radiation therapy for uterine cervical cancer Dong Ock Lee, Hoon Choi, Jung Gu Kim Other diseases of bone and mineral metabolism
PP486 The relationship between renal function, bone mineral density and arterial stiffness in healthy postmenopausal women. Yeon Soo Jung, Heejin Hwang, Young Sik Choi, Byung Seok Lee, Seok Kyo Seo Other diseases of bone and mineral metabolism
PP487 Preliminary study for the effect of PDGF or mesenchymal stem cells on tissue repair of cutaneous radiation injury Soon Jung Hwang, Tae Hyung Cho, Beomseok Lee, Ji Hye Oh, In Sook Kim Other diseases of bone and mineral metabolism
PP488 Circulating RANKL is not a reliable biomarker for bone loss in primary hyperparathyroidism Daniel Grigorie, Alina Sucaliuc, Elena Neacsu, Roxana Militaru, Alina Diaconescu, Mirela Ivan Other diseases of bone and mineral metabolism
PP489 Homeostasis of Calcium and Vitamin D in Patients with Aggressive Periodontitis. Maria Zyablitskaya, Victoria Atrushkevich, Ashot Mkrtumian Other diseases of bone and mineral metabolism
PP490 Fracture predictors in patients with endogenous cortisol excess Zhanna Belaya, Natalia Dragunova, Liudmila Rozhinskaya, Larisa Dzeranova, Galina Melnichenko Other diseases of bone and mineral metabolism
PP491 Cross sectional study of bone mass and 25OH vitamin D levels in Erythropoietic Protoporphyria Gonzalo Allo, Guillermo Martínez-Diaz-Guerra, Maria del Carmen Garrido-Astray, Rafael Enríquez de Salamanca, Federico Hawkins Other diseases of bone and mineral metabolism
PP492 Allele Dependent Silencing of Collagen Type I Using Small Interfering RNAs Targeting 3’UTR Indels – a Novel Therapeutic Approach in Osteogenesis Imperfecta Katarina Lindahl, Andreas Kindmark, Navya Laxman, Eva Åström, Carl-Johan Rubin, Östen Ljunggren Other diseases of bone and mineral metabolism
PP493 Functional assessment of Paget's disease-causing mutations in Sequestosome-1 (SQSTM1) Eman Azzam, Miep Helfrich, Lynne Hocking Other diseases of bone and mineral metabolism
PP494 BMP-9 induces the calcification of vascular smooth muscle cells. Dongxing Zhu, Neil Mackenzie, Colin Farquharson, Vicky MacRae Other diseases of bone and mineral metabolism
PP495 Long-term effects of symptomatic versus intensive bisphosphonate therapy for Paget's disease of bone: The PRISM-EZ study. Kirsteen Goodman, Graeme MacLennan, William Fraser, Peter Selby, Stuart Ralston Other diseases of bone and mineral metabolism
PP496 The miR-221/222 family regulates vascular smooth muscle cell calcification. Neil Mackenzie, Dongxing Zhu, Paul Genever, Vicky MacRae Other diseases of bone and mineral metabolism
PP497 A frameshift mutation in receptor activator of NFkB reveals a potential ligand-independent mechanism for NFκΒ activation. Cahal Dignan, David Mellis, Angela Duthie, Alessandra Pangrazio, Cristina Sobacchi, Ansgar Schulz, Miep Helfrich, Julie Crockett Other diseases of bone and mineral metabolism
PP498 TOXIC OSTEOMYELITIS OF THE JAW ONES AGAINST THE BACKGROUNDS OF CHRONIC INTOXICATION Margarita Skikevich, Liudmyla Voloshyna Other diseases of bone and mineral metabolism
PP499 Histological structure of the albino rats lower incisors of different ages after thymectomy A.A. Kochubey, V.I. Luzin, A.V. Yeryomin Other diseases of bone and mineral metabolism
PP500 IFITM5 c.-14C>T mutation causes variable type V osteogenesis imperfecta phenotype and decreased COL1A1 expression but increased mineralization by cultured proband osteoblasts Adi Reich, Alison S. Bae, Aileen M. Barnes, Wayne A. Cabral, David Chitayat, Joan C. Marini Other diseases of bone and mineral metabolism
PP501 Abnormal Type I Collagen Glycosylation Pattern and Cross-linking in a Cyclophilin B KO Mouse Model of Recessive Osteogenesis Imperfecta Wayne Cabral, Irina Perdivara, MaryAnn Weis, Masahiko Terajima, Angela Blissett, Weizhong Chang, Elena Makareeva, Sergey Leikin, David Eyre, Mitsuo Yamauchi Other diseases of bone and mineral metabolism
PP502 Craniofacial consequences of high dose zoledronic acid injections in onco-pediatric patients Frédéric LEZOT, Julie CHESNEAU, Séverine BATTAGLIA, Régis BRION, Jean-Christophe FARGES, Géraldine LESCAILLE, Beatriz CASTANEDA, Perrine MAREC-BERARD, Laurence BRUGIERES, Nadège CORRADINI, Dominique HEYMANN, Françoise REDINI Paediatric bone disease
PP503 High dickkopf-1 levels in sera and leukocytes from children with 21-hydroxylase deficiency on chronic glucocorticoid treatment. Giacomina Brunetti, Maria Felicia Faienza, Laura Piacente, Annamaria Ventura, Angela Oranger, Claudia Carbone, Adriana Di Benedetto, Graziana Colaianni, Giorgio Mori, Silvia Colucci, Luciano Cavallo, Maria Grano Paediatric bone disease
PP504 The serum levels of carboxylated and undercarboxylated osteocalcin in children with cystic fibrosis Jadwiga Ambroszkiewicz, Dorota Sands, Joanna Gajewska, Magdalena Chelchowska, Teresa Laskowska-Klita Paediatric bone disease
PP505 Associations between leptin, growth factors and bone turnover markers in prepubertal obese children Joanna Gajewska, Jadwiga Ambroszkiewicz, Magdalena Chelchowska, Witold Klemarczyk, Patrycja Kurpinska, Halina Weker, Teresa Laskowska-Klita Paediatric bone disease
PP506 Body composition in 3- and 4-years-old preterm and full-term infants - preliminary data Elzbieta Karczmarewicz, Edyta Czekuc-Kryskiewicz, Justyna Czech-Kowalska, Maciej Jaworski, Pawel Pludowski, Dorota Bulsiewicz, Maria Kornacka, Anna Niezgoda, Agata Pleskaczynska, Monika Nowakowska-Rysz, Anna Dobrzanska, Roman Lorenc Paediatric bone disease
PP507 Percieved activity capability in children and adolescents with Osteogenesis Imperfecta Maud Hagberg, Kristina Löwing, Eva Åström Paediatric bone disease
PP508 Comparison the bone densitometry and anthropometric parameters between the Ukraininan, Indian and Nigerian young male students, graduated in Lugansk State Medical University Luzin V, Stklyanina L, Ushko Y, Ignatyev A Paediatric bone disease
PP509 Prostate tumorigenesis in estrogen receptor β inactivated, prostate targeted fibroblast growth factor 8B transgenic mice Teresa Elo, Lan Yu, Eeva Valve, Sari Mäkelä, Pirkko Härkönen Steroid hormones and receptors
PP510 Glucocorticoids Inhibit Bone Formation Independent of miRNA Regulation Peng Liu, Ulrike Baschant, Marco Groth, Mario Baumgart, Matthias Platzer, Hans-Martin Jäck, Jan Tuckermann Steroid hormones and receptors
PP511 The survey perception by 85 specialist's physician of the corticosteroid adverse events kawtar nassar, saadia janani, wafaa rachidi, ouafaa mkinsi Steroid hormones and receptors
PP512 Positive regulation of osteogenesis by bile acid through FXR Chan Soo Shin, Sun Wook Cho, Hyojung Park, Jae-Yeon Yang, Sang Wan Kim, Young Joo Park, Mijung Yim, Jung Eun Kim, Seong Yeon Kim, Jee Hyun An Steroid hormones and receptors
PP513 Indole-3-carbonil and epigallocatechin-3-gallate for complex treatment of inflammatory periodontal diseases in female patients with gynecological pathologies. Victoria Atrushkevich, Ella Zabalueva, Elena Zoryan Steroid hormones and receptors
Workshop 0
Oral 0
Expert 0
Plenary 0
Catering and Social 0
Nurse 0
Other 0
Symposium 0
No Session Type 64
Sat 18 07:30
REGISTRATION OPEN
Sat 18 09:00
COFFEE
Sat 18 09:30
Clinical Update 1
Osteoporosis in premenopausal women and men
Auditorium II
Chairs: Serge Ferrari (Geneva, Switzerland) & Jaime da Cunha Branco (Lisbon, Portugal)
Sat 18 09:30
CU1.1
Clinical Update 1
Osteoporosis in premenopausal women
Sat 18 10:00
CU1.2
Clinical Update 1
Management of osteoporosis in premenopausal women
Sheffield, UK
Sat 18 10:30
CU1.3
Clinical Update 1
Male osteoporosis
Gothenburg, Sweden
Sat 18 11:00
CU1.4
Clinical Update 1
Medical management of Osteoporosis in men
Leuven, Belgium
Sat 18 11:30
CU1.5
Clinical Update 1
Glucocorticoid-induced osteoporosis
Southampton, UK
Sat 18 12:00
LUNCH
Sat 18 12:30
Clinical Update 2
Inflammatory disease and bone
Auditorium II
Chairs: Piet Geusens (Diepenbeek, Belgium) & Willem Lems (Amsterdam, The Netherlands)
Sat 18 12:30
CU2.1
Clinical Update 2
Osteo-immunology, the basic concepts
Erlangen, Germany
Sat 18 13:00
CU2.2
Clinical Update 2
Osteoporosis and fragility fractures in rheumatoid arthritis
Oslo, Norway
Sat 18 13:30
CU2.3
Clinical Update 2
Osteoporosis in SLE
Amsterdam, The Netherlands
Sat 18 14:00
CU2.4
Clinical Update 2
Osteoporosis in ankylosing spondylitis
Paris, France
Sat 18 14:30
CU2.5
Clinical Update 2
The effect of anti-inflammatory treatments (except GC) on bone
Amsterdam, The Netherlands
Sat 18 12:30
Allied Health Professionals (AHP) Session
Auditorium III
Chairs: Margaret Paggiosi (Sheffield, UK) & Andrea Marques (Coimbra, Portugal)
Sat 18 12:30
Allied Health Professionals (AHP) Session
Introduction to the highlights of the meeting
Coimbra, Portugal
Sat 18 12:55
AHP1.2
Allied Health Professionals (AHP) Session
Compliance with Osteoporosis: Can we improve patient understanding through education?
Barcelona, Spain
Sat 18 13:30
Coffee Break
Sat 18 13:45
Allied Health Professionals (AHP) Session continued
Sat 18 13:45
AHP1.3
Allied Health Professionals (AHP) Session continued
Could compliance be improved through monitoring?
Sheffield, UK
Sat 18 14:20
PP439
Allied Health Professionals (AHP) Session continued
Abstract presentation - The Direct And Indirect Costs Of An Osteoporotic Fracture: A Prospective Evaluation Of Elderly Patients With A Clinical Fracture
Amsterdam, The Netherlands
Sat 18 14:30
PP450
Allied Health Professionals (AHP) Session continued
Abstract Presentation - Transdermal Delivery of BA058, A Novel Analog of hPTHrP (1-34), with a Short Wear Time Patch in Preclinical and Clinical Studies
MA, USA
Sat 18 14:40
PP286
Allied Health Professionals (AHP) Session continued
Abstract Presentation - Muscle function and quality of life in primary hyperparathyroidism
Sat 18 14:50
PP111
Allied Health Professionals (AHP) Session continued
Abstract Presentation - The effect of gastric bypass treatment for obesity on hormones related to bone re-modeling and intestinal growth
Copenhagen, Denmark
Sat 18 15:00
BREAK
Sat 18 15:30
Satellite Symposium - Treatment of Severe Osteoporosis: an update - supported by Lilly
Supported by Lilly
Auditorium I
Sat 18 15:30
Satellite Symposium - Treatment of Severe Osteoporosis: an update - supported by Lilly
Welcome & Introductions
Sat 18 15:35
Satellite Symposium - Treatment of Severe Osteoporosis: an update - supported by Lilly
Epidemiology of Fragility Fractures: an update
Southampton, UK
Sat 18 15:50
Satellite Symposium - Treatment of Severe Osteoporosis: an update - supported by Lilly
Effects of Bone Active Agents on Cortical Bone
Sat 18 16:15
Satellite Symposium - Treatment of Severe Osteoporosis: an update - supported by Lilly
Role of Gender and Etiology in the Response to Bone Active Agents in Patients with Osteoporosis
Hamilton, Canada
Sat 18 16:50
Satellite Symposium - Treatment of Severe Osteoporosis: an update - supported by Lilly
Q & A and Closing Remarks
Sat 18 17:00
BREAK
Sat 18 17:15
Opening Ceremony
Auditorium I
Sat 18 17:15
Opening Ceremony
Welcome to the congress from the ECTS President
Aarhus, Denmark
Sat 18 17:20
Opening Ceremony
Welcome to Lisbon from the Chair of the Local Organising Committee
Lisbon, Portugal
Sat 18 17:30
Opening Ceremony: ECTS 50th Anniversary Symposium: 50 years of research in bone and mineral metabolism
Supported by Amgen in collaboration with GSK
Sat 18 17:30
OPC1
Opening Ceremony: ECTS 50th Anniversary Symposium: 50 years of research in bone and mineral metabolism
50 years of progress in bone biology
Boston, USA
Sat 18 18:00
OPC2
Opening Ceremony: ECTS 50th Anniversary Symposium: 50 years of research in bone and mineral metabolism
50 years of progress in bone imaging
San Francisco, USA
Sat 18 18:30
OPC3
Opening Ceremony: ECTS 50th Anniversary Symposium: 50 years of research in bone and mineral metabolism
50 years of progress in treatment of bone diseases
Oxford, UK
Sat 18 19:00
Awards 1 - 2013 ECTS / AMGEN BONE BIOLOGY FELLOWSHIP, 2013 ECTS / THE ALLIANCE FOR BETTER BONE HEALTH (WARNER CHILCOTT AND SANOFI) IAIN T BOYLE AWARD, 2013 ECTS PHILIPPE BORDIER CLINICAL AWARD, 2013 ECTS MIKE HORTON BASIC/TRANSLATIONAL AWARD
Auditorium I
Sat 18
Awards 1 - 2013 ECTS / AMGEN BONE BIOLOGY FELLOWSHIP, 2013 ECTS / THE ALLIANCE FOR BETTER BONE HEALTH (WARNER CHILCOTT AND SANOFI) IAIN T BOYLE AWARD, 2013 ECTS PHILIPPE BORDIER CLINICAL AWARD, 2013 ECTS MIKE HORTON BASIC/TRANSLATIONAL AWARD
2010 ECTS / SERVIER FELLOWSHIP,
Lisbon, Portugal
Sat 18 19:15
50th Anniversary Welcome Reception
Following the Opening Ceremony, we are delighted to invite all delegates to attend the Anniversary Welcome Reception to help us celebrate our 50-year anniversary. Complimentary drinks and refreshments and entertainment will be available, continuing with a pay bar into the late evening.
LISBON CONGRESS CENTRE
Sun 19 07:30
REGISTRATION OPEN
Sun 19 08:00
Symposium 1: Developmental origins of metabolic bone disease
Auditorium I
Chairs: Tim Spector (London, UK) & Jácome Bruges Armas (Porto, Portugal)
Sun 19 08:00
S1.1
Symposium 1: Developmental origins of metabolic bone disease
Developmental epigenetics and the intrauterine origins of chronic disease
Southampton, UK
Sun 19 08:30
S1.2
Symposium 1: Developmental origins of metabolic bone disease
Maternal environment and intrauterine skeletal development
Oxford, UK
Sun 19 09:00
Plenary Orals 1
Osteoporosis epidemiology and long term treatment complications
Auditorium I
Chairs: Bo Abrahamsen (Copenhagen, Denmark) & Katharina Jähn (Hamburg Germany)
Sun 19 09:00
OC1.1
Plenary Orals 1
Disease-specific perception of fracture risk and incident fracture rates among postmenopausal women: findings from the Global Longitudinal Study of Osteoporosis in Women (GLOW)
Bristol, UK
Sun 19 09:10
OC1.2
Plenary Orals 1
Hip fractures and bone mineral density of the elderly - importance of serum 25-hydroxy vitamin D
Reykjavik, Iceland
Sun 19 09:20
OC1.3
Plenary Orals 1
Size at birth is not associated with risk of hip fracture. Results from two population-based cohorts
Uppsala, Sweden
Sun 19 09:30
OC1.4
Plenary Orals 1
Intake and serum levels of α-tocopherol in relation to fractures in elderly women and men
Sun 19 09:40
OC1.5
Plenary Orals 1
Heart failure in patients treated with bisphosphonates
Aalborg, Denmark
Sun 19 09:50
OC1.6
Plenary Orals 1
Femur Geometrical Parameters in the Pathogenesis of Atypical Femur Fractures
Montréal, Canada
Sun 19 09:00
Plenary Orals 2
Bone quality and fracture repair - animal models
Auditorium II
Chairs: Martine Cohen-Solal (Paris, France) & Joana Caetano-Lopes (Lisbon, Portugal)
Sun 19 09:00
OC2.1
Plenary Orals 2
Treatment With Soluble Activin Type IIB-Receptor Improves Bone Mass And Strength In A Mouse Model Of Duchenne Muscular Dystrophy
Turku, Finland
Sun 19 09:10
OC2.2
Plenary Orals 2
Intermittent human parathyroid hormone (1-84) treatment improves bone mass and bone defect healing in rats with type 2 diabetes mellitus
Dresden, Germany
Sun 19 09:20
OC2.3
Plenary Orals 2
Low-magnitude high-frequency vibration (LMHFV) improves fracture healing in aged, ovariectomized mice
Ulm, Germany
Sun 19 09:30
OC2.4
Plenary Orals 2
PPAR beta deficiency induces muscle and bone loss with aging but does not impair the bone biomechanical response to loading: a sarco-osteopenic mouse model
Geneva, Switzerland
Sun 19 09:40
OC2.5
Plenary Orals 2
Glucagon-like peptide 1 receptor is required for optimal bone strength and quality
Angers, France
Sun 19 09:50
OC2.6
Plenary Orals 2
Growth hormone excess in bGH transgenic mice adversely affects bone density, architecture and quality
London, UK
Sun 19 10:00
COFFEE AND POSTERS
Sun 19 11:00
Workshop 1: Fat and bone
Auditorium I
Chairs: João Eurico Fonseca (Lisbon, Portugal) & Barbara Obermayer-Pietsch (Graz, Austria)
Sun 19 11:00
W1.1
Workshop 1: Fat and bone
Effects of fat on bone: location and age matter
Sheffield, UK
Sun 19 11:30
W1.2
Workshop 1: Fat and bone
Anorexia and bone
Boston, USA
Sun 19 12:00
W1.3
Workshop 1: Fat and bone
Obesity,bariatric surgery and bone
Sun 19 11:00
Workshop 2: Developmental biology and bone
Auditorium II
Chairs: Tim Arnett (London, UK) & Andrea del Fattore
Sun 19 11:00
W2.1
Workshop 2: Developmental biology and bone
Fish as a model organism for mineralization related pathologies
Faro, Portugal
Sun 19 11:30
W2.2
Workshop 2: Developmental biology and bone
Chondrocyte growth and differentiation during endochondral ossification
Essen, Germany
Sun 19 12:00
W2.3
Workshop 2: Developmental biology and bone
Bone shaping by muscle force during embryogenesis
Rehovot, Israel
Sun 19 12:30
LUNCH AND POSTERS
Sun 19 12:45
Meet the Professor Parallel Sessions
Sun 19 12:45
MTP1
Meet the Professor Parallel Sessions
ECTS Excellence in Research Lecture: Methods for assessing bone microstructure - AUDITORIUM III
London, UK
Sun 19 12:45
MTP2
Meet the Professor Parallel Sessions
The wnt signalling in and out of bone - AUDITORIUM IV
Boston, USA
Sun 19 12:45
MTP3
Meet the Professor Parallel Sessions
Epigenetic regulation: what and why? - Room 5A
Southampton, UK
Sun 19 12:45
MTP4
Meet the Professor Parallel Sessions
Fish as a model system for exploring skeletal development and regeneration - Room 5B
Faro, Portugal
Sun 19 12:45
MTP5
Meet the Professor Parallel Sessions
Mineralisation: the key role of extracellular ATP - Room 5C
London, UK & Isabelle Orriss
Sun 19 12:45
New Investigator Workshop 1
Auditorium II
Chair: Tim Spector (London, UK)
Sun 19
NIW1
New Investigator Workshop 1
Genomics and proteomics as emerging technologies in bone research
Rotterdam, The Netherlands
Sun 19 13:45
Symposium 2: Sarcopenia – causes and consequences
Joint Session with ASBMR
Auditorium I
Chairs: Steven Boonen (Leuven, Belgium) & José Melo-Gomes (Lisbon, Portugal)
Sun 19 13:45
S2.1
Symposium 2: Sarcopenia – causes and consequences
Skeletal muscle loss: sarcopenia and inactivity
Liverpool, UK
Sun 19 14:15
S2.2
Symposium 2: Sarcopenia – causes and consequences
Sarcopenia: Prevalence and consequences
Boston, USA
Sun 19 14:45
Awards 2
Previous Grant Winner Presentations
Auditorium I
Sun 19
Awards 2
2010 ECTS POSTDOCTORAL FELLOWSHIP
Zurich, Switzerland
Sun 19
Awards 2
2010 ECTS PHD STUDENTSHIP
Aberdeen, UK
Sun 19
Awards 2
2010 ECTS CAREER ESTABLISHMENT AWARD
Sun 19 15:00
Oral Posters 1: Pre-clinical
Auditorium I
Chairs: Miep Helfrich (Aberdeen, UK) & Sandra Casimiro (Lisbon, Portugal)
Sun 19 15:00
OP21
Oral Posters 1: Pre-clinical
IGF-1 regulates MC-3T3 and human primary osteoblast to osteocyte differentiation in 3D culture
Cardiff, UK
Sun 19 15:05
OP22
Oral Posters 1: Pre-clinical
The Effect of mTORC1 on Postnatal Skeletal Development
Adelaide, Australia
Sun 19 15:10
OP23
Oral Posters 1: Pre-clinical
MEK inhibitors in fracture healing and NF1 pseudarthrosis
Sun 19 15:15
OP24
Oral Posters 1: Pre-clinical
Identification and Characterization of a Mesenchymal Progenitor Cell Population Involved in Fracture Healing
Farmington, USA
Sun 19 15:20
OP25
Oral Posters 1: Pre-clinical
Oxygen tension-mediated regulation of chondrogenic differentiation: application to stem cells based osteochondral repair
Nantes, France
Sun 19 15:25
OP26
Oral Posters 1: Pre-clinical
Bone is the main target of activation of Canonical Wnt pathway in osteoarthritis
Paris, France
Sun 19 15:30
OP27
Oral Posters 1: Pre-clinical
Milk fat globule-epidermal growth factor 8 (MFG-E8) is a critical determinant of bone mass and alters the course of inflammation in arthritis
Dresden, Germany
Sun 19 15:35
OP28
Oral Posters 1: Pre-clinical
Functional assessment of Paget's disease-causing mutations in Sequestosome-1 (SQSTM1)
Aberdeen, UK
Sun 19 15:40
OP29
Oral Posters 1: Pre-clinical
miR-192 Impairs Invasion and Tumor-Induced Osteolysis by Repressing CCL2 in Bone Metastatic Colonization
Pamplona, Spain
Sun 19 15:45
OP30
Oral Posters 1: Pre-clinical
Clusterin Inhibition using OGX-011 Synergistically Enhances Zoledronic Acid Activity in Osteosarcoma.
Nantes, France
Sun 19 15:50
Oral Posters 1: Pre-clinical
Q&A
Sun 19 15:00
Oral Posters 1: Clinical
Auditorium II
Chairs: Robert Lindsay (West Haverstraw, USA) & Isabelle Orriss
Sun 19 15:00
PP384
Oral Posters 1: Clinical
Does Vitamin D status impact on hip fracture incidence? - evidence of fracture variation with latitude and season in Sweden
Sun 19 15:05
OP2
Oral Posters 1: Clinical
Meta-Analysis of the Effects of Vitamin D Supplements on Bone Mineral Density in Adults
Auckland, New Zealand
Sun 19 15:10
OP3
Oral Posters 1: Clinical
The risk of fractures in cirrhosis and chronic pancreatitis. A Danish nationwide retrospective matched cohort study
Hvidovre, Denmark
Sun 19 15:15
OP4
Oral Posters 1: Clinical
Relationship between bone mineral density, body composition, skin sclerosis and serum 25(OH) vitamin D levels in  systemic sclerosis
Foggia, Italy
Sun 19 15:20
PP22
Oral Posters 1: Clinical
Generalized Long Term Bone Loss in Early Rheumatoid Arthritis in the Biologic Treatment Era - A 10 Year prospective Observational Study
Bærum, Norway
Sun 19 15:25
OP6
Oral Posters 1: Clinical
Cortical and Trabecular Alterations in Patients with Bone Marrow Edema of the Lower Limb
Vienna, Austria
Sun 19 15:30
OP7
Oral Posters 1: Clinical
Bone Marrow Fat Is Metabolically Distinct Fat Depot
Sun 19 15:35
OP8
Oral Posters 1: Clinical
Genome-Wide Association Study meta-analysis identifies the SOAT1/AXDND1 locus to be associated with hip and forearm fracture risk
Umeå, Sweden
Sun 19 15:40
OP9
Oral Posters 1: Clinical
Interaction between FGF23 R176W mutation and C716T nonsynonymous change (T239M, rs 7955866) in FGF23 on the clinical phenotype in a family with autosomal dominant hypophosphatemic rickets
Siena, Italy
Sun 19 15:45
OP10
Oral Posters 1: Clinical
Regional heterogeneity of trabecular bone microdamage density in association with trabecular microarchitecture and bone resorption in whole human lumbar vertebrae
Paris, France
Sun 19 15:50
Oral Posters 1: Clinical
Q&A
Sun 19 16:00
COFFEE
Sun 19 16:30
Educational Symposium 1
ECTS-OARSI joint educational symposium on Osteoarthritis.
Supported by Biocientifica
Auditorium II
Chairs: Stuart Ralston & Virginia Kraus
Sun 19 16:30
Educational Symposium 1
Chair's Welcome
Sun 19 16:40
ES1.1
Educational Symposium 1
Epidemiology
Keele, UK
Sun 19 17:05
ES1.2
Educational Symposium 1
Disease mechanisms
Newcastle, UK
Sun 19 17:30
ES1.3
Educational Symposium 1
Management of osteoarthritis
Paris, France
Sun 19 18:00
BREAK
Sun 19 18:30
Satellite Symposium - Current and Future Strategies for the Management of Osteoporosis: Signaling a Change in the Conversation - Supported by MSD
MSD
Auditorium I
Chair: Jose Antonio Melo-Gomes
Sun 19
Satellite Symposium - Current and Future Strategies for the Management of Osteoporosis: Signaling a Change in the Conversation - Supported by MSD
Welcome & Introductions
Sun 19 18:35
Satellite Symposium - Current and Future Strategies for the Management of Osteoporosis: Signaling a Change in the Conversation - Supported by MSD
Optimizing Therapy in Osteoporosis
Paris, France
Sun 19 18:55
Satellite Symposium - Current and Future Strategies for the Management of Osteoporosis: Signaling a Change in the Conversation - Supported by MSD
The Impact of Selective Cathepsin K Inhibition on Bone Homeostatis
Boston, USA
Sun 19 19:15
Satellite Symposium - Current and Future Strategies for the Management of Osteoporosis: Signaling a Change in the Conversation - Supported by MSD
Odanacatib: A Novel Approach to the Treatment of Osteoporosis
Melbourne, Australia
Sun 19 19:35
Satellite Symposium - Current and Future Strategies for the Management of Osteoporosis: Signaling a Change in the Conversation - Supported by MSD
Q & A and Closing Remarks
Sun 19 20:00
ECTS New Investigator Seminar and Social Gathering
Auditorium II
Chairs: Riku Kiviranta & Andrea del Fattore & Davide Ruffoni
Sun 19 20:00
ECTS New Investigator Seminar and Social Gathering
Plenary Session: Bone Research – The Next 50 Years
Boston, USA
Sun 19 20:00
ECTS New Investigator Seminar and Social Gathering
Plenary Session: Bone Research – The Next 50 Years
San Francisco, USA
Sun 19 20:00
ECTS New Investigator Seminar and Social Gathering
Plenary Session: Bone Research – The Next 50 Years
Oxford, UK
Sun 19 21:00
PP27
ECTS New Investigator Seminar and Social Gathering
Sclerostin/MEPE axis in OA: lessons from long bone development
Edinburgh, Scotland
Sun 19 21:05
PP31
ECTS New Investigator Seminar and Social Gathering
A GWAS in an extreme high bone mass population shows exess signal from genes associated with BMD in normal population
Bristol, UK
Sun 19 21:10
PP38
ECTS New Investigator Seminar and Social Gathering
Bisphosphonate influence on bone quality at molecular level: study of human jaw bone sequesters by Raman microspectroscopy
Lille, France
Sun 19 21:15
PP139
ECTS New Investigator Seminar and Social Gathering
New PI3Kalpha-specific inhibitor, BYL719: therapeutic interest in osteosarcoma
NANTES cedex, France
Sun 19 21:20
PP175
ECTS New Investigator Seminar and Social Gathering
Identification of a small molecule kinase inhibitor that enhances osteoblast differentiation of human skeletal (mesenchymal) stem cells through regulation of TGFβ signaling
Odense C, Denmark
Sun 19 21:25
PP230
ECTS New Investigator Seminar and Social Gathering
Depletion of the autophagy adaptor OPTN leads to increased osteoclast formation, fusion and survival as well as increase NF-κB activation in vitro
Edinburgh, UK
Sun 19 21:30
PP282
ECTS New Investigator Seminar and Social Gathering
Phenotypic dissection of bone mineral density facilitates the identification of skeletal site specificity on the genetic regulation of bone
(Bristol, UK)
Sun 19 21:35
PP383
ECTS New Investigator Seminar and Social Gathering
Detection of autoantibodies to osteoprotegerin in patients with rheumatoid arthritis and their association with disease activity
Edinburgh, UK
Mon 20 07:30
REGISTRATION OPEN
Mon 20 08:00
Symposium 3: Extreme bone phenotypes
Auditorium I
Chairs: Anna Teti (L’Aquila, Italy) & Jirko Kuehnisch
Mon 20 08:00
S3.1
Symposium 3: Extreme bone phenotypes
Diagnosis and clinical management of of genetic skeletal disorders
Istanbul, Turkey
Mon 20 08:30
S3.2
Symposium 3: Extreme bone phenotypes
Insights from research in bone genetics: what do genetic skeletal disorders tell us on bone physiology?
Lausanne, Switzerland
Mon 20 09:00
Plenary Orals 3
Osteoporosis pathophysiology and genetics
Auditorium I
Chairs: Andre Uitterlinden (Rotterdam, The Netherlands) & Ana Maria Rodrigues (Lisbon, Portugal)
Mon 20 09:00
OC3.1
Plenary Orals 3
Heavy cannabis use negatively impacts on bone density - a population based prospective study
Edinburgh, UK
Mon 20 09:10
PP277
Plenary Orals 3
A genomic and transcriptomic approach to the high bone mass phenotype: evidence of heterogeneity and of additive effects of TWIST1, IL6R, DLX3 and PPARG
Barcelona, Spain
Mon 20 09:20
OC3.3
Plenary Orals 3
Distinct relationships of intramuscular and subcutaneous fat with cortical bone: findings from a cross-sectional study of young adult males and females
Bristol, UK
Mon 20 09:30
OC3.4
Plenary Orals 3
Cortical exceeds trabecular bone loss before menopause but net bone loss is modest because periosteal apposition occurs
Tromsø, Norway
Mon 20 09:40
OC3.5
Plenary Orals 3
Genome-wide association identifies a new susceptibility locus at 4q35 associated with clinical vertebral fractures in post-menopausal women: The GEFOS-GENOMOS consortium.
Edinburgh, UK
Mon 20 09:50
OC3.6
Plenary Orals 3
Causal metabolomic pathways to osteoporosis in elderly women
London, UK
Mon 20 09:01
Plenary Orals 4
Osteoblasts and osteocytes
Auditorium II
Mon 20 09:00
OC4.1
Plenary Orals 4
High-Throughput DEXA and MicroCT Screening in Gene Knockout Mice Identifies Bone Mass Phenotypes
Texas, USA
Mon 20 09:10
OC4.2
Plenary Orals 4
The p38alpha MAPK pathway in osteoblasts contributes to ovariectomy-induced bone loss by upregulating interleukin-6 expression
Geneva, Switzerland
Mon 20 09:20
OC4.3
Plenary Orals 4
Severe osteopenia, increased bone marrow adipogenesis and fibronectin matrix changes in mice lacking both TG2 and FXIIIA transglutaminases
Montreal, Canada
Mon 20 09:30
OC4.4
Plenary Orals 4
Glucocorticoid exposure reduces expression of sclerostin in bone marrow stromal cells
Dresden, Germany
Mon 20 09:40
OC4.5
Plenary Orals 4
Mechanical loading increases the effect of sclerostin antibody treatment in a mouse model of high turnover osteoporosis
Zurich, Switzerland
Mon 20 09:50
OC4.6
Plenary Orals 4
Periostin (Postn) synergizes with osteocytes beta-catenin to mediate the adaptive skeletal response to loading
Geneva, Switzerland
Mon 20 10:00
COFFEE AND POSTERS
Mon 20 10:00
AGM
Auditorium I
Mon 20 11:00
Workshop 3: Vertebral fractures
Auditorium I
Chairs: Richard Eastell (Sheffield, UK) & José António Pereira Silva (Coimbra, Portugal)
Mon 20 11:00
W3.1
Workshop 3: Vertebral fractures
The impact of vertebral fractures on morbidity and mortality
Barcelona, Spain
Mon 20 11:30
W3.2
Workshop 3: Vertebral fractures
How are vertebral fractures best detected and diagnosed?
(Bristol, UK)
Mon 20 12:00
W3.3
Workshop 3: Vertebral fractures
Treatment of vertebral fractures
Lisbon, Portugal
Mon 20 11:00
Workshop 4: Osteoclast activity and haematopoiesis
Auditorium II
Chairs: Hans van Leeuwen (Rotterdam, The Netherlands) & Ines Perpetuo (Lisbon, Portugal)
Mon 20 11:00
W4.1
Workshop 4: Osteoclast activity and haematopoiesis
The relationship between osteoclasts and haematopoiesis
London, UK
Mon 20 11:30
W4.2
Workshop 4: Osteoclast activity and haematopoiesis
Are osteoclasts dispensable for haematopoietic stem cell maintenance and mobilization?
Nice, France
Mon 20 12:00
W4.3
Workshop 4: Osteoclast activity and haematopoiesis
Osteoclasts and haematopoietic stem cell transplantation in clinical practice
Ulm, Germany
Mon 20 12:30
LUNCH AND POSTERS
Mon 20 12:45
Meet the Professor Sessions
Mon 20 12:45
MTP6
Meet the Professor Sessions
Bone Pain - Auditorium III
Copenhagen, Denmark
Mon 20 12:45
MTP7
Meet the Professor Sessions
Clinical utility of bone turnover markers - Auditorium IV
Mon 20 12:45
MTP8
Meet the Professor Sessions
What does bone genetics tell us on bone physiology - Room 5A
Edinburgh, UK
Mon 20 12:45
MTP9
Meet the Professor Sessions
Failure of osteoporosis treatment - Room 5B
Barcelona, Spain
Mon 20 12:45
MTP10
Meet the Professor Sessions
New osteoporosis treatment modalities - Room 5C
Lisbon, Portugal
Mon 20 12:45
New Investigator Workshop 2
Auditorium II
Mon 20
NIW2
New Investigator Workshop 2
How to manage your research time and team
Huddinge, Sweden
Mon 20 13:45
ECTS / ASBMR Clinical Debate: This house believes that muscle, not bone, is the preferred target to reduce non-vertebral fractures
Auditorium I
Chairs: Bente Langdahl (Aarhus, Denmark) & Jane Lian (Burlington, USA)
Mon 20
ECTS / ASBMR Clinical Debate: This house believes that muscle, not bone, is the preferred target to reduce non-vertebral fractures
Against the Motion
Mon 20
ECTS / ASBMR Clinical Debate: This house believes that muscle, not bone, is the preferred target to reduce non-vertebral fractures
In Support of the Motion
Mon 20 15:00
Oral Posters 2: Pre-clinical
Auditorium II
Chairs: Peter Croucher (Sydney, Australia) & Inês Perpétuo (Lisbon, Portugal)
Mon 20 15:00
OP31
Oral Posters 2: Pre-clinical
ADIPOGENESIS OCCURS AT THE EXPENSE OF OSTEOBLAST DIFFERENTIATION IN PRIMARY OSTEOBLASTS DEFICIENT IN PROTEASE-ACTIVATED RECEPTOR-2
Parkville, Australia
Mon 20 15:05
OP32
Oral Posters 2: Pre-clinical
Hepatic lipase is expressed by osteoblasts and modulates bone remodeling in obesity
Mon 20 15:10
OP33
Oral Posters 2: Pre-clinical
Regulation and function of immunosuppressive molecule human leukocyte antigen G5 in human bone tissue
Toulouse, France
Mon 20 15:15
OP34
Oral Posters 2: Pre-clinical
Activation of the Parathyroid Hormone-Receptor is Involved in the Pro-survival Effect of Hypotonic Shock in Osteocyte-like MLO-Y4 Cells
Madrid, Spain
Mon 20 15:20
OP35
Oral Posters 2: Pre-clinical
Effects of a mutated sclerostin peptide on bone and lean mass in mice.
Geneva, Switzerland
Mon 20 15:25
OP36
Oral Posters 2: Pre-clinical
N-Cadherin Governs Age-Related Determination in Mice Through Modulation of Wnt5a and Wnt10b.
Paris, France
Mon 20 15:30
OP37
Oral Posters 2: Pre-clinical
The D477N mutation in OPTN leads to increased bone turnover and enhanced osteoclast formation in OptnD477N/D477N mice
Edinburgh, UK
Mon 20 15:35
OP38
Oral Posters 2: Pre-clinical
BMP-9 induces the calcification of vascular smooth muscle cells.
Edinburgh, UK
Mon 20 15:40
OP39
Oral Posters 2: Pre-clinical
Thrombin receptor deficiency leads to osteopetrosis by decreasing the RANKL/OPG ratio
Mon 20 15:45
OP40
Oral Posters 2: Pre-clinical
Insertion of the clcn7 gene mutation pG213R in mouse induces Autosomal Dominant Osteopetrosis Type II (ADO2).
Rome, Italy
Mon 20 15:00
Oral Posters 2: Clinical
Auditorium I
Chairs: Jon Tobias (Bristol, UK) & Nerea Alonso Lopez
Mon 20 15:00
OP11
Oral Posters 2: Clinical
Health economic consequences of fractures in patients with osteoporosis: A national register based study of total and incremental health costs following fracture.

Unknown speaker

Holbæk, Denmark
Mon 20 15:05
OP12
Oral Posters 2: Clinical
Fracture Risk Assessment In A Primary Care Population: Case Finding Using Routine GP Data and a health reporting, analysis & intelligence delivery tool, In The United Kingdom
Newcastle upon Tyne, UK
Mon 20 15:10
OP13
Oral Posters 2: Clinical
Hip Fracture Trends in Denmark 1980-2010 with Age-Period-Cohort-effects
Malmo, Sweden
Mon 20 15:15
OP14
Oral Posters 2: Clinical
Impact of hip fracture on mortality and life expectancy
Mon 20 15:20
OP15
Oral Posters 2: Clinical
Fracture risk among men, in relation to osteopenia and osteoporosis defined by areal bone mineral density.
Geelong, Australia
Mon 20 15:25
OP16
Oral Posters 2: Clinical
Long-term effects of symptomatic versus intensive bisphosphonate therapy for Paget's disease of bone: The PRISM-EZ study.
Edinburgh, UK
Mon 20 15:30
OP17
Oral Posters 2: Clinical
Denosumab is associated with progressive improvements in hip cortical mass and thickness
Zug, Switzerland
Mon 20 15:35
OP18
Oral Posters 2: Clinical
Effects of Odanacatib on BMD and Safety in the Treatment of Osteoporosis in Postmenopausal Women Previously Treated with Alendronate- A Randomized Placebo-Controlled trial
Mon 20 15:40
OP19
Oral Posters 2: Clinical
Effects of Sclerostin Antibody and Maintenance of New Bone Induced by Sclerostin Antibody in Animal Models
Thousand Oaks, USA
Mon 20 15:45
OP20
Oral Posters 2: Clinical
Resolution of Effects on Bone Turnover Markers and Bone Mineral Density after Discontinuation of Long-term Bisphosphonate Use 
North Wales, USA
Mon 20 16:00
COFFEE
Mon 20 16:30
Educational Symposium 2
Approach to the finding of abnormal laboratory results
Supported by Alexion & IDS
Auditorium II
Chairs: Núria Guañabens (Barcelona, Spain) & Martina Rauner
Mon 20 16:40
ES2.1
Educational Symposium 2
Low alkaline phosphatase
St Louis, USA
Mon 20 17:05
ES2.2
Educational Symposium 2
Low phosphate
Tokushima, Japan
Mon 20 17:30
ES2.3
Educational Symposium 2
Low vitamin D
Mon 20 18:00
BREAK
Mon 20 18:30
Satellite Symposium - New evidence for osteoporosis therapy - Supported by Amgen in collaboration with GSK
Including panel discussion
Supported by Amgen in collaboration with GSK
Auditorium I
Chairs: Bente Langdahl (Aarhus, Denmark) & Jose Pereira Da Silva (Coimbra, Portugal)
Mon 20 18:35
Satellite Symposium - New evidence for osteoporosis therapy - Supported by Amgen in collaboration with GSK
Denosumab : valuable for my patients at increased risk for hip fracture?
Leuven, Belgium
Mon 20 19:00
Satellite Symposium - New evidence for osteoporosis therapy - Supported by Amgen in collaboration with GSK
What is the relevance for BMD increase in fracture risk reduction?
Mon 20 19:25
Satellite Symposium - New evidence for osteoporosis therapy - Supported by Amgen in collaboration with GSK
Transitioning osteoporosis therapies: what is the evidence?
Vienna, Austria
Tue 21 07:30
REGISTRATION OPEN
Tue 21 08:00
Symposium 4: Energy metabolism and bone
Auditorium I
Chairs: Lorenz Hofbauer (Dresden, Germany) & Astrid Bakker
Tue 21 08:00
S4.1
Symposium 4: Energy metabolism and bone
Energy metabolism, bone and reproduction
Tue 21 08:30
S4.2
Symposium 4: Energy metabolism and bone
Sweet bones - the effect of diabetes on bone
Tue 21 09:00
Orals 5 - Treatment of osteoporosis
Auditorium I
Chairs: John Eisman (Sydney, Australia) & Ana Maria Rodrigues
Tue 21 09:00
OC5.1
Orals 5 - Treatment of osteoporosis
A Three Year Randomized Sham-Controlled Trial of Low Magnitude Mechanical Stimulation in an Elderly Sample:  The "VIBES" Trial
Boston, USA
Tue 21 09:10
OC5.2
Orals 5 - Treatment of osteoporosis
Fracture Risk Factors During Treatment With Denosumab
Tue 21 09:20
OC5.3
Orals 5 - Treatment of osteoporosis
Effect of blosozumab on bone mineral density: Results of a Phase 2 study of postmenopausal women with low bone mineraly density
indianapolis, USA
Tue 21 09:30
OC5.4
Orals 5 - Treatment of osteoporosis
Effects of Romosozumab Administration on Trabecular and Cortical Bone Assessed With Quantitative Computed Tomography and Finite Element Analysis
Thousand Oaks, USA
Tue 21 09:40
OC5.5
Orals 5 - Treatment of osteoporosis
Bone Anabolic Efficacy and Safety of BA058, A Novel Analog of hPTHrP: 12 Month Extension Data from a Phase 2 Clinical Trial in Postmenopausal Women with Osteoporosis
MA, USA
Tue 21 09:50
OC5.6
Orals 5 - Treatment of osteoporosis
Testosterone Replacement has a Substantial Benefit on Bone Mass, Fracture Incidence, Libido and Sexual Activities in Male Cardiac Transplant Patients: A 5 Year Randomized Prospective Controlled Trial
Graz, Austria
Tue 21 09:00
Orals 6 - Mineralisation and energy metabolism
Auditorium II
Chairs: Graham Russell (Oxford, UK) & Eugénia Simões (Lisbon, Portugal)
Tue 21 09:00
OC6.1
Orals 6 - Mineralisation and energy metabolism
NPP1 (ecto-nucleotide pyrophosphatase/phosphodiesterase 1) is a key regulator of skeletal and soft tissue mineralisation
London, UK
Tue 21 09:10
OC6.2
Orals 6 - Mineralisation and energy metabolism
Deficiency of the bone mineralisation inhibitor NPP1 protects against obesity and diabetes
Paisley, UK
Tue 21 09:20
OC6.3
Orals 6 - Mineralisation and energy metabolism
Collagen XV as a bone matrix organizer
Oulu, Finland
Tue 21 09:30
OC6.4
Orals 6 - Mineralisation and energy metabolism
Inhibition of PTH-induced vasorelaxation modulates its anabolic action
London, UK
Tue 21 09:40
OC6.5
Orals 6 - Mineralisation and energy metabolism
A protective role for FGF23 in local defence against disrupted arterial wall integrity?
Edinburgh, UK
Tue 21 09:50
OC6.6
Orals 6 - Mineralisation and energy metabolism
An Emerging Role of PHOSPHO1 in the Regulation of Energy Metabolism 
Midlothian, UK
Tue 21 10:00
COFFEE AND POSTERS
Tue 21 11:15
Workshop 5: Anabolic bone therapies
Auditorium I
Chairs: Roland Baron (Boston, USA) & Eric Hesse
Tue 21 11:15
W5.1
Workshop 5: Anabolic bone therapies
The effect of PTH on fracture healing
Graz, Austria
Tue 21 11:45
W5.2
Workshop 5: Anabolic bone therapies
Wnt signaling - a clinical drug target
Boston, USA
Tue 21 12:15
W5.3
Workshop 5: Anabolic bone therapies
Therapeutic targeting of activin signaling
Rotterdam, Netherlands
Tue 21 11:15
Workshop 6: Cancer cells and Bone
Auditorium II
Chairs: Aymen Idris (Edinburgh, UK) & Hanna Taipaleenmaeki
Tue 21 11:15
W6.1
Workshop 6: Cancer cells and Bone
How do cancer cells home to bone?
Sydney, Australia
Tue 21 11:45
W6.2
Workshop 6: Cancer cells and Bone
Biology and clinical relevance of circulating tumour cells
Hamburg, Germany
Tue 21 12:15
W6.3
Workshop 6: Cancer cells and Bone
Clinical decision making in metastatic bone disease
Marburg, Germany
Tue 21 12:45
LUNCH AND POSTERS
Tue 21 13:00
Meet the Professor Sessions
Tue 21 13:00
MTP11
Meet the Professor Sessions
Long-term treatment of osteoporosis - Auditorium III
Tue 21 13:00
MTP12
Meet the Professor Sessions
Breast cancer treatment induced osteoporosis - pathophysiology, prevention and treatment - Auditorium IV
Marburg, Germany
Tue 21 13:00
MTP13
Meet the Professor Sessions
Arthritis, inflammation and bone: from bench to bedside - Room 5A
Lisboa, Portugal
Tue 21 13:00
MTP14.1
Meet the Professor Sessions
ERC Grants - Room 5B
Edinburgh, UK
Tue 21 13:00
MTP14.2
Meet the Professor Sessions
EU-Funding - Room 5B
Lisbon, Portugal
Tue 21 13:00
MTP15
Meet the Professor Sessions
State-of the-Art techniques in Bone research - Room 5C
Lisbon, Portugal
Tue 21 13:00
New Investigator Workshop 3
Auditorium II
Tue 21 13:00
NIW3
New Investigator Workshop 3
How to get started as a posdoc
Dresden, Germany
Tue 21 14:00
Symposium 5: Uncoupling of resorption and formation
Auditorium I
Chairs: Viviana Tavares (Lisbon, Portugal) & Erik Fink Eriksen (Oslo, Norway)
Tue 21 14:00
S5.1
Symposium 5: Uncoupling of resorption and formation
Novel antiresorptives - uncoupling or not?
Toyko, Japan
Tue 21 14:30
S5.2
Symposium 5: Uncoupling of resorption and formation
Effects of cathepsin K inhibition
Sydney, Australia
Tue 21 15:00
Closing Ceremony & Awards 3 - including 2013 ECTS NEW INVESTIGATOR AWARDS, 2013 ECTS ANNIVERSARY TRAVEL GRANTS, 2013 ECTS TRAVEL AWARDS, 2013 ECTS ALLIED HEALTH AWARD
Auditorium I

0 result(s) found.

Please wait...

     
      - 
     
     
     


    Abstracts from this event
      Abstracts from other events


          Session starts at:
          Abstract time:
        Event:


        Read full abstract